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ABSTRACT
The thoracic aortic wall can degenerate over time with catastrophic consequences.
Vascular smooth muscle cells (SMCs) can resist and repair artery damage but their
capacities decline with age and stress. Recently, cellular production of NAD+ via
nicotinamide phosphoribosyltransferase (Nampt) has emerged as a mediator of cell vitality.
However, a role for Nampt in aortic SMCs in vivo is unknown. The purpose of this thesis
was to determine if a Nampt-NAD+ control system exists within the aortic media and to
investigate the biological and clinical importance of such a system. An additional aim was
to determine if there was a requisite necessity for Nampt for adult mouse survival.
To study the role of Nampt in SMCs, mice with Nampt-deficient SMCs were
generated. SMC-Nampt knockout mice were viable but had mildly dilated aortas. Infusion
of angiotensin II led to aortic medial hemorrhage and dissection. SMCs were not apoptotic
but had indicators of premature senescence. Furthermore, there was evidence for oxidized
DNA lesions and DNA breaks.

This was linked to suppressed poly(ADP-ribose)

polymerase-1 activity and was reversible upon re-supplying NAD+ with nicotinamide
riboside (NR). Evaluating ascending aortas from patients with dilated aortopathy revealed
an inverse relationship between SMC NAMPT content and aortic diameter. Remarkably, I
discovered unrepaired DNA strand breaks in SMCs within the human ascending aorta,
which were specifically enriched in SMCs with low NAMPT. NAMPT promoter analysis
revealed CpG hypermethylation within the dilated human aorta and in SMCs cultured from
these tissues, which inversely correlated with NAMPT expression.
Global transcriptome analysis of Nampt knockout SMCs revealed a shift in gene
transcription. Transcripts associated with the production and assembly of collagens were
decreased, and transcripts associated with selected proteoglycans were increased. This was

i

associated with corresponding changes in extracellular matrix content in SMC-Nampt
knockout mouse aortas, which may be an additional reason for aortic wall vulnerability.
Finally, by generating a global inducible Nampt knockout mouse, I determined that
ablation of Nampt in the adult was lethal within 20 days. Interestingly, this early death was
not due to vascular SMC abnormalities but was associated with rapid degeneration of the
exocrine pancreas, gut epithelial abnormalities, and halted gastrointestinal transit of
undigested food. Remarkably, supplementing Nampt knockout mice with NR was able to
double their lifespan.
Collectively, my findings reveal new processes by which SMCs stay healthy and
functional, with important implications for mitigating the consequences of the
accumulation of the stresses that push blood vessels, and other organs, to catastrophic
failure.
Keywords:
Vascular smooth muscle cells, Aortic disease, Nampt, DNA damage, Cell senescence,
Extracellular matrix, Nicotinamide riboside
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CHAPTER 1 - GENERAL INTRODUCTION
Vascular smooth muscle cells (SMCs) are vital for regulating arterial tone and are
also major reparative cells of the artery wall. However, the ability of adult SMCs to
function with high fidelity declines with age and with environmental stress. This can lead
to vascular disease, including a predisposition to aortic aneurysms and dissections.
Accordingly, it is important to understand pathways that regulate the ability of human
SMCs to maintain a stress- and aging-resistant state in vivo.
The broad goal of my research was to elucidate the in vivo role of nicotinamide
phosphoribosyltransferase (Nampt), an NAD+ regenerating enzyme that increases
intracellular NAD+, with a particular emphasis on the aorta. In order to address this goal I
undertook four main aims:
1) To determine if Nampt-mediated NAD+ biosynthesis in smooth muscle cells was
required to maintain vascular stability in the mouse.
2) To determine if there is an association in humans between NAMPT expression and
aortopathy.
3) To determine the role of Nampt-mediated NAD+ regeneration in smooth muscle
cells in the context of the integrity of extracellular components of the aorta.
4) To determine the consequences of global loss of Nampt in the adult mouse and the
ability of nicotinamide riboside (NR) supplementation to mitigate the
consequences.
1.1
1.1.1

Vascular system in health and disease
Importance of vascular health
At the core of the human body is a system of blood-flowing conduits. It is through

this system that the heart pumps blood rich with oxygen and nutrients to every tissue in the
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body. Arteries transport blood away from the heart. Veins capture and return the blood to
the heart once oxygen and other nutrients have been delivered to the tissues and waste
products have been collected. The entirety of this network is the vascular system –
“vascular” being from the Latin meaning hollow container.
Diseases of the vascular system are a major factor contributing to global population
morbidity and mortality (Lloyd-Jones, D et al. 2010). The term “vascular disease” broadly
encompasses a great number of pathologies, and examples include: diseases relating to the
narrowing of cardiac or peripheral vessels (i.e. by the build-up of plaque in atherosclerotic
lesions or spontaneous spasm); the formation of blood clots; the disordered function of
veins or the valves therein (e.g. chronic venous insufficiency); and aortic aneurysms, either
thoracic or abdominal. Aneurysms can form in any blood vessel, but they occur most
commonly in the aorta which is the main blood vessel leaving the heart. The importance of
maintaining the integrity and proper functioning of the vascular system is underscored by
the reality that every tissue and organ is dependent on this network for delivery of oxygen
and nutrients and the removal of waste products generated by the normal function of each
terminal cell (Topol and Califf 2007).
1.1.2

Vessel morphology
The arterial side of the vascular system is a dynamic network that is able to control

the systemic delivery of blood oxygen and nutrients, and to respond to changes, even
sudden changes, in hemodynamic stresses. The healthy artery is comprised of 3 layers: the
outer tunica adventitia, the middle tunica media, and the inner (lumen-facing) tunica
intima. These layers are discrete, and are identifiable by their cellular components and
morphology. The outermost layer, the adventitia, is a loosely formed layer comprised of
fibroblasts, progenitor cells, and connective tissue, including collagen. The medial layer is
comprised mainly of layers of SMCs arranged in a mostly end-to-end fashion, interleaved
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with layers of elastin. SMCs regulate vessel tone through contraction. They also provide
structural integrity to the vessel wall through the synthesis and assembly of elastin and
collagen. The innermost layer, the intima, is a thin layer of endothelial cells, on top of a
specialized basement membrane composed of laminin, type IV collagen, and nidogen. The
intima is separated from the media by the internal elastic lamina, providing elasticity to the
arteries and allowing them to accommodate changes in blood pressure and flow. The media
is separated from the adventitia by the external elastic lamina (Fig. 1.1).
Vessels on the venous side of the vascular system function mainly as a collection
system for de-oxygenated blood and the waste products of cellular metabolism. The
cellular layers that make up a vein are similar to those that form an artery, however the
medial layer of SMCs is much thinner with fewer layers. As such, veins are less muscular,
contain less elastin, and have relatively larger lumen sizes.
Between the arterial system and venous system is an extensive bed of tiny vessels,
the thickness of one-to-two cell layers. This is where the delivery of oxygen and nutrients
to the tissues and organs occurs.
1.1.3

The aorta
The aorta is the largest blood vessel of the body, emerging directly from the heart

and serving as a conduit the rest of the vascular tree. The aorta begins at the aortic valve,
the most commonly replaced heart valve (Nishimura et al. 2014). The reasons for this
include congenital malformations (bicuspid) or age-related degeneration. The capacity of
the aorta to withstand a large and dynamic volume and pressure of blood that is pulsatile by
nature is upheld by the stretch-resistant capacity of SMCs and the elasticity of the internal
elastic lamina.
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Artery
tunica externa (adventitia)
tunica media
tunica intima
smooth muscle
internal elastic membrane

vaso vasorum
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Figure 1.1 Architecture of the vessel wall
Cross-sectional views of the arterial vessel (Top) and venous vessel (Bottom) walls. Vessel walls are
organized into three concentric layers, named: tunica externa (adventitia), tunica media, and tunica intima.
The tunica externa is mainly comprised of collagen fibres, fibroblasts, and the occasional small blood vessel
(vaso vasorum). The tunica media is comprised of smooth muscle cells, elastic fibres, and interstitial matrix –
predominantly collagen. The tunica intima is a thin layer of endothelial cells lining the lumen of the blood
vessel. Image adapted from “Types of Arteries and Arterioles” by Phil Schatz, Anatomy & Physiology.
OpenStax CNX. 2016 http://cnx.org/contents/14fb4ad7-39a1-4eee-ab6e-3ef2482e3e22@8.24
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1.1.4

Aortic diseases
The term “aortic disease” comprises a group of different pathologies of high

prevalence. Acute aortic dissection typically occurs when a small tear in the intimal layer
allows blood to enter into the medial space, which itself is often diseased and contains
degraded elastin and reduced SMC content. The pulsatile hemodynamic pressure forces
blood to travel along the medial layers, separating them to create a “false” lumen. Acute
aortic dissections are relatively uncommon in the broad population (approximately 3.5-6.0
per 100,000 patient-years) but have a high mortality rate (Mussa et al. 2016). Moreover,
dissections are much more prevalent in predisposed subpopulations with thoracic aortic
disease. Thoracic aortic disease comprises rare syndromic forms and common
nonsyndromic forms of thoracic aortic aneurysms (TAAs) and dissections (TAADs).
Mechanisms of TAA formation overlap those of aortic dissection and largely involve the
process that has historically been termed “cystic medial necrosis”, with focal degeneration
of the elastic and muscle tissue within the medial layer of the aortic wall. The aortic wall
subsequently weakens and dilates as a result of the high pressure of intraluminal blood
flow. Acquired and hereditary conditions can exacerbate the process of degeneration.
Chronic arterial hypertension is widely accepted as the most common acquired
condition that leads to aneurysm and dissection of the aorta. Nearly 75% of patients with
acute aortic dissection have a history of hypertension (Meszaros et al. 2000, Ramanath et
al. 2009). In a large series from the Mayo Clinic, hypertension was present in ~ 60% of
patients with a surgically resected thoracic aneurysm due to noninflammatory aortic
disease (Homme et al. 2006).
Heritable thoracic aortic disease (HTAD) refers to thoracic aortic disease caused by
mutation of a gene that confers a high risk for thoracic aortic disease. The most common
genetically inherited conditions that are associated HTAD include Marfan syndrome,
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vascular Ehlers-Danlos syndrome (or Ehlers-Danlos syndrome type IV), and Loeys-Dietz
syndrome (Ramanath et al. 2009). Moreover, up to 20% of individuals with thoracic aortic
disease who do not have features of Marfan syndrome, vEDS or Loeys-Dietz syndrome
have a family history, thus indicating that their disease is heritable (Biddinger et al. 1997).
Approximately 30% families with HTAD who do not have a clinical diagnosis of Marfan
syndrome or another syndrome have a causative pathogenic variant in one of the known
HTAD-related genes (Milewicz and Regalado 1993) (see Table 1).
Marfan syndrome may be the most prevalent amongst the etiologies, with an
incidence of approximately 1 in 10,000. The most common form of Marfan syndrome is
caused by a sequence variation of the fibrillin gene. The aortic pathology is characterized at
the histologic level by medial degeneration, abnormal extracellular matrix accumulation,
SMC loss, and elastin fragmentation (Halushka et al. 2016). Vascular Ehlers-Danlos
syndrome is a connective tissue disorder associated with a defect of either the expression or
assembly of type III procollagen, one of the collagen moieties present in high amounts in
the aortic media (Eagleton 2016). This syndrome is characterized by thin, translucent skin,
easy bruising, characteristic facial appearance, and arterial, intestinal, and/or uterine
fragility, and affected individuals are at risk for arterial rupture, aneurysm, and/or
dissection (Pepin et al. 1993). Loeys-Dietz syndrome, is associated with pathogenic genetic
variants of transforming growth factor beta receptors 1 and 2, Smad3, and the ligand
TGFβ-2 (Loeys and Dietz 1993). Patients with Loeys-Dietz syndrome manifest TAAs and
dissections in an autosomal dominant pattern of inheritance and at an early age of onset
(Loeys et al. 2006).
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Table 1-1 HTAD-related genes and syndromes
Syndrome/Disorder
Marfan
Loeys-Dietz

Vascular Ehlers-Danlos
Other

Associated genes
FBN-1; fibrillin-1
TGFBR1; TGF-β receptor 1
TGFBR2; TGF-β receptor 2
SMAD3; SMAD family member 3
TGFB2; TGF-β 2 ligand
TGFB3; TGF-β 3 ligand
COL3A1; type III procollagen
ACTA2; smooth muscle alpha-2-actin
MYH11; smooth muscle myosin heavy chain
MYLK; myosin light chain kinase
PRKG1; type I cGMP-dependent protein kinase regulating
smooth muscle cell relaxation
MFAP5; microfibril associated protein 5

(Milewicz and Regalado 1993, Goyal et al. 2017).
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Other congenital disorders can also result in susceptibility to aortic aneurysms
(Halushka et al. 2016). This includes: bicuspid aortic valve (BAV) disease (Edwards et al.
1978), coarctation of the aorta (Rosenthal 2005), tetralogy of Fallot (Rosenthal 2005), and
diverticulum of Kommerell (Kim et al. 2014). BAVs are among the most common
congenital heart abnormalities, occurring in approximately 2% of the population. It has
been established that there is an association between congenital BAVs, and proximal aortic
dilatation and aortic aneurysm/dissection (Ramanath et al. 2009). Patients with BAVs may
inherit a predisposition to medial degeneration of the aorta (McKusick 1972). Some studies
report that as many as half of all patients with a congenital BAV have or will develop
dilatation of the ascending aorta (Nistri et al. 1999, Kim et al. 2014).
Recent classification of degenerative pathology of the aorta by the Society for
Cardiovascular Pathology and the Association For European Cardiovascular Pathology has
also identified age as a risk factor for aortic disease (Halushka et al. 2016). In the aging
aorta the elastin, SMCs, and extracellular matrix are all altered in progressive and negative
ways. These changes can be exacerbated by the associated risk factors of smoking,
hypertension, and hypercholesterolemia.
1.2
1.2.1

Smooth muscle cell biology, dysfunction, and aging
SMC embryological origins
Vascular smooth muscle cells (SMCs) arise from multiple origins during the

development of the vascular system and constitutes an early event during embryogenesis.
The organization of endothelial cells into the primary vascular plexus is initiated shortly
after gastrulation (the period of formation of the three germ layers; ectoderm, mesoderm,
and endoderm) and marks the onset of vascular development. The endothelial vasculature
is subsequently remodeled by recruitment of SMCs and pericytes to form a complex
vascular system (Carmeliet 2000, Jain 2003). The origin of aortic SMCs is complex with
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contributions from several independent cell lineages (Gittenberger-de Groot et al. 1999,
Majesky 2007). SMCs of the basal aortic root is derived from the secondary heart field
(Waldo et al. 2005), whereas SMCs of the ascending aorta and the arch are neural crest
derived (Jiang et al. 2000). Descending aortic SMCs originate from paraxial (somitic)
mesoderm (Wasteson et al. 2008).
Recruitment of aortic SMCs to the primordial endothelial structure occurs in a
ventral to dorsal manner as well as in a radial pattern emanating from the layer of cells
most adjacent to the endothelium (Hungerford et al. 1996). Embryonic differentiating
SMCs exhibit high rates of cell proliferation and migration. They also produce a large
amount of extracellular matrix molecules, including collagens, elastin, and proteoglycans
that comprise a major portion of the blood vessel mass (Hungerford and Little 1999).
A major challenge in understanding differentiation of the SMC is that it can exhibit
a wide range of phenotypes at different stages of development. Even in adult organisms
SMCs are not terminally differentiated and are capable of major changes in their
phenotype, in response to changes in its local environment. This phenotypic plasticity is
often considered in terms of two functional phenotypes: “contractile” and “synthetic” (Fig.
1.2). Adult, differentiated SMCs are generally thought to be contractile SMCs; expressing a
repertoire of appropriate receptors, ion channels, signal transduction molecules, calcium
regulatory proteins, and contractile proteins necessary for the unique contractile properties
of the SMC (Owens 1995). A number of these genes are often used as signifiers of SMC
differentiation. Upon vascular injury these contractile SMCs have the ability to undergo a
phenotypic switch to a synthetic phenotype that plays a role in repair. This switch is
associated with a downregulation of many of the genes associated with a contractile
phenotype, and an upregulation of many of the factors that were being produced during
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Synthetic phenotype

Synthesis of:
- ECM
- MMPs
- Growth facotrs

Contractile phenotype
Contractile fibres
Focal adhesions
ECM components
Integrin-ECM interaction

Figure 1.2 Smooth muscle phenotypes
SMCs have been considered to have two distinct phenotypes: synthetic (Top) and contractile (Bottom). The
synthetic state is characterized by spread, flattened morphology in culture, where the cells are non-contractile.
These synthetic SMCs are proliferative and migratory. As well, they actively secrete ECM proteins, including
collagen and elastin, as well as MMPs and growth factors. The contractile state is characterized by an
elongated morphology in culture, owing to the accumulation of contractile-proteins. Contractile SMCs are
relatively non-proliferative and migratory, and they have low secretory activity. SMCs can readily switch
between synthetic and contractile phenotypes.
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development that led to the formation of the vessel wall. Whether the synthetic SMCs
active in the repair process are local contractile SMCs that have de-differentiated, or are
derived from infiltrating precursors to SMCs, is not always clear. In either case however
the production of various components that make up the artery wall is a necessity. The
ability to withstand the dynamic hemodynamic stress to which an artery is exposed is
conferred not only by the contractile apparatus of a differentiated vascular SMC, but also
by the components of the extracellular milieu that the synthetic SMC has produced (and
continues to produce even in the differentiated state, albeit at a lower level) (Humphrey et
al. 2015).
1.2.2

Extracellular components of the aorta

1.2.2.1 Elastic fibres
Elastin is the primary ECM molecule in large conduit vessels. In humans, the aortic
media is composed of over 50 alternating layers of elastic fibres and SMCs. The elastic
fibres are organized in concentric laminae. The core of elastin (Eln) is surrounded by
microfibrils. These microfibrils are 10 – 15 nm filaments composed primarily of a large
glycoprotein called fibrillin (Fbn1, Fbn2 and Fbn3). There are additional microfibrilassociated glycoproteins (Magps), including Magp-1 and Magp -2 (Mfap2 and Mfap5), and
elastin microfibril interfacer protein 1 (Emilin1). These microfibril extensions are
organized in an oblique orientation to the elastic fibres, and are attached to dense plaques in
the SMC cell membrane (Karimi and Milewicz 2016).
1.2.2.2 Collagen
Other than elastin, collagen is the most abundant matrix protein in the aorta. There
are 17 different collagen types expressed in the mouse aorta, with α chains for collagens I,
III, IV, V, and VI having the highest expression levels (Kelleher et al. 2004, Wagenseil and
Mecham 2009). Present in lesser amounts are collagens VII, VIII, IX, X, XI, XIV, XV,
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XVIII, and XIX. Collagens II, XII, XIII, and XVII have little to no expression. Collagen
types I, III, and V are fibril-forming collagens, with types I and III being mainly
responsible for imparting strength to the vessel wall (Wagenseil and Mecham 2009). Type
V collagen plays a critical role in collagen fibril nucleation (Wenstrup et al. 2004).
Expression of type VI collagen chains in the mouse aorta is similar in abundance to elastin
and collagen type I, but while it is a fibril-forming collagen, it does not colocalize in large
collagen bundles with collagens I and III. Instead, collagen VI is frequently associated with
fibrillin-1 and may serve to connect elastic lamellae to the basement membrane of SMCs,
or connect SMCs to other ECM structures (Dingemans et al. 2000). Collagens IV, VIII, and
X are members of the network-forming collagen family and create basket weave-like
structures through associations between their helical and non-helical domains. Type IV
collagen is the major structural protein of basement membranes. Collagens IX, XIV, and
XIX are FACIT (fibril associated collagens with interrupted triple helices) collagens that
attach to the surface of fibril-forming collagens but do not form fibers themselves.
Collagen XIII is a collagen with a transmembrane domain that resides in adhesive
structures of cells and has been implicated in cell adhesion. Collagens XV and XVIII are
closely related non-fibrillar collagens that are associated with basement membranes.
1.2.2.3 Proteoglycans
The proteoglycans constitute a number of genetically unrelated families of
multidomain proteins that have covalently attached glycosaminoglycan (GAG) chains.
Proteoglycans are categorized based on the type of attached GAGs: 1) chondroitin sulfate
and dermatan sulfate, 2) heparin and heparan sulfate, and 3) keratan sulphate. The
proteoglycans found in greatest abundance in the vessel wall can be categorized into two
classes: large proteoglycans that form large aggregates by interaction with hyaluronan, and
small leucine-rich proteoglycans (Wagenseil and Mecham 2009). The large proteoglycans
interact with hyaluronic acid to form an extensive, interconnected polymeric network in the
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extracellular space. Hyaluronan is a linear polymer composed of repeating disaccharides of
glucuronic acid and N-acetylglucosamine. It is synthesized at the plasma membrane by
three different but related hyaluronan synthases: Has1, Has2, and Has3 (Weigel et al.
1997). Versican is the largest proteoglycan in the vessel wall and has been localized to the
aortic media and endothelial layers (Yao et al. 1994). Interestingly, in vascular injury
models, high versican levels correlate with low elastin content, most likely due to
inhibition of elastic fibre assembly by the chondroitin sulfate GAGs on versican (Huang et
al. 2006, Wagenseil and Mecham 2009).
The small leucine-rich proteoglycans (SLRPs) are a family of secreted
proteoglycans that do not interact with hyaluronic acid but, instead, bind ECM molecules
such as collagen, tropoelastin, fibronectin, and fibrillin-containing microfibrils, among
others (Reinboth et al. 2002). The SLRP family includes decorin, biglycan, fibromodulin,
osteoglycin, and lumican (Wagenseil and Mecham 2009). Both biglycan and decorin bind
to and regulate collagen fibrillogenesis (Hocking et al. 1998). Biglycan localizes to all
layers of the human aorta, whereas decorin is found only in the adventitia (Theocharis and
Karamanos 2002).
1.2.2.4 MMPs/TIMPs
ECM

proteins,

including

matrix metalloproteinases

collagens

and

elastin,

can

be

cleaved

by

(MMPs), a family of endopeptidases. MMPs are usually

grouped according to substrate specificity as collagenases (Mmp-1, Mmp-8, Mmp-13 and
Mmp-18), gelatinases (Mmp-2 and Mmp-9), stromelysins (Mmp-3, Mmp-10 and Mmp11), matrilysins (Mmp-7 and Mmp-26), membrane type (Mmp-14-17, Mmp-24 and Mmp25), and others (Mmp-12, Mmp-19-21, Mmp-23, Mmp-27 and Mmp-28) (Visse and
Nagase 2003). In the arterial wall, contractile medial SMCs express Mmp-2 and minor
amounts of Mmp-14, a membrane-type Mmp-1 (Wang and Keiser 1998). However,
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activated SMCs, such as cells in atherosclerotic plaque, express large amounts of Mmp-1, 3, -9, and -14, and activated Mmp-2 (Galis et al. 1994, Wang and Keiser 1998). MMPs are
normally inhibited by endogenous inhibitors called TIMPs (tissue inhibitor of
metalloproteinases), of which there four isoforms (Timp1-4). Alterations in the balance
between ECM MMPs and TIMPs may contribute to the profibrotic phenotype in aging and
hypertension (Wang et al. 2006, Giannandrea and Parks 2014, Harvey et al. 2016).
1.2.3

SMC senescence
As outlined above, aortic SMCs are the main cellular mediators that give the aorta

its resilience against hemodynamic forces and other environmental stress. As such, a
dysfunctional SMC can lead to a vulnerable aortic wall. SMC dysfunction may be caused
by a mutation or a polymorphism that affects the expression of a gene associated with the
contractile or synthetic functions of the cell. Additionally, one process that has emerged as
a potential contributor to cellular dysfunction in the vasculature is cellular senescence.
Cellular senescence is a process typically induced by severe insult, whereby the
affected cell enters a state of essentially permanent cell cycle arrest (Childs et al. 2015).
This process is often explored in the context of tumor protection, where proliferative arrest
occurs in response to severe or unrepairable DNA damage, typically a double strand DNA
break, that could otherwise lead to oncogenic transformation. Thus, serves a vital
protective mechanism to safeguard against cancer (Campisi 2013). However, the first
description of cellular senescence was the observed proliferative arrest that occurs after
long-term culture of human fibroblasts (Hayflick and Moorhead 1961). This form of
senescence is termed replicative senescence and has been linked to progressive shortening
of telomeres. This concept can be congruent with what happens in replicating tumor cells,
but is also applied to aging cells both in culture and in vivo (van Deursen 2014).
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Senescence can also occur independent of continuous cell replication and critically
short telomeres. Some stresses such as oxidative stress and DNA damage elicit quite
similar cell growth arrest within just a few days (Collado et al. 2007). This circumstance
has been referred to as stress-induced premature senescence. Regardless of the cause,
senescent cells of all tissue types (including those undergoing replicative and stressinduced premature senescence) look alike and show similar characteristics (Bernadotte et
al. 2016). Senescent cells are defined not only by proliferative arrest but also by the
secretion of a set of proteins - a host of inflammatory cytokines and chemokines, growth
factors, and proteases, that can affect the senescent cell and also the local tissue (Coppe et
al. 2008, Tchkonia et al. 2013). This phenomenon is referred to as the senescenceassociated secretory phenotype (SASP) (Yin and Pickering 2016).
1.2.3.1 Mechanisms of cellular senescence
As noted, progressive shortening of telomeres upon repeated cell replication is an
established route to cellular senescence (Hayflick and Moorhead 1961). However, stressinduced senescence can be mediated by different stimuli that are beginning to be
understood more fully (Yin and Pickering 2016). These stimuli are signalled through
various pathways, many of which activate p53 (encoded by TP53 in humans and
by Trp53 in mice), and essentially all of them converge in the activation of the cyclindependent kinase (CDK) inhibitors p16 (also known as Ink4a; encoded by Cdkn2a), p15
(also known as Ink4b; encoded by Cdkn2b), p21 (also known as Waf1; encoded
by Cdkn1a) and p27 (encoded by Cdkn1b). The inhibition of CDK–cyclin complexes
results in proliferative arrest, and the crucial component responsible for the implementation
of senescence is the hypo-phosphorylated form of Rb (Chicas et al. 2010). (Fig. 1.3)
DNA damage is a potent driver of cellular senescence. The main mediators of the
DNA damage response are the DNA damage kinases ATM, ATR, CHK1 and CHK2,
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Figure 1.3 Molecular mechanisms leading to cell senescence
A range of stressors can trigger cell senescence. These include DNA damage, including critical telomere
shortening, as well as oncogene activation, oxidative stresses, and TGF-β produced either during normal
developmental remodeling or from senescent cells themselves. These stressors engage different signaling
cascades that induce expression of p16 and/or p21. The resulting inhibition of cyclin-dependent kinase
activity prevents Rb inactivation, leading to cellular senescence. ARF, alternative reading frame; ATM, ataxia
telangiectasia mutated kinase; ATR, ataxia telangiectasia and Rad3- related kinase; CDK, cyclin-dependent
kinase; ECM, extracellular matrix; Rb, retinoblastoma protein; SASP, senescence-associated secretory
phenotype; TGF, transforming growth factor.
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which phosphorylate and activate several cell cycle proteins, including p53 (Campisi and
d'Adda di Fagagna 2007).. In turn, phosphorylated p53 protein activates the expression of
p21, which binds to and inhibits certain CDK–cyclin complexes (Munoz-Espin and Serrano
2014).
Reactive oxygen species (ROS) also play an important role in the senescence of
vascular cells (Chen et al. 1995). Levels of ROS increase after many different types of
stresses, including chemotherapeutic drugs, loss of telomeric protective functions (Lee et
al. 2009), and oncogene activation. Additionally, angiotensin II (Ang II), which has been
widely implicated in the pathogenesis of cardiovascular disease, induces ROS production
in SMCs (Herbert et al. 2008).

A persistent ROS burden has been associated with an

increase of oxidized DNA lesions (Chen et al. 1995) as well as an increase in senescence
through several mechanisms, including lipid oxidation and interference with cellular
metabolism (Yin and Pickering 2016). In addition, oxidized DNA lesions themselves have
been found to be pathological and their continuous clearance is required to prevent the cell
from entering a senescent cascade (Rai et al. 2009). ROS also introduces DNA base or
sugar damage leading to single-strand break (SSB) formation (Lindahl 1993). Singlestrand DNA breaks are linked to cellular senescence, either directly or by predisposing to
double-strand DNA breakage (Kuzminov 2001, Nassour et al. 2016). As noted above,
double-strand DNA breakage in turn is a well established driver of cellular senescence
(d'Adda di Fagagna 2008). ROS can also induce senescence in a DNA damage-independent
fashion by activating p38 mitogen-activated protein kinase (MAPK). This stress-activated
kinase drives p21 transcription and also that of another cyclin- dependent kinase inhibitor,
p16Ink4a (Munoz-Espin and Serrano 2014).
Normal cells can respond to the activation of many oncogenes by undergoing
cellular senescence. A general feature of oncogene-induced senescence is the derepression
of the Cdkn2a locus. This type of senescence may also induce a robust DNA damage
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response owing to the DNA damage that is caused by aberrant DNA replication and/or
ROS (Munoz-Espin and Serrano 2014).
There is also a role that senescent cells themselves play in potentiating the spread of
senescence to other cells. The secretion of SASP factors, including pro-inflammatory
cytokines (interleukin-6 (IL-6) and IL-8), chemokines (monocyte chemoattractant proteins
(MCPs) and macrophage inflammatory proteins (MIPs)), growth factors (transforming
growth factor-β (TGF-β) and granulocyte–macrophage colony-stimulating factor (GMCSF)), and proteases causes inflammation. In some cases this response may be important
for the clearance of senescent cells by phagocytosis (Hoenicke and Zender 2012, MunozEspin and Serrano 2014). However, SASP components, most notably TGF-β, can also
trigger senescence in neighbouring cells in a paracrine manner, through a mechanism that
generates ROS and DNA damage (Nelson et al. 2012, Acosta et al. 2013).
1.2.3.2 Markers of senescence
There is no one marker that can identify a senescent cell. However, it is possible to
identify a senescent cell using a set of indicators taken together. Identifying cells in culture
that have ceased to replicate even under mitogenic conditions is a good indication that
senescence is occurring. These cells often become more flattened and spread in appearance.
Also, a powerful biomarker is the presence of senescence-associated β-galactosidase (SA-β
Gal) activity. In senescent cells, lysosomal β galactosidase activity can be detected at an
otherwise sub-optimal pH (pH 6), (Dimri et al. 1995) as a result of marked expansion of the
lysosomal compartment (Lee et al. 2006). Other molecular markers are on the basis of the
signaling hallmarks of cellular senescence, including high levels of p16Ink4a, p21,
phosphorylated p38, and the presence of double-stranded DNA breaks as denoted by the
modified histone, γ-H2AX (Yin and Pickering 2016).
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1.2.3.3 Vascular cell senescence
Senescent endothelial cells and SMCs have been identified in culture, and
senescence of these cells is mainly driven by culture conditions (van der Veer et al. 2007,
Borradaile and Pickering 2009). Senescent vascular cells have also been identified in vivo,
although at a low prevalence. This may be because senescence develops at a very low rate,
or because immune cells clear the senescent cells (Hoenicke and Zender 2012, MunozEspin and Serrano 2014). Regardless, there is good evidence that senescent cells are
associated with vascular disease and dysfunction. Senescent SMCs and endothelial cells
have been identified in human atherosclerotic samples (Minamino et al. 2002, Minamino et
al. 2003, Matthews et al. 2006). Senescent aortic SMCs have also been identified in mouse
models of hypertension (Boe et al. 2013, Vafaie et al. 2014) and aging (Yepuri et al. 2012,
Wang and Shah 2015).
1.2.3.4 Benefits of cellular senescence
Cellular senescence can be beneficial and, in fact, proceeds as part of normal
embryonic development. For example: the mesonephric tubules during mesonephros
involution; the endolymphatic sac of the inner ear, the apical ectodermal ridge of the limbs;
the regressing interdigital webs and the closing neural tube (Munoz-Espin et al. 2013,
Storer et al. 2013). In addition to embryonic development, senescence also occurs in a
physiologically programmed manner in adult organisms. Normal megakaryocytes and
placental syncytiotrophoblasts undergo senescence as part of their natural maturation
programmes (Besancenot et al. 2010, Chuprin et al. 2013). Senescence can also protect
against a damaging fibrotic response to injury. For example, senescent fibroblasts display a
collagen suppressive phenotype, with upregulation of matrix metalloproteinases and
downregulation of fibrillar collagen (Yin and Pickering 2016). The development of
senescent fibroblasts has been reported to be a mechanism for limiting fibrosis in the heart,
as well as in other organs (Krizhanovsky et al. 2008, Jun and Lau 2010, Zhu et al. 2013).
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However, as extensively reviewed in Munoz-Espin and Serrano (Munoz-Espin and Serrano
2014), there are a number of pathologies associated with cell senescence that illustrate the
detrimental effect senescence can have, including the aggravation of pulmonary fibrosis
and sarcopenia, and contributing to type II diabetes, cataracts, obesity, and radiationinduced oral mucositis. Senescence has been associated with human aneurysms in the brain
and the heart.
1.3

NAD+
Nicotinamide adenine dinucleotide (NAD+) is an essential dinucleotide that has

emerged as a multi-role determinant of cell health. NAD+ has classically been known as a
cofactor for the oxidation-reduction events of cellular nutrient metabolism. Importantly,
recent studies have established that, in addition to its redox carrier role, NAD+ can serve as
a signalling nucleotide that regulates gene expression, genome integrity, and mitochondrial
function.
1.3.1

NAD+ in redox reactions
NAD+ and its phosphorylated derivative, nicotinamide adenine dinucleotide

phosphate (NADP), serve as essential coenzymes for hydride-transfer enzymes. They
participate in redox reactions as hydride acceptors (NAD+ and NADP+) or donors [NADH
or NADPH (reduced forms)]. These two redox pairs are kept in chemical opposition:
NAD+ is mostly maintained in its oxidized form; NADP is mostly in its reduced form,
NADPH. As a cosubstrate, NAD+ is essential for energy generation by transferring
reducing equivalents from glycolysis (from the activity of glyceraldehyde-3-phosphate
dehydrogenase) and from the TCA cycle under the form of NADH. When oxygen is
limiting, NADH is converted to NAD+ by reduction of pyruvate into lactate. With oxygen,
cytoplasmic NADH transfers its reducing equivalent through the malate-aspartate shuttle or
the glycerol-3-3-phosphate shuttle to the mitochondrial matrix. These reducing equivalents
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are oxidized by complex I of the electron-transport chain, thereby coupling glycolysis and
the TCA cycle to ATP synthesis via oxidative phosphorylation. NADP is critical in several
pathways, including fatty acid oxidation and cholesterol synthesis, as well as in redox
protection. In these reactions, NAD+ and NADH (or NADP and NADPH) interconvert but
are not consumed. (Fig 1.4)
1.3.2

NAD+ in signaling.
Beyond its role as a coenzyme in redox reactions, NAD+ is an important cosubstrate

for three classes of enzymes: (i) the sirtuins (Sirts), (ii) the adenosine diphosphate (ADP)–
ribose transferases (ARTs) and poly(ADP-ribose) polymerases (Parps), and (iii) the cyclic
ADP-ribose (cADPR) synthases (CD38 and CD157). NAD+ is consumed by these enzymes
and continuously degraded.
1.3.2.1 Sirtuins
Silent information regulator 2 (Sir2) proteins, or sirtuins (Sirts), are NAD+dependent protein deacetylases/mono-ADP-ribosyltransferases found in organisms ranging
from bacteria to humans (Schwer and Verdin 2008, Soppa 2010). In mammals the sirtuin
family comprises seven proteins (Sirt1–Sirt7), which vary in tissue specificity, subcellular
localization, enzymatic activity and targets. Sirt1 is mainly localized in the nucleus but is
also present in the cytosol (Tanno et al. 2007). Sirt2 is considered to be cytosolic but is also
present in the nucleus in the G2 phase to M phase transition of the cell cycle (Vaquero et
al. 2006). Sirt3, Sirt4 and Sirt5 have a mitochondrial targeting sequence, and their
localization to this organelle has been confirmed experimentally (Huang et al. 2010). Sirt6
is predominantly nuclear (Mostoslavsky et al. 2006) and Sirt7 was reported to reside in the
nucleolus, (Ford et al. 2006) although recent reports identify a cytosolic pool and a
presence in the nucleus (Kiran et al. 2013). Sequence-based phylogenetic analysis revealed
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that mammalian sirtuins can be divided into four classes: Sirt1–Sirt3 belong to class I, Sirt4
to class II, Sirt5 to class III, and Sirt6 and Sirt7 to class IV (Frye 2000).
Sirtuins were originally described as NAD+-dependent type III HDACs, as the
founding member, Sir2 in yeast, silenced specific genomic loci by deacetylating histones
H3 and H4 (Braunstein et al. 1996). Not only do Sirts deacetylate histones, but they also
deacetylate a wide range of proteins in different subcellular compartments (Houtkooper et
al. 2010).

In addition, Sirt4 and Sirt6 were reported to function as ADP-

ribosyltransferases,(Liszt et al. 2005, Haigis et al. 2006) even though Sirt6 also can act as a
deacetylase (Zhong et al. 2010). Sirt5 was initially reported to be a deacetylase, but has
been shown to primarily demalonylate and desuccinylate proteins(Du et al. 2011).
Of the sirtuin family, Sirt1 has been studied the most extensively. The protein
deacetylase of Sirt1 functions as an epigenetic regulator by targeting specific histoneacetylated residues (e.g., H3K9, H3K14, and H4K16) but also regulates transcription by
deacetylating transcription factors (such as TP53, NF-κB, PGC-1α, and FOXO3a) (Verdin
2015). Sirtuin 3 is the major mitochondrial protein deacetylase, and several of its targets
have been identified, many of which have important roles in metabolic homeostasis
(Verdin 2015). Additionally, Sirt3 also affects oxidative stress defence by protecting cells
from ROS (Qiu et al. 2010).
The enzymatic reaction catalysed by sirtuins requires NAD+ as a substrate, the
concentration of which is determined by the nutritional state of the cell. Consequently,
NAD+ controls adaptive responses to energy stress by modulating the activity of sirtuins
and their downstream effectors. Sirtuins convert NAD+ to nicotinamide, which at higher
concentrations can non-competitively bind and thereby feedback-inhibit sirtuin activity
(Bitterman et al. 2002).
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1.3.2.2 Parps
The most potent NAD+-consuming reaction is believed to be one catalyzed by
poly(ADP-ribose)

polymerase

(Parp).

Poly(ADP-ribosyl)ation

(PARylation)

is

a

posttranslational protein modification catalyzed by members of the Parp enzyme
family. The best-characterized Parp is Parp-1. Parp-1 is a 116 kDa protein that contains a
“Parp signature” sequence required for the catalysis of PAR synthesis (Luo and Kraus
2012). Parp-1 belongs to a family of 17 proteins with confirmed or putative mono(ADPribosyl) and poly(ADP-ribosyl) transferase activity, which share the “Parp signature motif”
in the homologous catalytic domain (Kraus 2015). Some of the family members (e.g., Parp1 and Parp-2) catalyze the synthesis of PAR on target proteins using NAD + as a donor of
ADP-ribose units. However, other family members—the mono(ADP-ribosyl) transferases
(e.g., Parp-3 and Parp-16), which comprise most of the family—use NAD + to catalyze the
covalent attachment of mono-ADP-ribose (MAR) on target proteins. Finally, three
remaining family members lack any apparent catalytic activity (Hottiger et al. 2010,
Hottiger 2015).
Parp-1 catalyzes the covalent attachment of PAR polymers on itself and other
acceptor proteins, including histones, DNA repair proteins, transcription factors, and
chromatin modulators, using NAD+ as a donor of ADP-ribose units (D'Amours et al. 1999,
Hassa and Hottiger 2008). Parps are best characterized for their role in DNA damage
pathways, but more generally Parps regulate adaptive stress responses, including
inflammatory, oxidative, proteotoxic, and genotoxic stresses (Luo and Kraus 2012).
1.3.2.2.1 Parp-1 and DNA damage response
Parp1 is the most abundant Parp and is expressed ubiquitously. Parp1 is strongly
activated by DNA damage, leading to consumption of a large amount of cellular NAD+. In
fact, DNA damage leads to a decrease (up to 80% in acute situations) in cellular
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NAD+ concentrations. Parp1 has been reported to bind to a variety of aberrant DNA
structures, including cyclobutane pyrimidine dimers, 6,4-photoproducts, apurinic and
apyrimidinic sites, SSBs and double-strand breaks (DSBs) (Lonskaya et al. 2005,
Khodyreva et al. 2010). In fact, Parp1 is one of the first proteins to recognize damaged
DNA and its interaction with DNA lesions triggers the PARylation of a variety of proteins,
with Parp1 itself being the main PAR acceptor (Haince et al. 2007). Parp1 activation
immediately creates long negatively charged PAR polymers attached to Parp1 at DNA
lesion sites (D'Amours et al. 1999). Although none of the Parp family members have any
known DNA repair enzymatic activity, Parp activity has been linked to DNA repair
(Woodhouse et al. 2008). The evidence for this relationship: (i) DNA damage is the main
activator of PAR synthesis, (ii) the depletion or inhibition of Parps 1–3 sensitizes cells to
DNA-damaging agents and (iii) Parps 1–3 have been reported to interact physically and/or
functionally with diverse DNA repair proteins (Sousa et al. 2012). Parp1 has been reported
to be involved in different DNA repair systems, including BER, single-strand break repair
and double-strand break repair (Yelamos et al. 2011). Parp1 plays an important role in the
early steps of DNA repair targeting and in modulating the DNA repair proteins at the sites
of DNA lesions, with the formation of long PAR chains that possibly act as scaffolds on
which DNA damage repair proteins can assemble. Furthermore, Parp1-dependent
chromatin remodeling was shown to facilitate the access of DNA repair proteins to DNA
damage (Escargueil et al. 2008).
1.3.2.2.2 PAR-dependent cell death induction—parthanatos
When the levels of DNA damage are beyond the cellular repair capacity,
programmed cell death is activated to prevent cells from accumulating mutations that may
lead to carcinogenesis (Sousa et al. 2012). Because PARylation is a DNA damagedependent enzymatic activity, extensive DNA damage is accompanied by large-scale PAR
polymer synthesis (Herceg and Wang 2001). However, excessive PAR production may
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leads to a unique form of caspase-independent cell death, termed parthanatos (Andrabi et
al. 2008). This type of cell death is associated with rapid Parp1 activation, early PAR
accumulation, mitochondrial depolarization, early AIF translocation, loss of cellular NAD+
and ATP and late caspase activation (Yu et al. 2002, Andrabi et al. 2006, Yu et al. 2006).
1.3.2.3 cyclic ADP-ribose synthases
NAD(P)+-derived molecules are key elements of intracellular calcium signaling
(Verdin 2015). Several of these derivatives, namely, nicotinic acid adenine dinucleotide
phosphate (NAADP), cyclic ADP-ribose (cADPR) and ADPR have been characterized as
potent calcium-mobilizing agents. All three molecules, ADPR, cADPR and NAADP are
synthesized by multifunctional NAD+ glycohydrolases, in humans represented by the ADPribosyl cyclase CD38 and its structural and functional homolog, CD157 (Malavasi et al.
2008). CD38 and CD157 are membrane-bound ectoenzymes. Mice deficient in CD38 show
significantly elevated levels of NAD+ (10- to 30-fold) in tissues such as liver, muscle,
brain, and heart, (Aksoy et al. 2006, Barbosa et al. 2007) confirming the role of CD38 as a
major NAD+ consumer. Conversely, cells overexpressing CD38 showed reductions in
NAD+ levels and in the expression of proteins related to energy metabolism and antioxidant
defense (Hu et al. 2014).
An additional ectoenzyme has recently been shown to have NAD+ degrading
activity. CD73, mostly known as the ectoenzyme dephosphorylating extracellular AMP to
adenosine, is in fact also capable of degrading both NAD+ and NMN: specifically, CD73
degrades NAD+ to NMN, which is subsequently dephosphorylated by the same enzyme to
nicotinamide riboside (NR) (Garavaglia et al. 2012, Grozio et al. 2013).
1.3.3

NAD+ as a neurotransmitter
NAD+ is most widely considered in the paradigms outlined above: either as a

coenzyme in redox reactions or a cosubstrate for the activities of Sirts, Parps, and cADPR-
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synthases. However, there is evidence that NAD+ may also be an inhibitory
neurotransmitter candidate. NAD+ (referred to as ß-NAD in this field) is a purine substance
released by nerve stimulation in vascular and visceral smooth muscles and neuro-secretory
cells (Smyth et al. 2004, Smyth et al. 2006, Mutafova-Yambolieva et al. 2007). Purines can
be released from intrinsic enteric nerves, sympathetic nerves or sensory motor nerves
during axon reflexes, to act directly on smooth muscle purinoceptors mediating relaxation
or contraction or on epithelial cell receptors. They act on prejunctional nerve terminals to
modify transmitter release from motor and inhibitory neural control pathways (Burnstock
2014). They participate in synaptic transmission in myenteric and submucosal ganglia that
are involved in the control of gastrointestinal motility, mucosal secretion and absorption.
They act on blood vessels or interstitial cells of Cajal (ICC) thereby indirectly modulating
motility patterns. Purines also can act on sensory nerve endings in the gut wall after release
from epithelial cells to initiate local and/or central reflex activity that alters gastrointestinal
motility and secretory patterns and initiate nociception (Burnstock 2008, Burnstock 2014).
To date the role of NAD+ as an enteric neurotransmitter is controversial as ATP has
been assumed to be the known purine neurotransmitter (Xue et al. 1999), however
experiments on mouse (Mutafova-Yambolieva et al. 2007) and primate colons (Hwang et
al. 2011) showed that NAD+ and its bioactive metabolite, ADP-ribose (Durnin et al. 2013),
mimic the endogenous purine neurotransmitter better than ATP. To date, experiments have
shown both ATP and NAD+ and their metabolites, ADP and ADP-ribose, produced
relaxation of murine colonic smooth muscle, and it was suggested that they might be
involved in motility disorders (Durnin et al. 2012, Gallego et al. 2016).
1.3.4

NAD+ biosynthetic pathways
NAD+ can be synthesized from diverse dietary sources, including nicotinic acid

(NA) and nicotinamide (NAM), tryptophan, and nicotinamide riboside (NR). (Fig. 1.4)
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Figure 1.4 NAD+ metabolism
The different precursors to intracellular NAD metabolism—tryptophan, nicotinic acid (NA), nicotinamide,
NR, and NMN—are shown. The cytoplasmic and nuclear NAD+ pools probably equilibrate by diffusion
through the nuclear pore. However, the mitochondrial membrane is impermeable to both NAD+ and NADH.
Reducing equivalents generated by glycolysis are transferred to the mitochondrial matrix via the
malate/aspartate shuttle and the glyceraldehyde-3-phosphate shuttle. The resulting mitochondrial NADH
(malate/aspartate shuttle) is oxidized by complex I in the respiratory chain (ETC), whereas the resulting
FADH2 (glyceraldehyde-3-phosphate shuttle) is oxidized by complex II. In each of the three compartments,
different NAD+-consuming enzymes lead to the generation of nicotinamide, which is recycled via the
NAD+ salvage pathway. Different forms of the NMNAT enzyme and sirtuins are localized in different
compartments.
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The primary biosynthesis of NAD+ starts with the essential amino acid Ltryptophan, which is taken up from the diet (Bender 1983), and serves as the precursor for
NAD+ through the multi-step de novo kynurenine pathway. The first step in this pathway is
the rate-limiting conversion of tryptophan to N-formylkinurenine by either IDO or TDO.
Formylkinurenine is transformed into L-kinurenine, 3-hydroxykinurenine, and 3hydroxyanthranilic acid and finally to ACMS. This compound can spontaneously condense
and rearrange into quinolinic acid, which is transformed into NAMN, at which point it
converges with the Preiss-Handler pathway.
NAD + synthesis from NA, also known as the Preiss-Handler pathway, is initiated
by the NA phosphoribosyltransferase (Naprt) which forms NA mononucleotide (NAMN)
from NA. Together with ATP, NAMN is then converted into NA adenine dinucleotide
(NAAD) by the nicotinamide mononucleotide adenylyltransferase (Nmnat1–3) enzymes.
Finally, NAAD is transformed to NAD + through an amidation reaction catalyzed by the
NAD+ synthetase (Nadsyn) enzyme.
The synthesis of NAD+ from NAM or NR is more direct and relies on only two
steps each. NAM is converted by the rate-limiting Nampt to form nicotinamide
mononucleotide (NMN). NMN is also the product of phosphorylation of NR by the NR
kinases (Nrk1 and Nrk2). The subsequent conversion of NMN to NAD + is catalyzed by the
Nmnat1-3 enzymes.
The formation of NAD+ from NR can be considered a de novo pathway in some
respects as there have been nutritional sources of NR identified, i.e. milk (Bieganowski and
Brenner 2004). The salvage pathway uses NAM or NA (together called niacin or B3) to
make NAD+ (Bogan and Brenner 2008). While dietary maintenance may meet baseline
requirements for NAD+, the local salvage pathways that supply or regenerate NAD+ are
critical determinants of cell health and survival (Sauve 2008).
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1.4
1.4.1

Nampt
Biochemical function of Nampt
Nicotinamide phosphoribosyltransferase (Nampt) was originally identified as a

putative cytokine, pre-B enhancing colony factor (Pbef) (Samal et al. 1994, Rongvaux et al.
2002), and subsequently as a putative insulin-mimetic hormone, Visfatin (Fukuhara et al.
2005). Evidence for the former is inconclusive, and the index report for the latter has since
been retracted (Fukuhara et al. 2007). Bacterial and murine homologues of Nampt were
later identified as enzymes involved in NAD+ biosynthesis (Martin et al. 2001, Rongvaux
et al. 2002), and this was enzymatic activity was first confirmed in humans cells in aortic
SMCs (van der Veer et al. 2005). Nampt is known to catalyze NAD+ synthesis by
transferring the phosphoribosyl group of 5-phosporibosyl-1-pyrophosphate to NAM,
forming NMN. NAD+ synthesis is completed by Nmnat, which converts NMN into NAD+
(Fig. 1.5) (Rongvaux et al. 2002). Nampt’s catalytic activity is ~46-fold lower than Nmnat
activity, and thus Nampt catalyzes the rate-limiting step in this two-step pathway of NAD+
synthesis from NAM. Thus, even very small changes in Nampt activity levels, but not
Nmnat levels, can have a profound effect on NAD+ metabolism (Rongvaux et al. 2002,
Revollo et al. 2004).
1.4.2

Cellular localization of Nampt
Nampt is a ubiquitously expressed protein, and expression is variable across tissue

and cell types. Nampt is localized intracellularly (mainly in the cytoplasm and nucleus)
(Kitani et al. 2003), but also has been found extracellularly (Revollo et al. 2007), in which
case it is generally referred to as eNampt. eNampt has been found in human circulation
(Korner et al. 2007) and mouse circulation (Revollo et al. 2007), as well as in the
supernatant of certain cell types including differentiated adipocytes (Revollo et al. 2007,
Tanaka et al. 2007, Yoon et al. 2015),
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hepatocytes (Garten et al. 2010, Schuster et al. 2014), leucocytes (Friebe et al. 2011),
cardiomyocytes (Pillai et al. 2013), and neurons (Zhao et al. 2013, Jing et al. 2014).
However, a secretory pathway for eNampt has not been identified. Some reports claim that
eNampt is released via a “non-classical secretory pathway”, but these reports cannot
preclude that intracellular Nampt is simply being released upon cell death (Revollo et al.
2007, Tanaka et al. 2007, Garten et al. 2010). As well, a cell-surface role for eNampt has
yet to be identified and the role of eNampt in the extracellular space is still a matter of
debate. Several studies have measured enzymatic activity of eNampt (Revollo et al. 2007,
Garten et al. 2010, Friebe et al. 2011, Kover et al. 2013, Zamporlini et al. 2014). However,
it has been reported that eNampt is not enzymatically active in mouse plasma owing to the
low concentrations of PRPP and ATP (Hara et al. 2011).
1.4.3

Regulation of Nampt expression
Because Nampt is the rate-limiting enzyme in the regeneration of NAD+, Nampt is

a key regulator of the intracellular NAD+ pool (Rongvaux et al. 2002, Revollo et al. 2004).
Through its NAD+-biosynthetic activity, Nampt influences the activity of NAD+-dependent
enzymes, such as Sirts (Revollo et al. 2004, van der Veer et al. 2007, Yang et al. 2007,
Borradaile and Pickering 2009, Bruzzone et al. 2009, Ho et al. 2009, Van Gool et al. 2009,
Koltai et al. 2010, Bowlby et al. 2012) and Parps, (Pillai et al. 2013) and thereby regulates
cellular metabolism, mitochondrial biogenesis (van der Horst et al. 2004, Bordone et al.
2006, Rodgers et al. 2008) and adaptive responses to inflammatory, oxidative, proteotoxic
and genotoxic stress (Luo and Kraus 2012).
Nampt itself seems to be regulated in a circadian fashion. Levels of Nampt RNA
display a diurnal oscillation in the liver and white adipose tissue, with a peak around the
beginning of the dark period (Ramsey et al. 2009), a phenomenon also observed in serumentrained mouse embryonic fibroblasts (Nakahata et al. 2009). These robust diurnal and
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circadian oscillation patterns of Nampt RNA and protein are completely abolished in
tissues from the circadian rhythm-deficient ClockΔ19 mutant mice, or mice deficient in
Bmal1, the binding partner of Clock (Ramsey et al. 2009). The Nampt promoter region
contains putative E-box sequences (CACGTG sequences - DNA response elements acting
as protein-binding sites that have been found to impact the regulation of transcription).
Nakahata et al (Nakahata et al. 2009) demonstrated that the Nampt promoter is readily
activated by Clock:Bmal1 through the E-boxes in a time-dependent manner. Interestingly,
dual cross-linking ChIP assays showed that Sirt1 binds to the E-boxes in a time-dependent
manner, following the circadian timing of Clock:Bmal1 recruitment. In addition, Sirt1
negatively regulates the transcriptional activation of clock genes. Thus, Clock and Sirt1
contribute to circadian chromatin remodeling at the Nampt promoter. As NAD+
intracellular levels directly influence the histone deacetylase activity of Sirt1, an
enzymatic- transcription feedback loop seems to operate in which NAD+ levels determine
the oscillatory synthesis of Nampt.
1.4.4

Biological expression and importance of Nampt
Several studies have reported Nampt to be highly expressed in lung, liver, kidney,

heart, and skeletal muscle, with much lower expression in brain and pancreas (Samal et al.
1994, Revollo et al. 2007). The expression of Nampt was found to be upregulated in
immune cells upon activation (Samal et al. 1994, Rongvaux et al. 2002, Jia et al. 2004)
whereas another report identified this protein as a gene strongly expressed in adipocytes
(Revollo et al. 2007).
Within vascular tissue we have identified that Nampt is expressed in endothelial
cells and SMCs, with relatively higher expression in the former (Ho et al. 2009). We have
also shown that expression in smooth muscle cells is dynamic: Nampt expression is
decreased in aging and senescent primary human smooth muscle cells, and in HITC6 cells,
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and an increase in Nampt expression has been correlated with a shift of the SMC
phenotype from a contractile to a synthetic phenotype (van der Veer et al. 2007).
Overexpressing Nampt in SMCs and endothelial cells in culture enhances cell life
span via enhancing Sirt1 activity and p53 degradation (van der Veer et al. 2007). Nampt
overexpression leads to an increase of NAD+ in the cells, associated with prolonged cell
survival and resistance to oxidative stress (van der Veer et al. 2007, Borradaile and
Pickering 2009, Ho et al. 2009). Exposure of cells with an inhibitor of Nampt, FK866,
results in the decreased ability of the cell to withstand genotoxic stress (Rongvaux et al.
2008). Incubation with FK866 also aggravated brain infarction in a model of mouse
cerebral ischemia and activated T cells were found to undergo massive NAD+ depletion
upon treatment with FK866 (Bruzzone et al. 2009, Wang et al. 2011).
Gene-targeting strategies in mice have revealed a pattern of degenerative or agingrelated tissue dysfunction when Nampt is perturbed in skeletal muscle, adipose tissue, and
brain (Stein and Imai 2014, Frederick et al. 2016, Stromsdorfer et al. 2016, Zhou et al.
2016). Mice lacking Nampt in forebrain excitatory neurons showed hippocampal and
cortical atrophy, astrogliosis, microgliosis, and abnormal CA1 dendritic morphology by 2–
3 months of age (Stein et al. 2014). Ablation of Nampt in adult neural stem cells also
causes signs of accelerated aging in this neural cell population (Stein and Imai 2014).
Knockout of Nampt in skeletal muscle contributed to an aging phenotype-related loss mass
and contractile function (Frederick et al. 2016). Adipocyte-specific Nampt knockout mice
had severe insulin resistance in adipose tissue, liver, and skeletal muscle, and adipose tissue
dysfunction. This dysfunction was manifested by increased plasma free fatty acid
concentrations and decreased plasma concentrations of a major insulin-sensitizing
adipokine, adiponectin (Stromsdorfer et al. 2016). Additionally, Nampt is critically
required for the development of both T and B lymphocytes (Rongvaux et al. 2008).
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In contrast, there has been some evidence that a decrease in Nampt expression in
certain tissue may have a limited protective effect. shRNA-mediated knockdown of Nampt
in mouse liver increased plasma HDL-C levels, reduced the plaque area of the total aorta en
face and the cross-sectional aortic sinus, decreased macrophage number and apoptosis, and
promoted reverse cholesterol transport in high fat diet-fed ApoE KO mice (Li et al. 2016).
Heterozygous Nampt+/− mice were significantly protected when exposed to a model of
sepsis-induced acute lung injury (Hong et al. 2008), and also were protected from Ang IIinduced cardiac hypertrophy (Pillai et al. 2013). Overexpression of Nampt in
cardiomyocytes exacerbated Ang II-induced cardiac hypertrophy (Pillai et al. 2013),
however in another model of cardiomyocyte-specifc overexpression of Nampt, Nampt was
protective against ischemia-reperfusion injury (Hsu et al. 2009). In addition, female
Nampt+/− mice show moderately impaired glucose tolerance and reduced glucosestimulated insulin secretion, consistent with significant decreases in NAD+ biosynthesis
and insulin secretion in response to glucose in primary islets isolated from Nampt+/− mice
(Revollo et al. 2007).
A very recent report of global Nampt knockout in the adult mouse has shown that
Nampt is an essential gene, as mice in which Nampt has been ablated do not survive longer
than 10 days (Zhang et al. 2017). However, the reasons for poor survival were not
elaborated on beyond an indication that the endothelial cells of the gastrointestinal tract
were disturbed and death occurred due to a deficiency in gastrointestinal ion transport.
Taken together, the role of Nampt in vivo has not been clearly defined. The
evidence presented above speaks to the importance of Nampt with respect to maintaining a
healthy cell in vitro, and also resistant to the normal physiological stresses in vivo;
however, not much is know about the role that Nampt plays in normal cell and tissue
development. It has been reported that Nampt expression begins in the embryo around e8.5
and that knockout mice are embryonically lethal before e10.5 (Revollo et al. 2007, Zhang
34

et al. 2017). Additionally, male Nampt heterozygous mice are ostensibly normal (Revollo
et al. 2007). The extent to which Nampt is required for SMC and endothelial cell
development and function is, to this point, unknown.
1.5

Therapeutic augmentation of the NAD+ biosynthesis pathway
NAD+ levels in the cells depend on several variables, including the cellular redox

state (NAD+/NADH ratio) and the rates of NAD+ synthesis and NAD+ consumption. As
noted in previous sections, they can also fluctuate in a circadian manner, through activation
of the NAD+ salvage pathway (i.e. through Nampt activity) (Nakahata et al. 2009). In
addition, NAD+ concentrations increase in response to conditions associated with lower
energy loads, such as fasting, glucose deprivation, calorie restriction, and exercise
(Rodgers et al. 2005, Chen et al. 2008, Fulco et al. 2008, Canto et al. 2009, Nakahata et al.
2009, Ramsey et al. 2009, Costford et al. 2010). In contrast, NAD+ concentrations decrease
in animals on high-fat diets (Bai et al. 2011, Yoshino et al. 2011, Canto et al. 2012, Kraus
et al. 2014, Pirinen et al. 2014, Yang et al. 2014), and during aging and senescence
(Ramsey et al. 2008, Braidy et al. 2011, Yoshino et al. 2011, Massudi et al. 2012, Gomes et
al. 2013, Mouchiroud et al. 2013, Pugh et al. 2013, Cerutti et al. 2014).
It is interesting to note the conditions in which NAD+ is upregulated are conditions
associated with longevity. These data support the idea that decreased NAD+ levels
contribute to the aging process and that NAD+ supplementation might exert protective
effects during aging. Indeed, NAD+ supplementation increases life span in yeast and worms
(Belenky et al. 2007, Mouchiroud et al. 2013).
Lower overall NAD+ levels have been reported in various aged rat and human tissue
(Braidy et al. 2011, Massudi et al. 2012). Declining levels can be explained by increased
NAD+ consumption through hyperstimulation of NAD+-consuming enzymes, particularly
Parp1, the activity of which increases during aging as DNA damage accumulates (Braidy et
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al. 2011, Mouchiroud et al. 2013). Additionally, defective circadian rhythm regulation by
Clock and Bmal1 has been reported to lower levels of Nampt as well as NAD+ (Nakahata
et al. 2009). Reports of decreased Nampt expression levels in aged mice were associated
with chronic inflammation and oxidative stress; both lowering Nampt and NAD+ in
primary hepatocytes (Cavadini et al. 2007, Yoshino et al. 2011). Also, mitochondrial
homeostasis can be impacted by declining NAD+ levels, requiring more resource input to
generate ATP in less functional mitochondria in aged tissue (Gomes et al. 2013). Taken
together, increased consumption, decreased biosynthetic capacity and lower energy
production efficiency contribute to an NAD+-deficient system in aged models.
In the face of declining NAD+ levels in pathology, there may be an opportunity for
augmentation of NAD+ levels either by upregulating Nampt expression or with the delivery
of NAD+ precursors. Historically, niacin (consisting of NAD+ precursors NAM and NA)
has been used therapeutically to treat dyslipidemia by lowering triglycerides circulating in
the blood stream and raising HDL levels (Creider et al. 2012). However, two clinical trials
have reported that niacin did not reduce cardiac events in high-risk patients (Ginsberg and
Reyes-Soffer 2013). Additional studies suggest that niacin’s benefits on vascular health act
independently of its lipid-lowering effects (Wu et al. 2010, Huang et al. 2012, Lavigne and
Karas 2013). Instead, recent work suggests that niacin can improve endothelial function
and reduce oxidative stress (Kaplon et al. 2014), thereby enabling stress management in
models of ischemia & reperfusion injury or stroke (Chen et al. 2007).
NMN supplementation has been reported to protect the heart from ischemia &
reperfusion injury (Yamamoto et al. 2014) and to treat diabetes in aged mice (Yoshino et
al. 2011). Endogenous Nampt is decreased in response to cardiac ischemia and reperfusion
(Hsu et al. 2009). Augmenting NAD+ levels by NMN supplementation mitigates the effects
of the ischemia and reperfusion injury in a Sirt1-dependent fashion (Yamamoto et al.
2014). In diabetic mice induced by a high-fat diet, Nampt-mediated NAD+ biosynthesis is
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compromised in liver and adipose tissue. NMN administration successfully restored
NAD+ levels in the liver and adipose of diabetic mice, and even in diabetic skeletal muscle,
a moderate but significant increase in NAD+ was detected (Yoshino et al. 2011). NMN
supplementation was also beneficial in models of age-induced type II diabetes (Yoshino et
al. 2011). In two additional studies, NMN was found to overcome NAD+ decline in skeletal
muscle induced by age-associated increases in Parp activation (Gomes et al. 2013,
Mouchiroud et al. 2013). The mechanisms by which extracellular NMN is converted to
cellular NAD+ also remain elusive. On the one hand, it was claimed that NMN is
transported intact to hepatocytes (Yoshino et al. 2011). On the other hand, it has been
proposed that extracellular dephosphorylation of NMN to nicotinamide riboside (NR) is
required to elevate cellular NAD+ metabolism (Belenky et al. 2007, Nikiforov et al. 2011,
Grozio et al. 2013, Sociali et al. 2016).
NR metabolism constitutes an additional path for NAD + biosynthesis. NR has been
identified as a nutrient naturally present in the human diet including milk. NR offers a
favourable mechanism of absorption into the cell. NR is transported into cells by
nucleoside transporters (Nikiforov et al. 2011) and is then phosphorylated by the NR
kinases 1 and 2 (Nrks) (Bieganowski and Brenner 2004), generating NMN. NR has been
observed to stably elevate NAD+ levels and increase NAD+ bioavailability in HEK293,
Neuro2a, AB1, C2C 12 and Hepa1.6 mammalian cell lines (Yang et al. 2007, Canto et al.
2012). In addition, NR has potential therapeutic benefits over NAM. NAM has been
reported to negatively affecting Sirt activity, whereas NR increases Sirt activities (Canto et
al. 2012, Brown et al. 2014). Further, niacin (consisting of NA and NAM) has been known
to induce painful flushing; these side effects may be avoided by instead administering NR
(Creider et al. 2012).
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1.6

Aims of thesis
In summary, maintaining a pool of bioavailable NAD+ involves the metabolism of

different precursors, and the regenerative activity of Nampt. In short, it is a complex
process of biosynthesis that is of vital importance to the health and vitality of a cell. As the
rate-limiting enzyme in the regeneration of cellular NAD+, Nampt is a point of
vulnerability in maintaining an equilibrium of NAD+ levels. Work done by Dr. Pickering’s
research group had previously identified that Nampt is expressed in endothelial cells and
SMCs (Ho et al. 2009). We have also shown that expression in smooth muscle cells is
dynamic: Nampt expression is decreased in aging and senescent primary human smooth
muscle cells, and in HITC6 cells, and an increase in Nampt expression has been correlated
with a shift of the SMC phenotype from a contractile to a synthetic phenotype (van der
Veer et al. 2007). Overexpressing Nampt in SMCs and endothelial cells in culture enhances
cell life span via enhancing Sirt1 activity and p53 degradation (van der Veer et al. 2007).
Nampt overexpression leads to an increase of NAD+ in the cells, associated with prolonged
cell survival and resistance to oxidative stress (van der Veer et al. 2007, Borradaile and
Pickering 2009, Ho et al. 2009). It has also been established that increases in oxidative
stress and SMC senescence in vivo has been associated with vascular disease and
dysfunction. Senescent SMCs and endothelial cells have been identified in human
atherosclerotic samples (Minamino et al. 2002, Minamino et al. 2003, Matthews et al.
2006). Senescent aortic SMCs have also been identified in mouse models of hypertension
(Boe et al. 2013, Vafaie et al. 2014) and aging (Yepuri et al. 2012, Wang and Shah 2015).
However, the role of Nampt in SMCs in vivo is unknown. Additionally, although there is
very recent evidence that Nampt is globally important to the adult mouse, the tissuespecific vulnerabilities of global Nampt ablation are unclear and it is also unclear if a
global Nampt deficiency could be overcome by augmenting an NAD+ generation pathway.
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Therefore, the broad aims of my research were two-fold: 1) to the elucidate the role
that Nampt plays in maintaining the integrity of the vascular tissue; and 2) to determine the
role that Nampt plays globally and if a global Nampt deficiency is able to be overcome. To
address these 2 broad goals I generated two new mouse models of Nampt knockout in order
to characterize the ensuing deficiencies: a smooth muscle-specific Nampt knockout mouse
and a mouse model in which Nampt could be deleted in the whole body in an inducible
fashion.
In order to address the broad aims of my research I had four specific aims:
1. To determine if Nampt in smooth muscle cells is required to maintain vascular
stability in the mouse.
2. To determine if there is a relationship between Nampt biology and life-threatening
ascending aortic dysfunction in humans.
3. To determine if Nampt in smooth muscle cells regulates the mechanical structure of
the aorta.
4. To determine if there are fundamental Nampt requirements in organs in addition to
the aorta in the adult mouse.
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CHAPTER 2 - NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE IN
SMOOTH MUSCLE CELLS MAINTAINS GENOME INTEGRITY AND
RESISTS AORTIC MEDIAL DEGENERATION
2.1

Introduction
The aortic wall is subjected to unrelenting hemodynamic stress.

Although

structurally designed to withstand this stress, the aorta can nonetheless degenerate over
time, particularly when also subjected to hypertension, atherosclerosis, or the effects of
genetic mutations (Schlatmann and Becker 1977, Howard et al. 2013). When the aorta
degenerates it dilates and becomes vulnerable to dissection and rupture. Vascular SMCs
are critical to maintaining aortic integrity, evidenced by the development of thoracic
aneurysms in individuals with mutations in SMC-specific genes (Milewicz et al. 2008).
SMCs have a range of functions relevant to aortic homeostasis including contraction,
synthesis of extracellular matrix (ECM), and the assembly of ECM fibers in accordance
with local mechanical forces (Li et al. 2003, Humphrey et al. 2014). However, the
abundance and functionality of SMCs can decline with age and chronic diseases
(Schlatmann and Becker 1977, Ruiz-Torres et al. 1999, van der Veer et al. 2007, Halushka
et al. 2016). Understanding the molecular pathways that can be engaged by SMCs to
survive and retain their repertoire of functions in the stressed environment of the aortic wall
may be critical to advancing strategies for reducing aortic catastrophes.
Nicotinamide adenine dinucleotide (NAD+) is an essential dinucleotide that serves
as a cofactor for the oxidation-reduction events of cellular nutrient metabolism. NAD+ can
also serve as a signaling nucleotide that regulates gene expression, genome integrity, and
mitochondrial function. When NAD+ participates in signaling reactions, it does so as an
enzyme substrate rather than a cofactor and is thus consumed in the process. The most
potent NAD+-consuming reaction is believed to be the assembly of poly(ADP-ribose)
(PAR) on histones, an event triggered by DNA strand breakage and catalyzed by the
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enzyme poly(ADP-ribose) polymerase-1 (PARP1) (Dantzer et al. 2006). Other NAD+
consuming enzymes include those of the sirtuin family, which catalyze deacetylation and
ADP-ribose transfer reactions, and CD38, which generates cADPR (Nikiforov et al. 2015).
The growing recognition of the importance of NAD+-consuming reactions has
heightened interest in understanding the pathways by which NAD+ is generated and
replenished. NAD+ can be synthesized from dietary sources but the routes to NAD+
production are proving to be complex and tissue-specific (Canto et al. 2015). Important to
maintaining the NAD+ pool is the salvage pathway, wherein nicotinamide liberated during
NAD+-consuming reactions is recycled back to NAD+ (van der Veer et al. 2005, Revollo et
al. 2007, Nikiforov et al. 2015). Nicotinamide phosphoribosyltransferase (Nampt) is the
rate-limiting enzyme for this salvage pathway, converting nicotinamide to nicotinamide
mononucleotide (van der Veer et al. 2005). Development of the mouse embryo cannot
proceed without Nampt (Revollo et al. 2007). As well, gene targeting strategies in mice
have revealed a pattern of degenerative or aging-related tissue dysfunction when Nampt is
perturbed, including in the liver, skeletal muscle, and brain (Stein and Imai 2014, Frederick
et al. 2016, Zhou et al. 2016).
A role for Nampt in SMC-based vascular health is less clear but the possibility has
been raised. Nampt is expressed in cultured SMCs and its content and activity decline
during advanced SMC aging (van der Veer et al. 2005, van der Veer et al. 2007). As well,
Nampt has been found to regulate in vitro SMC longevity and migratory behaviour (van
der Veer et al. 2007, Yin et al. 2012) There are also reports that exogenous delivery of
Nampt impacts SMC contractile function, although with contradictory findings (Wang et
al. 2016) Nampt is expressed in peri-aortic adipose tissue (Wang et al. 2009) and altering
NAD+ metabolism through the diet has been found to suppressed age-related aortic
dysfunction (de Picciotto et al. 2016). However it remains unknown whether Nampt is
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needed for aortic health or if a Nampt-based NAD+ generation system exists within the
aortic media.
I have investigated the role of Nampt in the aortic media by in vivo ablation of
Nampt in SMCs in mice. My findings reveal the existence of an intrinsic NAD+ fueling
system in the aortic media and its necessity for maintaining aortic integrity. The findings
also shed new insights into DNA repair and senescence resistance cascades in the aortic
media that may underlie vulnerability in NAD+ homeostasis in thoracic aortopathy.
2.2
2.2.1

Methods
Generation of Nampt-deficient mouse models
Mouse experiments followed protocols approved by the Western University Animal

Use Committee. All mice were on a C57Bl/6 background. To generate mice with a SMCspecific knockout of Nampt, an initial cross was undertaken between female mice
harbouring loxP sites flanking exons 5 and 6 of Nampt (Namptflox/flox)(Rongvaux et al.
2002) and male transgenic mice expressing Cre recombinase and eGFP under the control of
the SMC-specific myosin heavy chain promoter (smMHC-Cre/eGFP, Jackson Laboratories,
Bar Harbor, ME) (Xin et al. 2002). Expression of Cre in the aorta of the latter mice was
verified by whole tissue epifluorescence microscopy (Zeiss SteREO Lumar V12
Microscope, Carl Zeiss Canada Ltd, Toronto, ON, Canada) and by immunostaining OCTembedded frozen sections using an anti-eGFP antibody (Fig. S1). In a second round of
breeding, the male SMC-targeted Nampt heterozygotes (Namptflox/+; smMHC-Cre+) were
bred with female Namptflox/flox mice. Because of transient expression of Cre in the sperm of
male smMHC-Cre/eGFP mice (de Lange et al. 2008), the floxed allele transmitted from the
Cre-expressing parent is recombined, yielding a global heterozygous null allele of Nampt
(hereafter referred to as “-”). Genotyping using PCR primers to amplify floxed, wildtype,
exon 5/6-deleted Nampt, and the Cre transgene (Rongvaux et al. 2002, Xin et al. 2002)
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confirmed the four possible genotypes of the offspring: Namptflox/+; smMHC-Cre- (wildtype), Namptflox/+; smMHC-Cre+ (SMC-specific Nampt heterozygous), Namptflox/-;
smMHC-Cre- (global Nampt heterozygous), and Namptflox/-; smMHC-Cre+ (SMC-specific
knockout with a global heterozygous Nampt background, “SMC-Nampt KO”). We used
the wild-type mice as control and global Nampt heterozygous as an additional control for
key endpoints. Importantly, prior studies have shown that global Nampt heterozygous mice
are not overtly different from wild-type mice (Revollo et al. 2007). SMC-Nampt KO mice
in the upper size tertile at 10-12 weeks of age were used for all studies.
We also generated mice in which Nampt could be globally and inducibly deleted.
Namptflox/flox mice were bred with mice expressing Cre recombinase fused to the mutated
ligand binding domain of the human estrogen receptor (ER) under the control of a chimeric
cytomegalovirus immediate-early enhancer/chicken ß-actin promoter (B6.Cg-Tg(CAGCre/Esr1)5Amc/J) (Jackson Laboratories, Bar Harbor, ME) (Hayashi and McMahon 2002).
SMCs harvested from aortas of Namptflox/flox Cre-ERT2 mice were subjected to hydroxyltamoxifen or sunflower oil vehicle for 24 hours.
2.2.2

NAD+ measurement
Mouse aortic medial NAD+ levels were determined in freshly harvested aorta after

removing the adventitial layer by dissection and denuding the endothelial layer by
scraping. NAD+ content in the mouse aortic media was determined using a colorimetric kit
(BioVision Research Products, Mountain View, CA, USA) and expressed relative to total
protein content.
2.2.3

Laser capture microdissection and RNA isolation of mouse aortas
Laser capture was undertaken on 10 µm-thick frozen sections of the mouse

descending thoracic aorta that had been embedded in OCT compound (Tissue-Tek). The
medial layer was micro-dissected (Arcturus 704 Veritas LCM System, Harlow Scientific,
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Arlington, VA) from 20 sections of an individual aorta and RNA extracted using TRIzol
(Life Technologies) with the addition of linearized polyacrylamide (2 mg/ml, Sigma)
following phase separation.
2.2.4

Drug Delivery in Mice
Mini-osmotic pumps (Alzet Model 2004, Durect Corp., Cupertino, CA) were

implanted subcutaneously in the right flank for infusion with either saline or Ang II (1.44
mg/kg/day) for 7 or 28 days. Implantation was performed after inducing anesthesia with
3% isofluorane in 100% oxygen at a flow rate of 1 L/min.

In a subset of mice,

phenylephrine (Sigma, 30 mg/kg/day) was infused via mini-pump for 14 days, with
implantation of an Ang II-infusing pump (1.44 mg/kg/day) on the opposite flank on day 7,
such that both phenylephrine and Ang II were infused for seven days. Parp activity was
inhibited by twice daily intraperitoneal injections of olaparib (50 mg/kg, AZD2281,
Selleckchem, Houston, TX) for eight days, beginning 24 hours prior to implantation of
saline or Ang II-loaded minpumps.
2.2.5

Blood pressure measurement
Blood pressure and heart rate were measured by noninvasive tail cuff (CODA, Kent

Scientific Corp., Torrington, CT) (Vafaie et al. 2014). Mice were acclimatized by
undergoing daily blood pressure recordings for one week prior to data acquisition. For data
acquisition, 35 serial blood pressure measurements were performed and the average of the
last 30 cycles recorded.
2.2.6

Aortic wall morphometry
Mice were anesthetized with ketamine/xylazine and perfused via the left ventricle

with phosphate-buffered saline (PBS) and then paraformaldehyde (4% wt/vol) under
physiological pressure for 30-45 minutes.

After immersion in 4% paraformaldehyde

overnight, two-mm segments from four distinct aortic zones (Owens et al. 2010) were
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embedded in paraffin: ascending aorta (1 mm distal to the aortic valve); descending
thoracic aorta (5 mm distal to the left subclavian artery); suprarenal abdominal aorta
(proximal to the superior mesenteric artery); and infrarenal abdominal aorta (distal to the
left renal artery).

Five-µm sections were stained with hematoxylin-eosin or Movat’s

pentachrome and visualized with an Olympus BX51 microscope. Medial area, lumen area,
and medial cell number were quantified from 3 sections 200 µm apart, in each of the four
aortic regions, avoiding areas with aortic hematoma or dissection, using ImageJ software
(NIH, Bethesda, MD). Focal areas of medial cell loss in the descending thoracic region
were traced and expressed relative to that of the media. Aortic dissection was defined by
the presence of blood in one or more of the aortic medial layers extending contiguously for
at least 200 µm.
2.2.7

Immunohistochemistry and apoptosis of mouse aortic tissue
Immunostaining was performed on paraffin-embedded sections (for Nampt, eGFP,

8-oxodG, smooth muscle α-actin, p16, γ-H2AX, and cascapse-3). Primary antibodies
were: rabbit polyclonal anti-eGFP (AB3080 1:50; EMD Millipore, Billerica, MA), mouse
monoclonal anti-smooth muscle α-actin (Clone 1A4, A5228 1:500, Sigma, Oakville, ON,
Canada), rabbit polyclonal anti-Nampt (A300-372A 1:50; Bethyl Laboratory, Montgomery,
TX), mouse monoclonal anti-8-oxodG (NWA-MOG020 1:50; Northwest Life Sciences,
Vancouver, WA), rabbit polyclonal anti-p16 (sc-28260 1:50; Santa Cruz Biotechnology,
Dallas, TX), rabbit monoclonal anti-γ-H2AX (#9718 1:400; Cell Signaling, Danvers, MA),
rabbit polyclonal anti-active caspase-3 (ab4051 1:50; Abcam, Cambridge, MA), rabbit
monoclonal anti-Ki67 (ab16667 1:100; Abcam, Cambridge, MA), and rabbit polyclonal
anti-CD45 (ab10558 1:200; Abcam, Cambridge, MA). Bound primary antibodies against
eGFP, Nampt, 8-oxodG, p16, Ki67 and CD45 were detected using goat anti-rabbit or goat
anti-mouse biotinylated antibody (Vector Labs, Burlington, ON, Canada) and visualized
using an ABC kit and diaminobenzidine (DAB, Vector Labs) and counterstained with
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Harris’ hematoxylin. Bound primary antibodies against smooth muscle α-actin and γH2AX were detected using Alexa Fluor 488-conjugated goat anti-mouse and donkey antirabbit secondary antibody, respectively (Molecular Probes; Life Technologies, Burlington,
ON, Canada) and nuclei were counterstained with propidium iodide. The proportion of
immuno-positive cells in a given aortic zone was ascertained from 3 sections, separated by
200 µm, with a minimum of 500 cells evaluated. Terminal deoxynucleotide transferasemediated dUTP nick end labeling (TUNEL) was used to assess apoptosis on paraffinembedded sections (Roche Applied Science).
2.2.8

Senescence associated ß-galactosidase activity
Senescence associated ß-galactosidase (SA ß-gal) activity in the mouse aortas was

determined as described (Vafaie et al. 2014) Briefly, anesthetized mice were subjected to
antegrade perfusion via the left ventricle of phosphate-buffered saline (PBS) followed SA
ß-gal solution (1 mg/ml X-Gal, 5 mmol/l potassium ferrocyanide, 5 mmol/l, potassium
ferricyanide, 150 mmol/l NaCl, 2 mmol/l MgCl2, 40 mmol/l citrate (titrated to pH 6.0 with
NaH2PO4). Aortas were then harvested, incubated in SA-ßGal staining solution at 37°C for
16 h, fixed in 4% paraformaldehyde for 16 hours. Whole aortas were imaged with a Nikon
SMZ800 stereomicroscope (Nikon Instruments, Mississauga, ON, Canada). Tissue was
then frozen, embedded in OCT, and 10-µm cryosections were imaged microscopically to
assess for positively stained blue cells.
2.2.9

Cell culture
Mouse aortic SMCs were isolated from aortas of 8-10-week-old mice via chemical

digestion using type III porcine pancreatic elastase (250 µg/ml, Sigma) and type I
collagenase (1 µg/ml, Worthington Biochemical Corporation, Lakewood, NJ) (Ray et al.
2001). SMCs were maintained in DMEM with 10% FBS and SMC identity confirmed by
immunostaining for smooth muscle a-actin. SMCs harvested from aortas of Namptflox/flox
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Cre-ERT2+ mice were subjected to 1 µM hydroxy-tamoxifen for 24 hours. In order to
control for the effect of tamoxifen, Namptflox/flox Cre-ERT2- (control) SMCs were also
subjected to 1 µM hydroxy-tamoxifen for 24 hours. Rat aortic SMCs were isolated as
previously described (Small and Pickering 2009) and maintained in DMEM with 10%
FBS. All cells were studied within the first 4 subcultures.
2.2.10 Western blot analysis
Western blot analysis was undertaken with chemiluminescent detection as
previously described (Frontini et al. 2009). Blots were probed by incubating with primary
antibodies reacting to PAR (#528815 1:2,000; Calbiochem/EMD Millipore, Billerica, MA),
Parp1 (ab6079 1:400; Abcam, Cambridge, MA), and α-tubulin (clone B-5-1-2 1:10,000,
Sigma).
2.2.11 Detection of double-strand DNA breakage
Mouse SMCs subjected to irradiation at a dose rate of 1 Gy/minute for ten minutes
(10 Gy) (Faxitron RX-650, Faxitron Bioptics, Tucson, AZ) or incubated with Ang II (10-7
mol/L) for 24 hours were fixed in 4% paraformaldehyde for 20 minutes. Cells were
permeabilized in 0.5% Triton X-100 and incubated with rabbit antibody to γ-H2AX (#9718
1:300; Cell Signaling, Danvers, MA). Signal was detected by incubating with anti-rabbit
Alexa Fluor 488 secondary antibody (Invitrogen, Burlington, ON, Canada) and nuclei were
counterstained with 4′,6′-diamidino-2-phenylindole (DAPI, Invitrogen). γ-H2AX foci were
quantified from at least 300 cells per condition based on fluorescent pixel density, applying
a single background threshold for all images and using ImageJ, as described (Fell and
Schild-Poulter 2012).
2.2.12 Detection of global DNA strand breakage by Comet assay
Mouse SMCs incubated with 1 mM H2O2 (15 minutes) or 10-7 mol/L Ang II (24
hours) were analyzed for DNA strand breaks by single cell alkaline electrophoresis
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(CometAssay, Trevigen Gaithersburg, MD). Cells were trypsinized, suspended in 50 µl of
low-melting point agar, transferred onto slides, and incubated at 4°C to allow the agar to
set. Cells were then lysed in alkaline buffer and electrophoresed for 30 minutes with 300
mAmps of current. Cells were subsequently stained with SYBR-gold DNA stain and
imaged (Olympus BX51). The comet tail moment (product of the tail length and fraction of
total

DNA

in

the

tail)

was

measured

using

ImageJ

and

OpenComet

(cometbio.org/index.html).
2.2.13 Time-lapse microscopy response to DNA damage
To evaluate the response to specific DNA damaging agents, Namptflox/flox SMCs,
with or without expression of Cre-ERT2, were incubated with 1µM hydroxyl-tamoxifen for
24 hours and cultured for an additional 72 hours to ensure Nampt depletion. Cells were
incubated with designated concentrations of H2O2 or MMS for 1 hour and morphology
tracked by video microscopy every 15 minutes for the following 24 hours. Cell death was
identified based on either cell rounding with detachment from the plate, or a combination
of collapse of the cytoskeleton, dissolution of nuclear structure, and complete cessation of
movement. The effect of nicotinamide riboside on MMS-induced DNA damage was
assessed by pre-incubating cells with 100 µM nicotinamide riboside (Chromadex, Irvine,
CA) for 24 hours in NAD+ precursor-free modified Eagle’s medium (MEM) prior to
addition of 600 µM MMS.
2.2.14 Immunocytochemical detection of poly(ADP-ribose)
Mouse SMCs fixed in 4% paraformaldehyde were permeabilized in 0.5% Triton X100 and incubated with mouse anti-PAR antibody (4335-MC-100, 1:500; Trevigen,
Gaithersburg, MD). PAR signal was detected with Alexa Fluor 546-conjugated goat antimouse secondary antibody (Molecular Probes; Life Technologies, Burlington, ON,
Canada) and nuclei were counterstained with DAPI. PAR signal was quantified from at

73

least 300 cells per condition based on fluorescent pixel density, applying a single
background threshold for all images and using ImageJ, as described (Fell and SchildPoulter 2012).
2.2.15 Quantitative real-time reverse transcription–polymerase chain reaction
Total RNA was isolated from homogenates of the mouse aorta using TRIzol (Life
Technologies) and the Rneasy Mini Kit following the manufacturer’s protocol (Qiagen,
Valencia, CA). Total RNA was isolated from mouse SMCs using the Rneasy Mini Kit
following the manufacturer’s protocol. Transcript abundance of Nampt and Gapdh in
microdissected mouse aortas was assessed using TaqMan chemistry-based primer-probe
sets (Nampt, Mm00451938_m1; Gapdh, Mm99999915_g1, Applied Biosystems).
Transcript abundance of mouse Nampt, Acta2, Mmp2, Col1a1, Timp1, and 18S were
assessed

using

SYBR-green

chemistry-based

primer

sets

(mouse

Nampt:

F-

GGCACCACTAATCATCAGACCTG R-AAGGTGGCAGCAACTTGTAGCC; mouse
Acta2: F-TGCTGACAGAGGCACCACTGAA R-CAGTTGTACGTCCAGAGGCATAG;
mouse

Mmp2:

F-GAGACCATGCAGTCAGCTCTAG

TAGAGCTGCCTCTTGTCTGGT;
CCTCAGGGTATTGCTGGACAAC

mouse

Col1a1:

R-CAGAAGGACCTTGTTTGCCAGG;

RFmouse

Timp1: F-TCTTGGTTCCCTGGCGTACTCT R-GTGAGTGTCACTCTCCAGTTTGC;
mouse 18S F-GTAACCCGTTGAACCCCATT R-CCATCCAATCGGTAGTAGCG).
Quantitative real-time RT-PCR was performed using an ABI Prism (model 7900HT) and
Sequence Detection System software (Life Technologies; Applied Biosystems). For mouse
aortas and SMCs, relative mRNA abundance was quantified based on critical threshold
(CT) using the comparative CT formula, 2-ΔΔCT, with Gapdh or 18S mRNA as an internal
control.
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2.2.16 Statistical analyses
Values are expressed as mean±standard error of the mean. Statistical analyses were
performed using GraphPad Prism software (GraphPad, La Jolla, CA, USA). Mean data
were compared using Student’s t-test or one- or two-way ANOVA with Holm-Sidak post
hoc testing. The prevalence of aortic dissection and of in vivo SA ß-gal activity were
compared among groups by chi-squared analyses.
2.3
2.3.1

Results
Generation of mice with SMC Nampt gene ablation
To determine if Nampt within SMCs plays a role in aortic health, I generated mice

with targeted deletion of Nampt in SMCs, using the smMHC-Cre/eGFP expressing mouse
line(Xin et al. 2002) and Namptflox/flox mice (Rongvaux et al. 2008). Evaluation of eGFP in
smMHC-Cre/eGFP mice confirmed Cre recombinase in the aorta, as assessed by whole
organ microscopy and immunostaining (Fig. 2.1). Analysis of over 200 offspring from a
two-step breeding protocol revealed close to expected Mendelian ratios for the predicted
genotypes: 26.7% WT, 29.1% SMC-specific Nampt heterozygous, 20.6% Nampt
heterozygous, and 23.5% SMC-Nampt KO.
Laser capture microdissection and quantitative RT-PCR revealed that Nampt
transcript abundance in thoracic aortic media of SMC-Nampt KO mice was reduced to
13.5% that of control mice (Fig. 2.2a). Immunostaining revealed nuclear and extra-nuclear
Nampt protein in medial SMCs of control aortas, with the nuclear signal being stronger
(Fig. 2.2b). Nampt was undetectable in the aortic media of SMC-Nampt KO mice in all but
rare cells but still detectable in endothelial cells and adventitial cells (Fig. 2.2b). I also
determined aortic NAD+ content, using an NAD+ cycling assay. This revealed a 43.2%
reduction in NAD+ content in SMC-Nampt compared to control mice (Fig. 2.2c). Thus,
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smMHC Cre -

smMHC Cre +

40 μM

40 μM

Figure 2.1 eGFP expression in aorta of smMHC-Cre-eGFP+ mice
Fluorescent stereomicroscopy images of whole thoracic aortas (top) and paraformaldehyde-fixed sections of
thoracic aorta (bottom), immunostained for eGFP signal in 8-week-old smMHC-Cre-eGFP+ mice.
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Figure 2.2 Generation of mice with Nampt-deficient aortas

D
ControlNampt transcript abundance in the
A. Graph depicting
KOmouse aortic media harvested using laser capture
microdissection, measured by quantitative RT-PCR, and normalized to 18S expression. Medial tissues from
3 mice for each genotype were studied. *P=0.0034 vs Control, †P<0.0001 vs Control, by 1-way Anova. B.
Photomicrographs of thoracic aortic sections from control and SMC-Nampt KO mice, immunostained for
Nampt. Black arrows depict Nampt expression in SMCs, red arrows depict Nampt expression in endothelial
40 μm

cells. C. Graph of NAD+ content in acidic extracts of endothelium-denuded aortas of control and SMCNampt KO mice. *P=0.024 vs control, by Student’s T-test.
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Nampt is expressed in SMCs of the mouse aortic media and its depletion in SMCs,
obtained using a Cre-lox approach, compromised aortic NAD+ homeostasis.
2.3.2

Mice with SMC Nampt deletion have modestly dilated thoracic aortas
SMC-Nampt KO mice were viable and displayed no gross evidence of vascular

anomalies. The average mean arterial pressure and heart rate of 8-week old SMC-Nampt
KO mice were not significantly different than those of control mice (Fig. 2.3a).
Immunostaining revealed abundant smooth muscle α-actin in medial SMCs, a normal
number of lamellar units throughout the aorta, and unaltered medial SMC content (Fig.
2.3b-c). Quantification of lumen area of aortas fixed at physiologic pressure did however
reveal modest dilatation of the ascending and descending thoracic aortic regions (by 16.7%
and 12.4%, Fig. 2.3d). As well, the aortic medial areas of SMC-Nampt KO mice were
mildly reduced in the ascending, descending thoracic, and suprarenal regions (by 13.2,
17.0, 24.5%, respectively, Fig. 2.3e).

Transcript analysis revealed a modest (27.2%)

decrease in mRNA abundance of SM-a-actin (P=0.001) and a 1.4-fold increase in Mmp2
expression (P=0.005) with no change in Timp1 expression (P=0.010).
2.3.3

Mice with SMC Nampt deletion are susceptible to Ang II-induced aortic
dissection
To ascertain the response of the Nampt-deficient aorta to disease-associated stress,

mice were subjected to continuous delivery of Ang II (1.44 mg/kg/day) by subcutaneous
mini-pump.

Interestingly, this was associated with a 54% decrease in aortic Nampt

transcript abundance (P=0.009) and a concordant trend for NAD+ content (P=0.063, Fig.
2.4a,b). Mean arterial blood pressure increased at 7 days, with no significant differences
among the groups (25.3±4.3, 16.5±18.0, and 34.5±22.3 mm Hg for WT control, Nampt
heterozygous control, and SMC-Nampt KO, respectively, p=0.285). However, there was
striking aortic hemorrhage in SMC-Nampt KO mice, evident microscopically and grossly.
Half of the mice displayed aortic hematomas after 7 days and this increased to 62.5% on
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Figure 2.3 Deletion of Nampt in SMCs in mice yields modest aortic dilatation
A. Blood pressure and heart rate measurements of wild-type, Nampt heterozygous, and SMC-Nampt
knockout mice were obtained weekly for 6 weeks for each mouse and averaged. Values depict mean data
from 10-12 mice per genotype. B-E. Graphs showing the number of elastic lamellae per regional cross
section (E), medial cell density (F), regional aortic lumen area (G) and medial area (H). *P=0.023 and
†P=0.029 vs. respective lumen area control, *P=0.029, †P=0.004, and ‡P=0.027 vs. respective medial area
control. N=5-6 mice per group.
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Figure 2.4 Angiotensin II decreases Nampt expression and NAD+ content in mSMCs and mouse aortas
A. Graph depicting Nampt transcript abundance as normalized to 18S transcript abundance in the media of the
thoracic aorta of C57Bl/6 mice infused with Ang II (1.44mg/kg/day) or vehicle for 7 days, measured by
quantitative RT-PCR (n=3 mice per group) B. Graph of NAD+ content in acidic extracts of aortic media of
vehicle- or Ang II-infused mice (n=4 mice per group).
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day 28. The hemorrhage typically was within the outer one or two medial layers and could
be extensive, with local elastin breakage (Fig. 2.5a). The hematomas did not rupture into
the adventitia, as typically seen in Ang II-infused atherosclerotic mice, but instead could be
found at multiple sites and dissecting along the length of the aortic media. In contrast,
there was no grossly detectable hemorrhage in control mice subjected to Ang II, although
microscopic hemorrhage in the ascending aorta was found in 24% of mice. These small
bleeds, also noted in other reports (Rateri et al. 2014), had resolved by 28 days of Ang II
delivery (Table 2.1). A similar profile was observed for Nampt heterozygous mice (14%
microscopic hemorrhage in the ascending aorta). Transcript analysis of whole aortas
revealed that SM-a-actin expression was 22.2% lower in Ang II-infused SMC-Nampt KO
than Ang II-infused control mice (P=0.0001) and expression of Col1a1 was 37.4% lower
(P=0.002). However, the Mmp2/Timp1 ratio did not increase and in fact reduced somewhat
(20.9% P=0.002). Immunostaining for CD45 showed no differences between control and
SMC-KO mice before or after Ang II infusion (data not shown).
Because of a trend toward greater Ang II-induced blood pressure response in SMCNampt KO mice, I determined if blood pressure elevation, in and of itself, might be
responsible for the more striking aortic disruption. For this, control mice were subjected to
double infusion of phenylephrine and Ang II, which elevated the mean arterial pressure by
37.2±16.4 mmHg. This increase was associated with only localized hemorrhage confined
to the ascending aorta in 25% of mice (n=8), a profile not different than that of control
mice. Collectively, these findings reveal that aortas in SMC-Nampt KO mice are prone to
Ang II-induced disruption by hematoma and dissection, with minor changes in expression
of SM-α-actin and type I collagen chains. Furthermore, whereas control mice adapted to
the disrupting potential of Ang II over 28 days, SMC-Nampt KO mice remained
vulnerable.
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Figure 2.5 SMC-Nampt KO mice are susceptible to aortic wall degeneration and dissection
A. Light micrographs of sections of the descending thoracic aorta of a control (left) and SMC-Nampt KO
(middle) mouse following 28 days of infusion with Ang II, stained with hematoxylin and eosin. The right
panel depicts an adjacent section of the KO aorta stained with elastin trichrome, showing confinement of
hemorrhage to the aortic media. B. Photomicrographs of sections of the ascending aorta stained with
hematoxylin and eosin from vehicle- and Ang II-infused (28 days) control and SMC-Nampt KO mice. C. D.
Graphs depicting cell content of the media cross-section after Ang II infusion in ascending (C), *P<0.0001 vs
control, and descending thoracic (D) aortas *P=0.002 vs. control.

82

Online Table II. Angiotensin
II-induced
aortic
medial hemorrhage
in mice in mice
Table 2-1 Angiotensin
II-induced
aortic
medial
hemorrhage
WT

Ascending
Thoracic
Suprarenal
Infrarenal
Total
(all regions)
Total
(all mice)

Nampt Heterozygous

SMC-Nampt KO

Ang II (7 days)
(n=17)

Ang II (28 days)
(n=10)

Ang II (7 days)
(n=7)

Ang II (28 days)
(n=7)

Ang II (7 days)*
(n=14)

Ang II (28 days)†
(n=8)

4 (23%)
0
0
0

0
0
0
0

1 (14%)
0
0
0

1 (14%)
0
0
0

6 (43%)
1 (7%)
2 (14%)
0

1 (13%)
1 (13%)
4 (50%)
0

4 (5.9%)

0

1 (3.6%)

1 (3.6%)

9 (16%)

6 (18.7%)

4 (23%)

0

1 (14%)

1 (14%)

7 (50%)

5 (62.5%)

*P=0.0002 vs 7-day WT distributions, P=0.0068 vs 7 day Nampt -Heterozygous distributions
†P=0.0106 vs. 28-day WT distributions, P=0.0328 vs 28-day Nampt Heterozygous distributions

!

"' !
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2.3.4

Ang II-induced cell loss in mice with SMC-Nampt KO mice
Twenty-eight days of Ang II infusion in control mice resulted in a 1.8-fold increase

in medial SMC content in the ascending aorta (Fig. 2.5b,c) but no change in SMC content
in the descending thoracic aorta, confirming a site-specific response that has been
previously noted (Owens et al. 2010) In contrast, in SMC-Nampt KO mice medial SMC
content in the ascending aorta did not increase in response to Ang II and in the descending
thoracic aorta SMC content actually fell by 25.2% (Fig. 2.5d). These aberrant responses
occurred despite evidence for residual SMC proliferation in Ang II-infused SMC-Nampt
KO mice, as indicated by Ki67 immunostaining (Fig. 2.6a,b), supporting a turnover profile
skewed toward cell loss. This loss of SMCs was evident both as scattered SMC dropout
and cell-free foci of proteoglycan-rich matrix (Fig. 2.6c).

Cell-poor zones were

occasionally observed in control aortas subjected to Ang II but were 70% larger in aortas of
SMC-Nampt KO mice (Fig 2.6d). Thus Nampt-depleted SMCs failed to adaptively fortify
the ascending aorta and repopulate damaged regions in the descending aorta.
2.3.5

SMCs within the aorta of SMC-Nampt KO mice are susceptible to stressinduced premature senescence
To determine if the aberrant SMC responses to Ang II were due to induction of

apoptosis, aortas were evaluated using TUNEL and active caspase-3 immunostaining.
Surprisingly, although Ang II-induced apoptosis was evident in adventitial cells, I did not
identify apoptosis signals in the ascending or descending thoracic aortic media of either
control or Nampt-deficient mice (Fig. 2.7a,b). I next asked if SMCs instead developed
features of senescence, recognizing that in vitro studies have implicated Nampt in slowing
SMC aging (van der Veer et al. 2007). Intravenous infusion and ex vivo immersion in XGal solution (Vafaie et al. 2014) revealed no SA ß-gal activity in the aorta of control mice
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Figure 2.6 Aortas of SMC-Nampt KO mice are not proliferative and have areas of cell-free zones
A. Mouse aortic medial SMC proliferation as determined by immunostaining for Ki67. Micrographs of
mouse ascending aorta 7 days after infusion with vehicle or Ang II (1.44 mg/kg/day), depicting Ki-67
immunoreactivity in control and SMC-Nampt KO mice (arrows). N=4 mice per group. B. Quantitative data
for both ascending and descending thoracic aorta sections are shown in the graph. C. Sections of descending
thoracic aorta from control (left) and SMC-Nampt KO (middle, right) mice following 28 days of infusion
with Ang II illustrating focal cell loss. The right panel is an adjacent section to that in the middle and stained
with Movat’s pentachrome. Arrow depicts proteoglycan-rich cell-poor zone.

D. Graph depicts the area of

focal zones of SMC loss in the thoracic aorta, *P=0.0003 vs. control. N=5 mice per group.
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Figure 2.7 Assessment of apoptosis in aortas by TUNEL and active caspase-3 expression
A. Fluorescent photomicrographs of ascending aorta of mice infused with Ang II for 7 days stained using
TUNEL (green). Nuclei were counter-stained with propidium iodide (red). Arrow indicates a TUNELpositive nucleus in the adventitia. Lu, lumen; Adv, adventitia B. Ascending aorta sections of mice infused
with vehicle or Ang II for 7 days and immunostained for active caspase-3 and counterstained with
hematoxylin. Arrows indicate active caspase-3 positive endothelial cell and adventitial cell nuclei
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subjected to Ang II. Remarkably however, in SMC-Nampt deficient mice there was SA ßgal activity throughout the ascending aorta, arch, and proximal descending thoracic aorta
after 7 days of Ang II infusion (Fig. 2.8a). Microscopy established that SA ß-gal activity
was confined to the medial layers of the aorta and particularly the outer medial layers (Fig
2.8b).
As an additional test for cell senescence, I immunostained aortic sections for the
cell cycle inhibitor, p16INK4a. This revealed a 6.1-fold increase in the abundance of p16expressing cells in the media of the ascending aorta of Ang II-infused SMC-Nampt KO
mice relative to Ang II-infused control mice and a 4.7-fold increase in the thoracic aorta
(Fig 2.8e). Therefore, Nampt deficiency impacts the fate of SMCs in the aorta, whereby
Ang II sends them into a state of premature senescence.
2.3.6

Nampt-deficient SMCs accumulate oxidized DNA lesions and single-stranded
DNA breaks
To explore why Nampt-ablated SMCs were prone to senescence I assessed for DNA

integrity. I first immunostained for the oxidized nucleoside, 8-oxo-2'-deoxyguanosine (8oxodG), recognizing that ROS can drive cell senescence (Yin and Pickering 2016). The
proportion of ascending aorta medial SMCs with oxidized DNA was 3-fold higher in SMCNampt KO mice than in control mice. After a 7-day infusion of Ang II, DNA oxidation in
SMC-Nampt KO aortas was even more prevalent and was 2.5-fold greater than in Ang IIinfused control mice (Fig 2.9a,b). The oxidized DNA profile for SMCs in the thoracic
aorta was similar although less striking (Fig. 2.9b).
I next asked if Nampt-deficient SMCs accumulated overt breaks in the DNA. For
this, I established a culture system that enabled us to time the ablation of Nampt and
evaluate different DNA break pressures. SMCs were cultured from aortas of Namptflox/flox
mice expressing Cre recombinase under the control of a tamoxifen-inducible promoter
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Figure 2.8 Nampt-deficient SMCs within the aorta undergo cellular senescence in response to Ang II
infusion
A. Whole mount images of ascending, arch, and proximal descending thoracic aortas harvested after 7 days of
Ang II infusion and stained for senescence-associated β-galactosidase (SA-ßGal) activity (blue).

B.

Cryosections of the ascending aorta depicting SA-ßGal activity localized to the aortic media. C. Chart
showing proportion of aortas (n=16) with SA-ßGal activity. *P=0.0011 D. Micrographs of ascending aorta
subjected to 7 days of vehicle or Ang II infusion and immunostained for p16. Arrows depict p16-postive
nuclei. E. Graph depicting prevalence of p16-positive nuclei.
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Figure 2.9 Nampt deficient aortas are susceptible to oxidative DNA damage
A. Micrographs of ascending aorta 7 days after infusion with Ang II, depicting oxidative DNA lesions as
indicated by 8-oxo-2’-deoxyguanosine (8-oxodG) immunoreactivity. B. Graph showing the percentage of 8oxodG-positive cells in the ascending and descending thoracic aortas. N=4 mice per group.
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(Cre-ERT2). I then evaluated electrophoretic migration of cleaved DNA out of harvested
nucleoids (“Comet” assay) after delivery of vehicle or hydroxy-tamoxifen. That latter
induced robust Nampt knockdown (Fig. 2.10a). Interestingly, there was evidence for
cleaved DNA in Nampt-ablated SMCs under baseline culture conditions (Fig. 10b,c).
Incubation with H2O2, (100 µM, 1 h) to induce single strand DNA breaks yielded more
striking DNA fragment tails and these were substantially more prominent in Nampt-ablated
SMCs. Incubation with Ang II (10-7 mol/L, 24 h) yielded a modest DNA fragment signal
that was significantly greater in Nampt-ablated SMCs (Fig 2.10b,c).
To further assess the response to DNA break-inducing agents, SMCs were tracked
by video microscopy. This revealed a striking death response in Nampt-depleted SMCs,
with cell rounding, anoikis, and cessation of cell membrane activity (Fig. 2.11a,b).
Incubating SMCs with MMS, another single-strand DNA breaking reagent, led to similarly
worse survival for Nampt-ablated SMCs (Fig. 2.11a,c). Notably, incubating SMCs with
nicotinamide riboside prior to MMS inhibited the death response (Fig. 2.11d). Together,
these studies reveal that Nampt protects SMCs from accumulating both oxidized DNA
lesions and a toxic burden of single-strand DNA breaks.
2.3.7

Nampt-deficient SMCs have impaired double-strand DNA break repair
Double-strand DNA breaks are a particularly stressful form of DNA damage and

potent driver of cell senescence (d'Adda di Fagagna 2008). Using the above culture system,
I assessed the potential for accumulating double-strand breaks by subjecting SMCs to
irradiation (10 Gy) and immunostaining for phosphorylated histone (γ-H2AX).
Interestingly, DNA damage foci were found in low abundance in Nampt-ablated SMCs
prior to irradiation. Upon irradiation, damage foci accumulated and were significantly
more abundant in Nampt-ablated SMCs. This difference was evident after 15 minutes but
also after 24 hours, at which time control SMCs showed near-complete resolution of the
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Figure 2.10 Nampt deficiency and susceptibility to oxidative DNA damage
A. Conditional deletion of Nampt in mouse aortic smooth muscle cells: SMCs were harvested and cultured
from aortas of Namptflox/flox; CreERT2+ mice and incubated with vehicle or hydroxy-tamoxifen for 24 hours.
Abundance of Nampt mRNA was evaluated by RT q-PCR and normalized to expression of Gapdh mRNA.
*P<0.0001 B. Fluorescent micrographs of fragmented DNA “comet” tails from mouse aortic SMCs subjected
to vehicle, 100 µM H2O2 (1 h), and 10-7 mol/L Ang II (24 h). C. Graph depicting mean±SEM SMC comet tail
moments, relative to controls SMCs incubated with vehicle. *P=<0.0001
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Figure 2.11 Nampt-depleted mouse SMCs are susceptible to death following exposure to H2O2 and
MMS
A. Time-lapse video images of control (vehicle-treated) and Nampt-deleted (hydroxy-tamoxifen-treated)
aortic SMCs harvested from Namptflox/flox; CreERT2+ mice. SMCs were incubated for one hour with H2O2
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undergoing anoiksis. Arrows depict a zone of cell content disintegration. B, C. Graphs depicting survival of
mouse aortic SMCs, 24 hours after incubation with H2O2 (*P=0.012, †P=0.014, ‡P=0.0001) or MMS
(*P=0.009, †P<0.0001). N=3 experimental replicates E. Graph depicting the survival of mouse aortic SMCs,
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breaks (Fig. 2.12a,b).

Incubation of Nampt-ablated SMCs with Ang II (24 h) also

increased double-strand DNA damage foci and this effect was still evident 24 h after Ang
II washout (Fig. 2.12c).
I next assessed if this form of DNA damage could be found in vivo. There were no
γ-H2AX-positive SMCs in the aortic media of mice subjected to vehicle infusion. Rare
(<0.5%) γ-H2AX-positive cells were found in control mice subjected to Ang II infusion
(Fig. 2.13a,b). In contrast, γ-H2AX-positive-SMCs were consistently detected in both
ascending (4.0%) and descending (3.8%) thoracic aortas of Ang II-infused SMC-Nampt
KO mice (Fig. 2.13b).
2.3.8

Parp activity is impaired in Nampt-deficient SMCs and its inhibition in vivo
promotes aortic SMC DNA damage and senescence
Parp1 has roles in repairing multiple types of DNA damage (Dantzer et al. 2006).

To determine if Parp1 activity was impacted by the disrupted NAD+ metabolism, I assessed
PAR assembly by Western blot analysis following irradiation of rat aortic SMCs.
Irradiation-induced PAR formation was markedly suppressed in SMCs incubated with the
Nampt inhibitor, FK866 (100 nM, Fig. 2.14a). The abundance of PARP1 itself did not
change upon Nampt inhibition. I also immunostained mouse aortic SMCs for PAR.
Abundant nuclear PAR signal emerged 15 minutes after control SMCs were exposed to
H2 O2 .

However, there was barely detectable nuclear PAR in Nampt-ablated SMCs

subjected to H2O2 (Fig. 2.14b,c). In the presence of nicotinamide riboside, PAR assembly
in irradiated Nampt-ablated SMCs was restored. Nuclear PAR also accumulated upon 24 h
of Ang II exposure. As seen with H2O2, the Ang II-induced PAR response was not evident
in Nampt-ablated SMCs, but was restored in the presence of nicotinamide riboside (Fig.
2.14d).
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Figure 2.12 Reduced Nampt and doubled-stranded DNA damage in mouse SMCs
A. Fluorescent micrographs depicting the response of mouse aortic SMCs to irradiation (10 Gy). Cells were
immunostained for γ-H2AX (green) and nuclei were labeled with Hoechst 33258 dye (blue). B. Graph
showing the cumulative pixel intensity per cell of γ-H2AX signal. C. γ-H2AX signal in control and Namptablated mouse aortic SMCs incubated with vehicle or 10-7M Ang II for 24 hours, and 24 hours after Ang II
washout.
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Figure 2.13 Reduced Nampt and double-stranded DNA damage in mouse aortas
A. Micrographs showing γ-H2AX-positive foci (green) in nuclei in the aortic media of mice subjected to a 7day infusion of Ang II. Nuclei were counterstained with propidium iodide (red). B. Graph depicting the
proportion of γ-H2AX-positive cells in the aortic media of mice subjected to a 7-day infusion of Ang II,
*P=0.044 vs. Control, ascending aorta; *P=0.022 vs. Control, thoracic aorta.
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Figure 2.14 Parp inactivation in Nampt-depleted SMCs
A. Western blots depicting poly(ADP-ribose) (PAR) moieties, Parp1, and tubulin content in rat aortic smooth
muscle cells incubated with FK866 (24 h) and subjected to irradiation (50 Gy). B. Immunofluorescence
images showing the presence of PAR moieties (green) in control and Nampt-KO SMCs subjected to 1 mM
H2O2 for 15 minutes. Nuclei were counterstained with DAPI (red). C. Graph depicting cumulative pixel
intensity per cell of PAR signal, *P<0.0001 vs. KO. D. Nuclear PAR signal, assessed by immunofluoresence,
in mouse aortic SMCs subjected to 10-7M Ang II or 24 hours, with and without the addition of 100 µM
nicotinamide riboside (NR) *P<0.0001 vs. KO.
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In addition, in vivo inhibition of Parp by IP injections of olaparib produced SMC
defects in control mice subjected to Ang II that were similar to those in Ang II-infused
SMC-Nampt KO mice. The proportion of p16-expressing medial SMCs increased by 2.7fold and 3.7-fold in the ascending and descending thoracic aorta, respectively (p=0.002,
p=0.023) and the proportion of SMCs positive for 8-oxodG increased by 2.2-fold and 1.9fold (p=0.0003, p=0.003, Fig. 15a,b). As well, γ-H2AX-positive SMCs were identified in
the media of Ang II-infused mice that received olaparib, and in a range similar to that of
Ang II-infused SMC-Nampt KO mice (Fig. 2.15c).
Collectively, these data indicate the presence of a NAD+-PARP1-DNA repair axis
in aortic SMCs and the dependence of this cascade on Nampt.
2.4

Discussion
This study reveals that aortic integrity depends on an intrinsic NAD+ generating

system within SMCs. By evaluating the consequences of Nampt knockout in these new
mouse models, I demonstrate that: i) ablation of Nampt in SMCs reduces NAD+ content in
the aortic wall and renders it vulnerable to dissection; ii) Ang II sends Nampt-depleted
SMCs in the aorta into a state of premature senescence; and iii) Nampt-deficient SMCs are
prone to accumulating a range of DNA lesions and are susceptible to exhaustion of Parp
activity.
The finding that SMC-Nampt KO mice have reduced aortic medial NAD+ content is
important given the multiple routes for synthesizing NAD+. There are at least five dietary
precursors to NAD+, four of which do not require Nampt. As well, NAD+ itself may be
directly delivered to cells from nearby cellular sources and an extracellular supply of
Nampt has been characterized (eNampt) (Revollo et al. 2007, Nikiforov et al. 2015).
However, the 43% drop in NAD+ in the aortic media revealed that none of these potential
alternative pathways circumvented the local loss of Nampt in SMCs. Given the resulting
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Figure 2.15 Effect of Parp inhibition on aortic SMC senescence and susceptibility to oxidative DNA
damage
A. Micrographs of ascending aorta sections 7 days after infusion with Ang II (1.44 mg/kg/day) as well as
daily i.p. injections of the Parp inhibitor, olaparib (50 mg/kg).
(arrows).

Sections were immunostained for p16

Graph depicting the prevalence of p16-positive nuclei in the ascending and descending thoracic

aorta is shown on the right. B. Sections of ascending aorta depicting oxidative DNA lesions, as indicated by
8-oxo-2’-deoxyguanosine (8-oxodG) immunoreactivity. Graph on the right depicts the abundance of 8oxodG-positive SMCs. C. Micrographs showing γ-H2AX-positive foci (green) in nuclei in the aortic media
of mice subjected to Ang II infusion and PARP inhibition with olaparib. Nuclei were counterstained with
DAPI (pseudocoloured red). Lu, lumen; Adv, adentitia. Data on the right depict the proportion of γ-H2AXpositive cells in the ascending and descending thoracic aortic media.
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aortic compromise, and our prior studies showing no evidence for secretion of Nampt by
SMCs (van der Veer et al. 2005), the current data indicate that an autonomous, Namptdependent NAD+ production cascade in SMCs serves as a vital metabolic hub for the aorta.
The observed drop in aortic medial NAD+ was sufficient to lead to mild dilation,
but more striking consequences became apparent with the stress of Ang II. Rather than
adapt to this stress, the Nampt-deficient aortic wall degenerated, with abrogated SMC
hyperplasia, overt SMC dropout, and medial hematomas and dissections. The latter had
similar distributions to that of other models of aortic disruption (Rateri et al. 2014),
suggesting that the reduced Nampt acted on a background of prevailing aortic
susceptibilities.

The additional finding of widespread SMC senescence provides an

intriguing mechanistic basis for the Nampt-driven maladaptive response to Ang II. Ang II
has been found to induce SMC senescence in vitro and in atherosclerotic arteries (Kunieda
et al. 2006, Matthews et al. 2006) and the current data thus expand the in vivo contexts for
SMC senescence. Several attributes of senescent or otherwise aged SMCs could adversely
impact aortic stability including the relative inability to replicate, perturbed contractility,
and an altered secretory profile that favours a pro-degeneration phenotype (Liu et al. 2013,
Yin and Pickering 2016).
The inability to maintain genomic integrity is a hallmark of accelerated aging and a
key stimulus for cellular senescence. The range of DNA lesions that I identified places
Nampt as an important guardian of genomic health. The presence of oxidized guanine
residues in SMCs reflects a persistent ROS burden that could promote senescence through
several mechanisms, including lipid oxidation and interference with cellular metabolism
(Yin and Pickering 2016). In addition, 8-oxodG DNA lesions themselves have been found
to be pathological and their continuous clearance is required to prevent the cell from
entering a senescent cascade (Rai et al. 2009). Single-strand DNA breaks, readily detected
in aortic SMCs depleted of Nampt, is also linked to cellular senescence, either directly or
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by predisposing to double-strand DNA breakage (Kuzminov 2001, Nassour et al. 2016).
Double-strand DNA breakage in turn is a well established driver of cellular senescence
(d'Adda di Fagagna 2008). Taken together, the findings establish that compromised NAD+
constitutes an intracellular milieu that is hazardous for DNA integrity.
Although several upstream defects may contribute to the observed DNA lesions,
these findings point to incapacitation of Parp1 as an important mechanism. One of the
best-understood roles of Parp1 is the sensing and repair of single-strand DNA breaks,
effectively serving as the first line of defense to this common DNA assault (Dantzer et al.
2006). More recent evidence has established that protein PARylation, mediated in part by
Parp1, also functions in double-strand break repair (Wang et al. 2006, Beck et al. 2014). As
well, Parp1 participates in clearance of oxidized nucleotides through binding to 8oxoguanine-DNA glycolase, an enzyme fundamental to removing 8-oxodG base lesions
(Fisher et al. 2007, Noren Hooten et al. 2011, Beck et al. 2014). The possibility cannot be
excluded that molecular perturbations arising from NAD+ depletion other than Parp
incapacitation may have contributed to aortic wall degeneration. In this regard, Sirt1
activity in SMCs has been shown to depend on a Nampt-mediated supply of NAD+ (Ho et
al. 2009) and Sirt1 has been found to protect against aortic disruption in response to Ang II
(Fry et al. 2015, Chen et al. 2016) As well, substantially reduced NAD+ can lead to critical
ATP depletion and energetic stress, which has been found to cause muscle degeneration in
skeletal muscle-specific Nampt-knock out mice (Frederick et al. 2016). However, the
threshold NAD+ level below which ATP production becomes compromised in the aorta
remains to be elucidated.
In summary, I demonstrate that Nampt within SMCs protects the aorta from
degenerating. My findings indicate that low Nampt, while not necessarily an inciting
event, can substantially compromise the manner in which the aorta responds to stress. I
speculate that an “NAD+ fatigue” phenomenon may underlie progression in aortopathy
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(Fig. 2.16). Nampt fuels a critical DNA repair system in the medial aortic layer and resists
premature cellular senescence. These findings raise the possibility that disturbed local
NAD+ metabolism renders the aortic tissue susceptible to forces that lead to disruption.
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Figure 2.16 Schematic depicting aortic wall consequences of reduced SMC Nampt
In the setting of aortic wall insults and compromised NAD+ (right), SMC DNA damage accumulates and is
inadequately repaired.

This can lead to accelerated SMC aging and destabilization of the aortic wall.

Deleterious DNA events that can be exacerbated by low Nampt are outlined in red. A proposed route to
decreasing Nampt and a self-sustaining damage cycle are noted by the dashed lines. SSB, single strand
break; DSB, double strand break; PAR, poly(ADP ribose).
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CHAPTER 3 - NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE IN
SMOOTH MUSCLE CELLS IS SUPPRESSED IN HUMAN THORACIC
AORTIC ANEURYSM DISEASE
3.1

Introduction
The aorta is a highly important conduit vessel that collects oxygenated blood from

the heart and delivers it to the branching and peripheral vessels supplying every organ and
tissue in the body. Failure of this vessel is often catastrophic. As outlined in previous
chapters, the aorta is structurally designed to withstand stress; however, it can nevertheless
degenerate over time when subjected to hypertension, atherosclerosis, or the effect of
genetic mutations (Schlatmann and Becker 1977, Howard et al. 2013)
Thoracic aortic diseases (TAD) encompass dilation as well as aneurysms and
dissections of the ascending or descending thoracic aorta (Ramanath et al. 2009).
Population-based studies estimate an annual incidence of 6-16 cases per 100,000, and
aortic dissection is the most devastating complication of TAD (Kuzmik et al. 2012,
Andelfinger et al. 2016). Clinical studies have suggested that a familial predisposition
exists for TADs: up to 20% of individuals who do not have features of Marfan syndrome,
vascular Ehlers Danlos syndrome, or Loeys-Dietz syndrome have a familial history of
TAD (Milewicz and Regalado 1993, Biddinger et al. 1997). In these individuals there is at
least one genetic cause. To date, there are a number of causative genes identified, including
those associated with extracellular matrix regulation, cytoskeleton, and the TGF-β
signalling pathway (Coady et al. 1999, Zhang et al. 2013, Zhang and Wang 2016).
It has recently become evident that Nampt is a determinant of SMC health and
longevity. Nicotinamide phosphoribosyltransferase (Nampt) is the rate-limiting enzyme for
the NAD+ salvage pathway, converting nicotinamide to nicotinamide mononucleotide (van
der Veer et al. 2005). As outlined in previous chapters, nicotinamide adenine dinucleotide
(NAD+) is an essential dinucleotide that serves as a cofactor for the oxidation-reduction
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events of cellular nutrient metabolism. NAD+ can also serve as a signaling nucleotide that
regulates gene expression, genome integrity, and mitochondrial function. I have previously
shown that Nampt is crucial to the aortic resistance of hemodynamic stress in a mouse
model of SMC Nampt depletion (Watson et al. 2017). In this model, SMC Nampt depletion
led to an absence of Parp1 activity (the activity of which depends on the requisite
bioavailability of NAD+) and an accumulation of DNA damage. This accumulation was
associated with an increase in aortic dissection events.
I have studied the expression of NAMPT in the aortic media of patients with lifethreatening thoracic aortic dilation disease. The findings reveal that the expression of
NAMPT is in the aortic media of human aotopathy patients is negatively correlated with
aortic diameter. Additionally, low levels of NAMPT expression in dilated human
aortopathy samples are associated with the presence of double-strand DNA breaks in aortic
smooth muscle cells. The findings also shed new light on the epigenetic mechanisms that
may underlie vulnerability in NAD+ homeostasis in human thoracic aortopathy.
3.2
3.2.1

Methods
Human aorta material
Human ascending aortic tissue was obtained from patients undergoing ascending

aortic replacement, coronary bypass surgery, or cardiac transplantation, as approved by the
institutional review board of Western University Research Ethics Committee. Maximum
aortic diameter was determined from contrast-enhanced CT scan or echocardiogram
obtained prior to surgery. NAMPT levels were assessed by histology of the aortopathy
material, performed on the maximally dilated region of the ascending aorta. NAMPT
transcript abundance was assessed in human aortic medial tissue from which the adventitial
and intimal layers were dissected away. RNA was isolated using TRIzol (Life
Technologies) and the RNeasy Mini Kit following the manufacturer’s protocol (Qiagen,
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Valencia, CA). Human aortic SMCs were isolated by explant outgrowth as previously
described (Vafaie et al. 2014).
3.2.2

Immunohistochemistry of human aortic tissue
NAMPT immunostaining was performed on paraformaldehyde-fixed, paraffin-

embedded sections as above. NAMPT staining was quantified in 5 equally spaced fields of
view (x40 objective) across the specimen, avoiding regions of inflammatory cell infiltration
and vascularization to restrict analyses to medial SMCs. Signal was quantified using
ImageJ software (NIH) with a DAB Deconvolution Plugin that separates the hematoxylin
from the DAB signal. Background signal was ascertained in each tissue by capitalizing on
the normal presence of interlamellar regions that do not contain SMCs. An area of at least
300 µm2 was utilized for this. The SMC NAMPT signal was determined as the cumulative
signal intensity and expressed relative to the number of nuclei in the field of view.
Sections were also double-stained for NAMPT and γ-H2AX (ab26350, 1:100;
Abcam, Cambridge, MA). Bound primary antibodies were visualized with Alexa Fluor
488-conjugated donkey anti-rabbit secondary antibody and Alex Fluor 546-conjugated
anti-mouse

secondary

antibody,

respectively

(Molecular

Probes).

Nuclei

were

counterstained with DAPI. NAMPT and γ-H2AX signal intensities were determined a cellby-cell basis (total of 524 cells) using ImageJ.
3.2.3

Quantitative real-time reverse transcription–polymerase chain reaction
Total RNA was isolated from homogenates of aortic media using TRIzol (Life

Technologies) and the RNeasy Mini Kit following the manufacturer’s protocol (Qiagen,
Valencia, CA). Total RNA was isolated from human SMCs using the RNeasy Mini Kit
following the manufacturer’s protocol. Transcript abundance of NAMPT and 18S were
assessed

using

SYBR-green

chemistry-based

primer

sets

(human

NAMPT

F-

AGGGTTACAAGTTGCTGCCACC R-CTCCACCAGAACCGAAGGCAAT; human 18S
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F-ACCCGTTGAACCCCATTCGTGA

R-GCCTCACTAAACCATCCAATCGG).

Quantitative real-time RT-PCR was performed using an ABI Prism (model 7900HT) and
Sequence Detection System software (Life Technologies; Applied Biosystems). For human
aortic medial tissue and human primary SMCs, mRNA abundance was quantified based on
the standard curve method, with 18S mRNA as an internal reference control, and expressed
as relative units (r.u.)
3.2.4

Analysis of DNA methylation
Human aortic media was isolated by laser capture microdissection of 10 µm-thick

frozen sections. Genomic DNA was harvested from this tissue and from cultured human
SMCs using the DNeasy Blood and Tissue Kit (Qiagen). DNA was subjected to selective
digestion-based PCR to quantify methylation status using the Epitect Methyl DNA
Restriction Kit (Qiagen) and the pre-designed Epitect qPCR Methyl Promoter Primer set
(335002 EPHS113392-1A).

The amount of input DNA that was methylated was

determined using the manufacturer-supplied algorithm.
3.2.5

Statistical analyses
Values are expressed as mean±standard error of the mean. Statistical analyses were

performed using GraphPad Prism software (GraphPad, La Jolla, CA, USA). Mean data
were compared using Student’s t-test or one- or two-way ANOVA with Holm-Sidak post
hoc testing. The relationship between NAMPT content and human aortic dilatation was
determined using linear regression analysis (SPSS, IBM Corp. Armonk, NY). To assess
the single-cell relationship between NAMPT and g-H2AX signal, within-patient cellular
NAMPT content was segregated into tertiles.

112

3.3
3.3.1

Results
Medial SMCs in dilated human thoracic aortas have reduced NAMPT
To determine if NAMPT is expressed in SMCs of the human aorta, I evaluated

ascending aortas surgically harvested from patients with dilated ascending aortopathy
(n=20, mean age 58.4±16.4) and compared the findings with those of non-dilated
ascending aorta harvested from individuals undergoing heart transplantation or coronary
artery bypass surgery (n=16, mean age 68.7±14.1). The mean aortic diameter of diseased
ascending aortas measured at the maximally dilated point was 54.3±9.5 mm. The mean
aortic diameter of control ascending aortas was 31.1±2.8 mm (P<0.0001). Individual
patient demographic data, aortic diameter, and aortic valve configuration and function are
presented in Table 3.1.
Immunostaining revealed widespread NAMPT expression in medial SMCs of the
normal calibre aortas, with signal in both cytoplasm and nucleus (Fig. 3.1a). Medial cell
NAMPT expression was also evident in dilated aortas. However, the NAMPT signal was
more heterogeneous, and largely absent from the nucleus (Fig.3.1 b-c) DAB intensity
analysis revealed that the NAMPT staining signal was 34% lower in dilated aortas (Fig.
3.2a). Reduced NAMPT expression in the media of dilated aortas was also observed at the
transcript level (Fig. 3.2b). Interestingly, there was an inverse relationship between aortic
medial NAMPT content and the maximal diameter of the ascending aorta (R2=0.44,
P<0.0001). This inverse relationship existed for both the entire patient cohort as well as
only those patients with ascending aortopathy (R2=0.31, P=0.009, Fig. 3.2c), and persisted
after adjusting for patient age (P=0.016). These findings implicate a NAMPT-based NAD+
biosynthesis pathway within SMCs of the human aorta. Moreover, they suggest that this
local biosynthetic machinery is related to aortic medial integrity.
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Table 3-1 Demographic and clinical characteristics of study subjects
Age

Sex

64
Female
82
Male
37
Male
44
Male
73
Male
55
Male
59
Male
40
Male
64
Male
80
Female
79
Male
75
Female
52
Male
56
Male
32
Male
62
Male
61
Male
49
Female
30
Female
75
Male
83
Male
53
Male
85
Female
ND
ND
70
Female
39
Female
70
Male
78
Male
79
Female
86
Female
78
Male
50
Male
68
Female
72
Male
66
Male
54
Male
*Marfan syndrome;
disease

Maximum
diameter of
ascending
aorta (mm)
Bicuspid
Severe AR
54
Tricuspid
Moderate AR
57
Bicuspid
None
57
Bicuspid
Severe AR
68
Bicuspid
Moderate AR/AS
55
Tricuspid
Severe AR*
77
Bicuspid
Severe AS
42
Bicuspid
Severe AR/AS
57
Bicuspid
Severe AS
43
Tricuspid
Moderate AR
56
Bicuspid
None
56
Tricuspid
None
63
Bicuspid
Moderate AR
61
Bicuspid
None
53
Bicuspid
Severe AR
40
Tricuspid
Moderate AR
60
Bicuspid
Severe AS
43
Bicuspid
Severe AS
41
Tricuspid
Mild AR*
50
Bicuspid
Moderate AR
54
Tricuspid
None (CAD)
35
Tricuspid
None (CAD)
30
Tricuspid
None (CAD)
33
ND
None (Transplant donor)
ND
Tricuspid
None (Transplant recipient)
24
Tricuspid
None (Transplant recipient)
29
Tricuspid
None (CAD)
34
Tricuspid
None (CAD)
32
Tricuspid
Moderate AS
28
Tricuspid
None (CAD)
33
None (Mitral valve insufficiency) 31
Tricuspid
)insufficiency)
Tricuspid
None
(CAD)
31
Tricuspid
None (CAD)
29
Tricuspid
None (CAD)
32
Tricuspid
None (CAD)
34
Tricuspid
None (CAD)
32
AR-Aortic Regurgitation; AS-Aortic Stenosis; CAD-coronary artery
Aortic valve
configuration

Aortic Valve
Dysfunction
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A

A (33 mm)
Non-dilated

20 μm

50 μm

B

Dilated (63 mm)

20 μm

50 μm

C

Dilated (57 mm)

20 μm

50 μm

Figure 3.1 NAMPT is present in the nucleus and cytoplasm of SMCs in the media of human aortic
media
Photomicrographs of paraformaldehyde-fixed non-dilated (A) and dilated (B, C) human aorta sections
immunostained for NAMPT and counterstained with hematoxylin. Arrow in zoomed image of A depicts
nuclear signal and arrowhead depicts cytoplasmic signal. Arrows in zoomed image of B indicate NAMPTnegative cells. Arrow in zoomed image of C indicates absent nuclear signal and arrowhead depicts weak
cytoplasmic signal.
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B

150

100

Relative NAMPT mRNA abundance

SMC NAMPT signal intensity (a.u.)

A

*
50

0

Non-dilated

Dilated

10
8
6
4
2
0

*
Non-dilated

Dilated

SMC NAMPT signal intensity (a.u.)

C
150

R2=0.31
P=0.009

100

50

0
30

40

50
60
70
Aortic diameter (mm)

80

Figure 3.2 Human ascending aortic dilation is associated with reduced NAMPT
A. Graph depicting NAMPT content – immunostaining signal per cell - in aortas from patients with control,
non-dilated aortas (n=16) and dilated aortas (n=20). *P<0.0001

B. Graph depicting NAMPT mRNA

abundance in control (n=6) and dilated (n=6) aortas. P=0.038 NAMPT mRNA abundance was normalized to
18S mRNA abundance C. Inverse relationship between NAMPT content in dilated aortas and aortic diameter;
n=20.
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3.3.2

The media of dilated human thoracic aortas is populated by SMCs with DNA
strand breaks and low NAMPT
Given my previous work demonstrating compromised genomic integrity in the

mouse models (Watson et al. 2017), I asked if DNA integrity was compromised in SMCs
within the human ascending aorta. This was of interest because although double-strand
DNA breaks have been found in atherosclerotic lesions (Gray et al. 2015), the media of the
non-atherosclerotic aorta is considered a more quiescent vascular setting. Remarkably, γH2AX-immunostaining revealed that 25% of normal caliber aortas contained unrepaired
DNA strand breaks in the medial layer cells. On average, 2.4% of medial cells displayed
DNA damage foci (range 0-10.1%). Even more striking was that 90% of aortopathy
samples had evidence of unrepaired DNA strand breaks, with an average of 28.7% SMCs
with DNA damage foci (range 7.3-60.0% of cells, Fig. 3.3a). To more precisely define the
relationship between NAMPT expression and unrepaired DNA damage, I doubleimmunolabeled aortas for NAMPT and γ-H2AX (Fig. 3.3b). NAMPT content was then
quantified in a total of 524 individual SMCs, which were separated into tertiles based on
NAMPT expression. SMCs in the lowest tertile had more than 5-fold greater DNA damage
signal than those in the mid and highest NAMPT tertiles (Fig. 3.3c).
3.3.3

Hypermethylation of the NAMPT promoter in dilated human thoracic aortas
Given the linkages between low NAMPT and DNA damage, I assessed what might

underlie the low NAMPT in human thoracic aortopathy. Epigenetic control of genes
relevant to aortopathy has recently been described (Gomez et al. 2013). To determine if this
might be the case for NAMPT, I first assessed if the expression profile of NAMPT in human
aortic SMCs was preserved between in vivo and culture environments. This revealed that
NAMPT transcript abundance in early passage SMCs correlated with NAMPT abundance
in the corresponding aortic media (R2=0.72, P=0.004, Fig. 3.4a). Furthermore, NAMPT
transcript abundance in SMCs derived from both normal and dilated aortas was stable over
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SMC γ-H2AX signal intensity (a.u.)

A

γ-H2AX-+ve SMCs (%)

30

*
20

10

0

Non-dilated Dilated

200

*

150
100
50
0.0

Non-dilated Dilated

B
Non-dilated

Dilated

Nampt γ-H2AX

SMC γ-H2AX signal intensity (a.u.)

C
*†

300

200

100

0

Upper

Mid

Lower

Cellular Nampt Content
(tertiles)

Figure 3.3 Correlation of double-strand DNA damage with reduced NAMPT in human aortic SMCs
A. Prevalence of medial SMCs in aortas with γ-H2AX signal (Right, *P=0.047) and intensity of γ-H2AX
signal (Left, *P=0.021). B. Confocal photomicrographs illustrating reciprocal relationship between NAMPT
(green) and γ-H2AX-positivity (red) in human ascending aorta. Nuclei were counterstained with DAPI. C.
Cellular DNA damage signal, stratified by cellular NAMPT content in 524 independent cells. *P=0.034 vs.
upper NAMPT tertile, †P=0.013 vs. mid NAMPT tertile.
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A
Relative cellular NAMPT
mRNA abundance

30

20
R2=0.72
P=0.004

10

0

0

50
100
NAMPT expression in tissue (a.u.)

B
Control

Relative NAMPT mRNA
abundance

30

Control
Control
Dilated

20

Dilated
Dilated

10

0

0

1

2

3

4

Cell passage

Figure 3.4 Cultured SMCs from patients with dilated ascending aortopathy express NAMPT
A. Relationship between NAMPT transcript abundance in human SMCs cultured from the ascending aorta
and NAMPT content in situ in the corresponding aortic media, as assessed by immunostaining. B. NAMPT
transcript abundance in early passage human SMCs derived from control and dilated patients measured over
early serial cell subcultures, showing stability.
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3 serial subcultures and differences between patient SMCs were maintained (Fig. 3.4b). To
determine if there was potential for epigenetic control by DNA methylation, I performed a
bioinformatic

assessment

(http://genome.ucsc.edu/)

of

the

NAMPT

gene

locus.

Bioinformatic tools provided by the UCSC genome browser predicted a ~1000-base CpG
island surrounding the NAMPT transcriptional start site (Fig. 3.5). CpG islands are regions
with a high frequency of CpG sites. Methylation of cytosine residues in the region of the
transcriptional start site (in the context of CpG dinucleotides) could serve as an epigenetic
repression of gene transcription (Jones 2012). Methylation analysis using selective
digestion-based PCR revealed little to no methylation of NAMPT promoter DNA from nondilated human aortas.

However, 13.0±4.1% of input DNA from dilated aortas was

methylated (P=0.044, Fig. 3.6a). Furthermore, in SMCs cultured from the ascending aorta,
the level of promoter methylation inversely correlated with NAMPT mRNA abundance in
the corresponding SMCs (R2=0.028, P=0.024). This also revealed that the NAMPT
promoter in SMCs from patients with dilated aortas was hypermethylated relative to that of
SMCs cultured from control aortas (P=0.004, Fig. 3.6b,c).
3.4

Discussion
By evaluating human aortopathy material, I demonstrate that: i) NAMPT is reduced

in the aortic media of patients with aneurysmal thoracic aortic disease, ii) SMCs with low
NAMPT and unrepaired DNA damage constitute a previously unrecognized SMC
phenotype in human aortopathy, and iii) low NAMPT levels in human aortopathy are
associated with hypermethylation of the NAMPT promoter.
The possibility that the functional linkage between low SMC Nampt and aortic
degeneration in mice translates to human aortopathy was supported by several findings.
SMC NAMPT content was lower in dilated human aortas that in non-dilated aortas.
Moreover, there was an inverse relationship between the aortic diameter and medial SMC
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Figure 3.5 The promoter region of NAMPT is associated with a potential CpG locus
Scale diagrammatic representation of the NAMPT gene locus including the genome base position (Top row),
the percentage of G (guanine) and C (cytosine) bases in 5-base windows (Second row; low to high GC
content is expressed by light to very dark colour), the transcription start site of NAMPT (TSS, third row),
NAMPT exon position (Fourth row), and the putative location of a CpG island (Fifth row).
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Figure 3.6 Hypermethylation of the NAMPT promoter in the aortic media and cultured SMCs of
patients with dilated ascending aortopathy
A. Methylation of the NAMPT promoter in the media of control, non-dilated (n=3) and dilated (n=6) aortas,
*P=0.044 vs. control. B. Relationship between methylation of the NAMPT promoter in primary early
passage (1-4) human SMCs and NAMPT transcript abundance in the respective SMCs. C. Methylation of the
NAMPT promoter in early passage human SMCs derived from the ascending aorta of patients with nondilated (n=8) and dilated (n=10) aortas, *P=0.004 vs. control.
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NAMPT content. This fits an emerging pattern of reduced Nampt in aged or compromised
tissues (Yoshino et al. 2011, Stein and Imai 2014), and the current study may be the first to
identify such a relationship in human diseased tissue. It is noted that aortic medial
dissection, prominent in the previous mouse model work, was not represented in the patient
series. Nonetheless, ascending aortic diameter is a strong predictor of dissection risk in
patients (Hiratzka et al. 2010). Also remarkable was the discovery of unrepaired DNA
breaks in aortic medial SMCs in situ and the relatively high prevalence of this genome
pathology in the aorta of individuals with aortopathy. Although the data do not prove
causation, the single-cell relationship between low NAMPT and unresolved DNA strand
breaks strengthens the potential for a mechanistic relationship. Moreover, the combination
of unresolved DNA breaks and low Nampt can be considered to denote a SMC phenotype
of substantially declined cellular vitality.
The findings indicate that low Nampt, while not necessarily an inciting event, can
substantially compromise the manner in which the aorta responds to stress independent of
the primary cause of the aortopathy. Low aortic NAMPT was observed not only the dilated
aortas of patients with a bicuspid aortic valve but also those with a tricuspid aortic valve
and Marfan syndrome. A larger series would be required to determine if there are aortic
disease-specific differences in NAD+ control and also if NAD+ homeostasis in SMCs is
relevant to atherosclerotic abdominal aortic aneurysms.

The chronic nature of aortic

dilation disease is such that a suboptimal NAD+ regenerating system could both potentiate
and sustain aortic wall degeneration.
In summary, I demonstrate that low Nampt within medial SMCs is associated with a
degenerative aortic phenotype; findings that raise the possibility that disturbed local NAD+
metabolism underlies the progression of degenerative aortic disease.
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CHAPTER 4 - NAMPT IN SMOOTH MUSCLE CELLS REGULATES
EXTRACELLULAR MATRIX GENE EXPRESSION HOMEOSTASIS
4.1

Introduction
Vascular smooth muscle cells (SMCs) perform a number of functions that are

relevant to withstanding hemodynamic stress, including contraction and the synthesis and
assembly of extracellular matrix (ECM) components (Li et al. 2003, Humphrey et al.
2014). The aorta is an elastic artery of which the main structural components, outside of
smooth muscle cells, are elastin, collagen fibres, and a proteoglycan-rich ground substance.
In most instances of thoracic aortic disease, regardless of etiology, there is a disruption in
the extracellular matrix (Ishii and Asuwa 2000, Koullias et al. 2004, Borges et al. 2009).
The underlying molecular mechanisms that control how SMCs in the aorta tightly regulate
ECM production during environmental stress remains poorly understood.
My work in previous chapters has shown that the regeneration of nicotinamide
adenine dinucleotide (NAD+) by Nampt in SMCs is essential to maintaining an aorta that is
resistant to hemodynamic stress. Nampt is expressed in cultured SMCs and its content and
activity decline during advanced SMC aging (van der Veer et al. 2005, van der Veer et al.
2007). As well, Nampt has been found to regulate in vitro SMC longevity and migratory
behavior (van der Veer et al. 2007, Yin et al. 2012). I have shown that NAMPT content is
decreased in aortic samples from aortopathy patients and that this decrease is correlated
with an increase in DNA lesions and SMC senescence (Watson et al. 2017). However, it is
unclear if there is a direct link between a decrease in Nampt in the aorta and the integrity of
the ECM.
To elucidate relationships between expression of Nampt in SMCs and gene
expression profiles, I have undertaken genome-wide assessment of mouse aortic SMCs. I
report that when Nampt is ablated in SMCs, there is a striking change in overall gene
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transcription. Importantly, this includes the expression of transcripts associated with
collagen and proteoglycan expression and assembly. I further report that there is a decrease
in fibrillar collagen in SMC-Nampt KO mouse aortas and an increase in proteoglycan
accumulation. Bioinformatic analysis suggested that these changes are potentially mediated
by an upstream shift in the transcription regulator Smad7.
4.2
4.2.1

Methods
Generation of Nampt-deficient smooth muscle cells in vitro
Mouse experiments followed protocols approved by the Western University Animal

Use Committee. All mice were on a C57Bl/6 background. We generated mice in which
Nampt could be globally and inducibly deleted. Namptflox/flox mice (Rongvaux et al. 2008)
were bred with mice expressing Cre recombinase fused to the mutated ligand binding
domain of the human estrogen receptor (ER) under the control of a chimeric
cytomegalovirus immediate-early enhancer/chicken ß-actin promoter (B6.Cg-Tg(CAGCre/Esr1)5Amc/J) (Jackson Laboratories, Bar Harbor, ME) (Hayashi and McMahon 2002).
Aortas were harvested from 8-10-week-old mice anesthetized mice in one piece, and
placed in sterile PBS. The adventitial layer was removed, and the endothelial layer scraped
away. Aortas were minced into 3-4 mm pieces and mouse aortic SMCs were isolated via
digestion using type III porcine pancreatic elastase (250 µg/ml, Sigma) and type I
collagenase (1 µg/ml, Worthington Biochemical Corporation, Lakewood, NJ) (Ray et al.
2001). Aortic tissue was digested at 37°C with agitation for 1-4 hours. SMCs were
maintained in DMEM-F12 with addition of a SMC-specific bullet kit: smGM-2 BulletKit
(Lonza, Allendale, NJ). SMC identity was confirmed by immunostaining for smooth
muscle α-actin. SMCs harvested from aortas of Namptflox/flox Cre-ERT2+ mice were
subjected to 1 µM hydroxy-tamoxifen for 24 hours. In order to control for the effect of
tamoxifen, Namptflox/flox Cre-ERT2- (control) SMCs were also subjected to 1 µM hydroxy128

tamoxifen for 24 hours. SMCs underwent a maximum of five subcultures, and experiments
were performed with cells from the third or fourth subculture.
4.2.2

Generation of SMC-Nampt deficient mice
We generated mice with a SMC-specific knockout of Nampt as previously

described (Watson et al. 2017). Briefly, an initial cross was undertaken between female
mice harbouring loxP sites flanking exons 5 and 6 of Nampt (Namptflox/flox) (Rongvaux et
al. 2008) and male transgenic mice expressing Cre recombinase and eGFP under the
control of the SMC-specific myosin heavy chain promoter (smMHC-Cre/eGFP, Jackson
Laboratories, Bar Harbor, ME) (Xin et al. 2002). In a second round of breeding, the male
SMC-targeted Nampt heterozygotes (Namptflox/+; smMHC-Cre+) were bred with female
Namptflox/flox mice to generate Namptflox/+; smMHC-Cre- (control) and Namptflox/flox;
smMHC-Cre+ (SMC-Nampt KO) mice.
4.2.3

RNA isolation, quality assessment, probe preparation and GeneChip
hybridization
Total RNA was prepared from three independent cell cultures of control mouse

aortic smooth muscle cells, and three independent cell cultures of mouse aortic smooth
muscle cells wherein Nampt had been knocked out (Nampt-KO SMCs). All six
independent cells cultures were harvested at passage three. Cell monolayers were harvested
using trypsin and lysed with QIAshredder columns (Qiagen). Total RNA was isolated
using an RNeasy Mini Kit (Qiagen), and eluted with nuclease-free water.
All subsequent sample handling, labeling, and GeneChip (Human Gene 1.0 ST
arrays) processing was performed at the London Regional Genomics Center (Robarts
Research Institute, London, Ontario, Canada; http://www.lrgc.ca). RNA quality was
assessed using an Agilent 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA)
and the RNA 6000 Nano kit (Caliper Life Sciences, Mountain View, CA). Single stranded
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complimentary DNA was prepared from 100 ng of total RNA as per the Affymetrix
GeneChip WT PLUS Reagent Kit (Affymetrix, Santa Clara, CA). Total RNA was first
converted to cDNA, followed by in vitro transcription to make cRNA. 5.5 µg of single
stranded cDNA was synthesized, end labeled and hybridized, for 16 h at 45 °C, to Mouse
Gene 2.0 ST arrays (Affymetrix). All liquid handling steps were performed by a GeneChip
Fluidics Station 450 and GeneChips were scanned with the GeneChip Scanner 3000 7G
(Affymetrix) using Command Console v3.2.4.
4.2.4

Statistical analyses of changes in global gene expression
All microarray data complies with MIAME guidelines. Probe level (.CEL file) data

was generated using Affymetrix Command Console v3.2.4. Probes were summarized to
gene level data in Partek Genomics Suite v6.6 (Partek) using the robust multi-array average
(RMA) algorithm (Irizarry et al. 2003). Partek was used to determine gene level
ANOVA P-values and fold changes. A filtered gene list was generated for expression
changes of least 1.5 fold and having a P-value of less than 0.05. A Fisher’s exact test was
used to create P-values for GO and KEGG Pathway enrichment. Gene ontology (GO) and
KEGG pathway analysis was performed using the online resource DAVID (available at
https://david.ncifcrf.gov) (Huang da et al. 2009, Huang da et al. 2009). Upstream
Regulators were generated through the use of QIAGEN’s Ingenuity Pathway Analysis
(IPA®) and the Biological Processes and QIAGEN’s Ingenuity® iReport (QIAGEN
Redwood City, www.qiagen.com/ingenuity).
4.2.5

NAD+ measurement
Mouse aortic SMC NAD+ levels were determined in freshly harvested cells. NAD+

content in the mouse aortic media was determined using a colorimetric kit (BioVision
Research Products, Mountain View, CA, USA) and expressed relative to total protein
content.
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4.2.6

Real time quantitative PCR
Changes in the expression of selected genes were independently assessed by real

time quantitative PCR (qRT-PCR). cDNA was synthesized from RNA samples from
control and Nampt-KO SMCs (isolated as noted above), in addition to total RNA isolated
from homogenates of de-endothelialized mouse aortas using TRIzol (Life Technologies)
and the RNeasy Mini Kit following the manufacturer’s protocol (Qiagen, Valencia, CA),
using a High Capacity RNA-to-cDNA kit (Applied Biosystems). Transcript abundance of
mouse Nampt, Mmp2, Mmp9, Mmp13, Col1a1, Fibronectin, Tenascin C, Decorin, Perlecan,
Biglycan, Versican, N-cadherin, and 18S, were assessed using SYBR-green chemistrybased

primer

sets

(Nampt:

F-GGCACCACTAATCATCAGACCTG

R-

AAGGTGGCAGCAACTTGTAGCC; Mmp2: F-GAGACCATGCAGTCAGCTCTAG RTAGAGCTGCCTCTTGTCTGGT; Mmp9: F-GCTGACTACGATAAGGACGGCA RTAGTGGTGCAGGCAGAGTAGGA; Mmp13: F- GATGACCTGTCTGAGGAAGACC
R-GCATTTCTCGGAGCCTGTCAAC; Col1a1: F-CCTCAGGGTATTGCTGGACAAC
R-CAGAAGGACCTTGTTTGCCAGG; Fn1: F-CCCTATCTCTGATACCGTTGTCC RTGCCGCAACTACTGTGATTCGG; Tnc: F-GAGACCTGACACGGAGTATGAG RCTCCAAGGTGATGCTGTTGTCTG; Dcn: F-ACTCTCCAGGAACTTCGTGTCC RAGTCCCTGGAAGGCTCCGTTTT; Hspg2: F-CATTCAGGTGGTCGTCCTCTCA RAGGTCAAGCGTCTGTCCTTCAG; Bgn: F-TGAACCAGGAGCCTTTGATGGC RGTCCTCCAACTCAATAGCCTGG; Vcan: F-GGACCAAGTTCCACCCTGACAT RCTTCACTGCAAGGTTCCTCTTCT; Cdh2: F-CCTCCAGAGTTTACTGCCATGAC RCCACCACTGATTCTGTATGCCG;

18S:

F-GTAACCCGTTGAACCCCATT

R-

CCATCCAATCGGTAGTAGCG). Quantitative real-time RT-PCR was performed using
an ABI Prism (model 7900HT) and Sequence Detection System software (Life
Technologies; Applied Biosystems). Relative mRNA abundance was quantified based on
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critical threshold (CT) using the comparative CT formula, 2-

ΔΔ

CT

, with 18S mRNA as an

internal control.
4.2.7

Assessment of collagen fibrils by circular polarization microscopy
Paraformaldehyde-fixed aortic sections were stained with Picrosirius red using a

commercially available kit from Polysciences, Inc (Warrington, PA). Briefly,
deparaffinized sections were incubated with 0.1% Sirius red F3BA in saturated picric acid
for 30 minutes and rinsing twice with 0.01 mol/L HCl. Collagen organization was assessed
using circular polarization microscopy. Picrosirius red–stained sections of aorta were
visualized as described (Nong et al, 2011). Briefly, measurements were obtained using an
Olympus BX51 microscope (Olympus Canada, Inc., Richmond Hill, ON, Canada) with
polarizer-interference filters, a liquid crystal compensator, a charge-coupled device video
camera,

and

Abrio

software

(Abrio

LC-PolScope;

Cambridge

Research

and

Instrumentation, Inc., Hopkinton, MA). This system enabled measurement of light
retardation by collagen, in absolute terms (nanometers), in defined fields of view. Mean
collagen birefringence was assessed in the medial layers of n=5 mice: the full medial field
of view (objective, ×60) yielding the sum of retardation signals (in nanometers) for all
pixels in the images. Mean collagen fiber width was determined by measuring a minimum
of 20 equidistant widths of per-elastic collagen fibers in one field of view, from a minimum
of n=5 mice.
4.2.8

Glycosaminoglycan assessment of aortas by Movat’s staining
Paraformaldehyde-fixed aortic sections were stained according to Movat’s

pentachrome protocol. Briefly, sections were first deparaffinized and incubated with Alcian
blue

in

order

to

stain

acid

polysaccharides.

They

are

then

stained

with

Verhoeff hematoxylin, crocein scarlet combined with acidic fuchsine and saffron. The
percentage of area occupied by blue-stained proteoglycan was quantified from 3 sections
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200 µm apart, in the ascending and descending thoracic aorta regions, avoiding areas with
aortic hematoma or dissection, using ImageJ software (NIH, Bethesda, MD).
4.2.9

Statistical analyses
Values are expressed as mean ± standard error of the mean. Statistical analyses

were performed using GraphPad Prism software (GraphPad, La Jolla, CA, USA). Mean
data were compared using Student’s t-test or one- or two-way ANOVA with Holm-Sidak
post hoc testing.
4.3
4.3.1

Results
Nampt knockout elicits a change in the gene expression pattern in aortic
SMCs.
I previously demonstrated that Nampt in smooth muscle cells is required to

maintain vascular integrity by maintaining genomic integrity. Here, I sought to determine
whether there were other processes impacted by Nampt that may contribute to vascular
integrity. To address this question, I generated mice wherein Nampt could be conditionally
deleted with the use of the CreER recombinase/LoxP system. Mouse aortic smooth muscle
cells

were

isolated

from

the

aortas

of

3

Namptflox/flox;CreERT2+

and

3

Namptflox/flox;CreERT2- (control) mice and subjected to 1 µm 4-hydroxytamoxifen for 24
hours in order to induce Nampt deletion in culture. Seventy-two hours following Nampt
ablation, Nampt mRNA transcript level in KO mSMCs was decreased by 86.5%
(P<0.0001, Fig. 4.1a). Additionally, NAD+ levels measured in these cells were decreased
by 84.9% (P<0.0001, Fig. 4.1b).
To explore how Nampt reduction in SMCs might impact vascular associated
processes, I undertook a global, unbiased comparison of gene expression in control and
Nampt-KO SMCs using Affymetrix high-density microarray analyses. Gene expression
microarray analysis was performed using RNA isolated from 3 independent primary
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Figure 4.1 Nampt knockout in SMCs leads to decreased NAD+ levels
A. Smooth muscle cells were harvested and cultured from aortas of Namptflox/flox;CreERT2+ mice and
incubated with vehicle or hydroxy-tamoxifen for 24 hours. Abundance of Nampt mRNA was evaluated by
RT q-PCR and normalized to expression of Gapdh mRNA (n=3 mice per condition, *P<0.0001) B. Namptdepleted cells were harvested 72 hours following Nampt knockdown. Graph of NAD+ content in acidic
extracts of control and Nampt-depleted smooth muscle cells (SMCs). (n=3 independent cultures per
condition, *P=0.024).
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cultures of Nampt-KO SMCs and WT control SMCs. As illustrated by Volcano plot,
Nampt knockout evoked a transcriptional response in SMCs, with balance of statistically
significantly up-regulated and down-regulated genes (Fig. 4.2). Lists of differentially
expressed genes in response to Nampt depletion were generated using the criteria of 1.5fold change in expression level with P<0.05. Within 72 hours of Nampt disruption in
SMCs 856 genes were upregulated and 633 genes were downregulated (as illustrated by
heatmap in Fig. 4.3).
4.3.2

Transcriptome alteration in Nampt-deficient aortic SMCs indicates a defect in
extracellular matrix
To determine what gene expression patterns were changed in Nampt-KO SMCs, I

utilized DAVID Bioinformatics Resources (available at https://david.ncifcrf.gov) and
analyzed Gene Ontology (GO) and Kegg Pathway terms that were statistically
overrepresented in the lists of up- and down-regulated genes (P<0.05). The most
overrepresented down-regulated genes in the Biological Process and Cellular Compartment
GO categories were those belonging to the Extracellular Matrix categories (Fig. 4.4a).
Additionally, analysis of genes in Kegg Pathway categories showed that the most
overrepresented down-regulated genes belong to the ECM-receptor interaction group (Fig.
4.4b). The most significant GO terms for Biological Processes and Kegg Pathway
categories corresponding to genes upregulated in Nampt-KO SMCs were those relating to
RNA, specifically Poly(A) RNA Binding and Ribosome Biogenesis in Eukaryotes (Fig.
4.5a,b). Interestingly, the most significant GO terms for Cellular Compartments category
corresponding to genes upregulated in Nampt-KO SMCs also corresponded to Extracellular
Matrix.
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Figure 4.2 Nampt knockout in SMCs induces global transcriptome changes
Volcano plot depicting differences in gene expression between SMCs with or without Nampt ablation. The xaxis represents the log-transformed fold-change (log2 fold change) of transcript abundance between the two
groups. The y-axis represents the negative log transformed p value (-log10 p value).
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Figure 4.3 Nampt knockout in SMCs and gene expression changes
Heatmap depicting the microarray analysis of differentially expressed genes (greater than 1.5-fold change,
P≤0.05) between 3 independent cultures of control, vehicle-treated SMCs and 3 independent cultures of
Nampt-ablated SMCs. Each column represents one independent SMC culture and each row represents one
mRNA transcript. Transcript abundance across the 6 independent cultures was normalized and the Z-score is
depicted; Green indicates relative higher expression, Red indicates relative lower expression. Rows and
columns were ordered by hierarchical clustering according to the similarity of expression patterns.
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Figure 4.4 GO and KEGG pathways most significantly over-represented in the transcripts
downregulated in SMCs after Nampt ablation
A. Bar graphs depicting the top 5 overrepresented GO categories from each of the GO classifications:
Biological Processes, Cellular Components, and Molecular Functions. B. Graph depicting the top
overrepresented KEGG pathways as determined by DAVID analysis.
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Figure 4.5 GO and KEGG pathways most significantly over-represented in the transcripts upregulated
in SMCs after Nampt ablation
A. Bar graphs depicting the top 5 overrepresented GO categories from each of the GO classifications:
Biological Processes, Cellular Components, and Molecular Functions. B. Graph depicting the top
overrepresented KEGG pathways as determined by DAVID analysis.
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4.3.3

Transcripts associated with collagen and proteoglycan equilibrium are altered
in Nampt-deficient SMCS.
To further define the changes in ECM as a consequence of Nampt ablation in

SMCs, I curated the differentially expressed transcripts for genes known to be associated
with pathology of the vascular ECM. I identified a number of transcripts among the
overrepresented genes in the ECM categories that were associated with the production or
degradation of extracellular collagen (Table 4.1). Notably, there was a 3.65-fold decrease
in the expression of col3a1 (P=0.022), a 1.75-fold decrease in the expression of col1a1
(P=0.021), and a 4.97-fold decrease in col14a1 (P=0.046). Matrix metalloproteinase 13
(Mmp13) was significantly upregulated in Nampt-KO SMCs, which also may contribute to
a disturbed collagen balance in the extracellular environment of these SMCs.
As a corollary to this collagen depletion phenotype, I identified a number of
transcripts in the lists of overrepresented genes in the ECM categories that were associated
with the production of vascular proteoglycans (Table 4.2). These include a 1.54-fold
increase in versican (P=0.006), and an increase in the enzymes that synthesize the
glycosaminoglycan hyaluronan (or, hyaluronic acid): hyaluronan synthases 1 and 2 (1.99fold and 1.57-fold, P=0.001 and 0.034, respectively).
I next confirmed differential expression of ECM components including MMPs,
collagens, fibronectin, and proteoglycans in Nampt-KO SMCs, by quantitative RT-PCR.
Expression of MMPs 2, 9, and 13 were all significantly upregulated by 1.78-, 10.40-, and
3.90-fold, respectively (P=0.0001, <0.0001, and <0.0001, respectively, Fig. 4.6). The
expression of col1a1 was decreased by 57.9% (P=0.021) while the expression of
fibronectin increased 1.85-fold (P<0.0001).

Interestingly, the expression of various

proteoglycans associated with the vascular space was increased. Versican was upregulated
140

Table 4-1 Microarray analysis identifies that Nampt ablation in SMCs changes expression of genes
associated with collagen production and assembly
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Table 4-2 Microarray analysis identifies that Nampt ablation in SMCs changes expression of genes
associated with proteoglycan production and assembly
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Figure 4.6 Nampt ablation in SMCs changes expression of ECM transcripts
Graphs depicting the relative transcript abundance of A) Mmp2, B) Mmp9, C) Mmp13, D) Col1a1, E)
Fibronectin, F) Tenascin C, G) Decorin, H) Perlecan, I) Biglycan, and J) Versican, in control and in SMCs
after Nampt ablation, as assessed by quantitative RT-PCR. mRNA data are expressed as ΔΔCT (n=3
independent cultures per condition, transcript abundance of 18s was used as an internal normalizing
reference).
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1.96-fold (P=0.009), decorin was upregulated 3.07-fold (P<0.0001) and perlecan was
upregulated 1.63-fold (P=0.001) (Fig. 4.7). Additionally, the expression of the glycoprotein
tenascin C was increased by 3.24-fold (P<0.0001), Taken together, these transcriptional
data are evidence for a disruption in the SMC ECM environment when Nampt is ablated.
4.3.4

Collagen deposition and organization is abrogated in SMC-Nampt deficient
aortas at baseline and following Ang II infusion
We have previously shown that mice with Nampt ablated in their smooth muscle

cells were prone to Ang II-induced aortic disruption. Because of our evidence that collagen
expression is suppressed in Nampt-KO SMCs in culture, I next determined whether the
collagen component of the aorta was compromised in SMC-Nampt deficient mouse aortas.
It has been shown that aortic fibrosis, caused by increased collagen content, is detectable in
the mouse aorta as early as 7 days after initiation of Ang II infusion (Xu et al. 2011).
Therefore,

I

infused

Namptflox/flox;smMHC-Cre+

(SMC-Nampt

KO)

mice

and

Namptflox/+;smMHC-Cre- (control) mice Ang II for 7 or 28 days (1.44 mg/kg/day).
Following Ang II infusion the aortas were perfusion-fixed and sectioned. Fibrillar collagen
content and organization was assessed using circular polarization images of picrosirius redstained aortic cross sections (Fig. 4.7a). This revealed that, consistent with previous
studies, control mice substantially increased the fibrillar collagen content in response to
Ang II at both 7 and 28 days. These changes were evident in both the ascending and
descending thoracic aortic segments. Strikingly, this fibrillar response was completely
absent in the aortas of SMC-Nampt KO mice (Fig. 4.7b).
To further evaluate the impact of Nampt knockout on the architecture of the
collagen fibers, and the possibility that this might predispose to medial dissection, we
resolved the collagen fibers into two distinct components: 1) tracks of collagen that were
closely opposed to either side of each elastic lamella (Fig. 4.7c); and 2) collagen fibers that
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Figure 4.7 Collagen deposition and organization in response to Ang II is abrogated in the aortas of
SMC-Nampt KO mice
Control and SMC-Nampt KO mice were infused with Ang II (1.44mg/kg/day) or vehicle (PBS) for 7 or 28
days. Following infusion, paraformaldehyde-perfusion fixed ascending and descending thoracic aortas were
harvested and stained with picrosirius red (PSR). Micrographs depict digitally acquired light retardation
images of the ascending aortas, imaged with polarized light and liquid crystal compensation. The resulting
retardation images are independent of illumination intensity, such that images can be directly compared; A.
Representative images of control and SMC-Nampt KO ascending aortas infused with Ang II for 7 days; B.
Quantification of the area fraction of birefringent collagen in the media of the ascending and thoracic aortas;
C. Graph depicting the mean retardation values (a measure of collagen deposition and organization) of the
inter-lamellar spaces (white arrows) in the ascending and thoracic aortas of KO mice; D. Graph depicting the
mean retardation values of peri-elastin lamellae collagen tracks (white arrowheads); E. Graph depicting the
thickness of the inter-lamellar tracks of collagen, (n = 4-5 mice per group).
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existed between elastic lamellae and oriented primarily orthogonal to the peri-elastic
collagen fibers (Fig. 4.7d). Notably, both collagen components in Nampt KO aortic media
were attenuated at baseline, and not responsive to Ang II stimulation. Interestingly, the
mean thickness of the peri-elastic collagen tracks in SMC-Nampt KO mice was also less
than that of control mice, even before Ang II stimulation. In control mice, the mean
thickness of the peri-elastic collagen tracks increased with Ang II stimulation. However, no
increase was noted in SMC-Nampt deficient aortas (Fig. 4.7e). Taken together, these
findings suggest an inability of Nampt-deficient SMCs to produce and/or assemble
collagen fibrils at both baseline and under Ang II-induced biochemical and biomechanical
stress.
4.3.5

Glycosaminoglycan elaboration is increased in SMC-Nampt deficient aortas at
baseline and following Ang II infusion
I next sought to determine if the ECM elaboration response to Ang II in SMC-

Nampt deficient aortas shifted to other, non-collagen ECM components. Quantitative
transcript analysis by RT-PCR of aortas infused with Ang II for 7 days revealed that
Col1a1 expression in SMC-Nampt KO aortas was 27.3% lower than that in control aortas
infused with Ang II (P=0.0002, Fig. 4.8a). Surprisingly, fibronectin expression was also
lower in Ang II-infused SMC-Nampt KO aortas than infused control aortas (42.5%,
P=0.0004, Fig. 4.8b). Additionally, N-cadherin, important in maintaining SMC adhesion,
was also 43.4% lower in Ang II-infused aortas as compared to control infused aortas
(P=0.002, Fig. 4.8c). In contrast, expression of the small leucine-rich repeat proteoglycan
biglycan was higher in SMC-Nampt KO aortas than control aortas infused with Ang II
(1.91-fold, P=0.002, Fig. 4.8d).
To further determine whether proteoglycan moieties were accumulating in the Ang
II-infused SMC-Nampt KO mouse aortas, I stained paraformaldehyde-fixed sections of
aorta with Movat’s petachrome stain (Fig. 4.8e). This stain contains alcian blue, which
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Figure 4.8 ECM expression in response to Ang II is perturbed in the aortas of SMC-Nampt KO mice
Graphs depicting the relative transcript abundance (ΔΔCT) of A) Col1a1, B) Fibronectin, C) N-Cadherin, and
D) Biglycan, in control and Nampt-KO mouse aortic medias, as assessed by quantitative RT-PCR (n=3
independent cultures per condition, transcript abundance of 18s was used as an internal reference). E.
Representative images of control and SMC-Nampt KO ascending aortas infused with Ang II, 1.44 mg/kg/day
for 7 days, and stained with Movat’s pentachrome stain. Areas of blue stain are predominantly enriched with
GAG (white arrowhead). F. Quantification of blue GAG stain expressed as the percentage of the medial area
of both the ascending and thoracic aorta (n = 4-5 per group, by one-way ANOVA with Holm-Sidak post hoc
testing).
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binds to acidic polysaccharides such as glycosaminoglycans (GAGs) – the side chains that
together with a core protein make up a proteoglycan. Interestingly, even without Ang II
infusion, SMC-Nampt KO aortas have a detectable amount of GAG accumulation while
GAG accumulation in control aortas was virtually undetectable, both in the ascending and
thoracic regions (P=0.03 and P=0.007, respectively, Fig. 4.8f). Following 7 days of Ang II
infusion the area fraction of GAG accumulation was 4.2-fold higher in SMC-Nampt KO
ascending aortas (P<0.0001) than that of Ang II-infused control ascending aortas.
Similarly, both KO and control thoracic aortas had an increase in the area fraction of
proteoglycan present in response to Ang II (P=0.02). This evidence of proteoglycan
accumulation, along with reduction in the more structurally resistant ECM components
(e.g. collagen), points to a vascular structural weakening in response to Nampt ablation.
4.3.6

Smad7 is a potential upstream regulator of Nampt-dependent changes in the
ECM equilibrium
To screen for potential drivers of the gene-expression phenotypes related to Nampt-

ablation in the SMCs, I performed Ingenuity Pathway Analysis (IPA) on the up- and downregulated genes revealed by the microarray analysis data. Specifically, I evaluated the data
set using the Upstream Regulator Analytic. Transcription regulators potentially affected by
SMC-Nampt depletion were identified based on the number of up- and down-regulated
genes that were statistically overrepresented in the potential downstream target gene set
(Fig. 4.9a). The transcription factor predicted to be most significantly impacted by Nampt
ablation was Smad7 (P=5.52x10-14), and it was predicted to be activated (activation Zscore=2.27). Smad7 was followed by Jun, Myc, Foxm1 and Nupr1. Interestingly, the
putative downstream targets of Smad7, as predicted by the IPA platform, include a number
of ECM components that were differentially expressed in Nampt depleted SMCs (Fig.
4.9b). Although the involvement of Smad7 remains to be validated, it may represent a key
node through which Nampt regulates the ECM environment of SMCs.
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Figure 4.7 Predicted transcription factors mediating transcript changes by loss of Nampt
A. The 5 upstream transcription regulators most strongly predicted to be impacted by Nampt depletion in
SMCs as identified by Ingenuity Pathway Analysis of SMC-Nampt knockout microarray data. B. Heatmap of
specific ECM transcripts downstream of Smad7, as identified by IPA, which are also differentially expressed
(greater than 1.5-fold change, P<0.05) in Nampt-KO SMCs. Each column represents one independent SMC
culture and each row represents one mRNA transcript. mRNA Transcript expression across the 6 independent
cultures was normalized and the Z-score is depicted; Yellow indicates relative high expression, Blue indicates
relative low expression.
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4.4

Discussion
This study reveals that ECM homeostasis in the aortic media depends on a NAD+

fueling system. By evaluating changes in Nampt-KO SMCs and in SMC Nampt-deficient
aortas we show that: 1) Nampt knockdown in SMCs profoundly changes the expression
pattern of SMC gene transcripts, 2) there were reciprocal shifts in the expression of
transcripts associated with collagen synthesis and assembly, and proteoglycan synthesis, 3)
Nampt-deficient mouse aortas displayed decreased content and organization of fibrillar
collagen at baseline and following infusion with Ang II, 4) Nampt-deficient mouse aortas
had increased proteoglycan accumulation at baseline, and following Ang II infusion, and 5)
the Smad7 signaling pathway may be altered in response to Nampt knockdown in SMCs.
Nampt was originally identified as a putative cytokine, pre-B enhancing colony
factor (PBEF) (Samal et al. 1994, Rongvaux et al. 2002), and subsequently as a putative
insulin-mimetic hormone, Visfatin (Fukuhara et al. 2005). Evidence for the former is
inconclusive, and the index report for the latter has been retracted (Fukuhara et al. 2007).
Our previous work has established Nampt as a phosphoribosyltransferase, impacting the
ability of SMCs in vitro to withstand the effects of replicative stress in culture (van der
Veer et al. 2007). Additionally, my recent findings have revealed the importance of an
autonomous, Nampt-dependent NAD+ production cascade in SMCs that serves as a vital
metabolic hub for the aorta. The current findings highlight the magnitude of transcript
control exerted by this hub. Two major NAD+-dependent enzyme families are likely central
to this transcript program, Parps and Sirtuins. Parp’s actions include ADP-ribosylation of
histones (Verdone et al. 2015). Sirtuins couple NAD+ breakdown to the deacetylation
and/or ADP-ribosylation of target proteins. Numerous target proteins, including histones
and a variety of transcription factors, have been reported for sirtuins (Dai and Faller 2008,
Imai 2009). Major gene expression changes have been found in mouse fibroblasts with
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increased Nampt, which is at least partly due to augmenting the transcriptional regulatory
activity of Sirt1 by increasing NAD+ bioavailability (Revollo et al. 2004). The current data
shed light on the converse paradigm, i.e. decreased Nampt content depressed total cellular
NAD+ and re-wired gene expression in SMCs.
Remarkably, both the Gene Ontology (GO) terms and KEGG pathways that were
most particularly enriched by altered Nampt-KO SMC transcripts are those associated with
extracellular matrix production and assembly. In particular, this revealed an abundance of
genes associated with the synthesis and assembly of collagens, with a profile suggesting a
collagen depletion phenotype. Consistent with this, I found that aortas of SMC-Nampt KO
mice had reduced collagen content and organization. Ang II has been found to directly
contribute to vascular smooth muscle cell growth and vessel remodeling, including an
upregulation of collagen synthesis (Intengan and Schiffrin 2001, Sparks et al. 2011), and
this was also impaired in the SMC-Nampt KO mice. It has been reported that the
deacetylation activity of Sirt1 increases the expression of collagen type I (Col1a2)
transcription in vascular SMCs by directly antagonizing the Col1a2 repressor, RFX5 (Xia
et al. 2012). As well, Y. Wang et al. have reported that the inhibition of Parp1 prevented
fibrosis in response to Ang II (Wang et al. 2013). Under baseline conditions, Parp1
associates in the nucleus with the transcription factor Smad3. When activated by DNA
damage, Parp1 poly-ADP-ribosylates target histones, but also undergoes auto-poly-ADPribosylation. This modification caused it to dissociate from Smad3, and Smad3 was able to
bind to the promoter of its target genes: including Col1a1 and Col11a1, thus increasing
collagen production by vSMCs (Huang et al. 2011). These findings, together with my data,
support that idea that the reduced collagen in the aortas of KO mice may be due to
decreased Sirt1 and Parp1 activity.

152

The observed decrease in collagen production, both at baseline and in response to
Ang II, was accompanied by an increase in proteoglycan transcripts. The molecular basis
of this reciprocal relationship is unclear, however the end-result is associated with both
structural weakness of the aorta and the pathology of human aortopathy (Lakatta et al.
2009, Humphrey 2013, Roccabianca et al. 2014).
The statistical determination that Smad7 is an upstream transcription factor that
drives the expression profile is noteworthy. NAD+-dependent Sirt1-mediated deacetylation
of Smad7 has been documented. Deacetylation of Smad7 targets it for degradation, and
inhibition of Smad7 deacetylation leads to greater Smad7 stability and activity (Kume et al.
2007). Smad7 is a key negative regulator of TGF-β signalling (Yan and Chen 2011, Beppu
2013). In the vascular compartment TGF-β has been implicated in matrix deposition and in
matrix degradation, positioning it as a critical regulator of the vascular ECM (Jones and
Ikonomidis 2010). In particular, TGF-β can enhance collagen and fibronectin synthesis and
deposition (Ignotz and Massague 1986), increase elastin expression (Kucich et al. 2002),
and repress MMPs (Yan and Boyd 2007). TGF-β signalling also can increase the size of
glycosaminoglycan chains on both bigylcan and decorin (Schonherr et al. 1993, Dadlani et
al. 2008). A Nampt-regulated shift in TGF-β signalling due increased Smad7 stability could
well be responsible for unbalancing the homeostasis of the aortic extracellular
environment, leaving the aorta vulnerable to disruption.
In summary, I demonstrate that a SMC-autonomous supply of NAD+ generated
Nampt is necessary for vascular SMCs to synthesize maintain a physiologic balance of
collagen versus proteoglycans. Upsetting this Nampt-regulated balance may weaken the
aorta and increase its susceptibility to dissection.
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CHAPTER 5 - NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE IS
ESSENTIAL FOR ADULT MICE SURVIVAL
5.1

Introduction
Nampt is required for the regeneration of NAD+ when NAD+ has been depleted by

NAD+-consuming reactions, including the ADP ribosylation of proteins, protein
deacetylation, and the production of cyclic ADP ribose (Sauve and Schramm 2004, Lee
2012, Luo and Kraus 2012). Several studies have reported Nampt to be highly expressed in
lung, liver, kidney, heart, adipose, and skeletal muscle, with much lower expression in
brain and pancreas (Samal et al. 1994, Revollo et al. 2007).
Tissue-specific gene targeting strategies in mice have revealed a pattern of
degenerative or aging-related tissue dysfunction when Nampt is perturbed in skeletal
muscle, adipose tissue, and brain (Stein and Imai 2014, Frederick et al. 2016, Stromsdorfer
et al. 2016, Zhou et al. 2016), in addition to the data presented in earlier chapters outlining
the degenerative consequences of Nampt knockout in SMCs.
Mice lacking Nampt in forebrain excitatory neurons showed hippocampal and
cortical atrophy, astrogliosis, microgliosis, and abnormal CA1 dendritic morphology by 2–
3 months of age (Stein et al. 2014). Ablation of Nampt in adult neural stem cells also
causes signs of accelerated aging in this neural cell population (Stein and Imai 2014).
Knockout of Nampt in skeletal muscle contributed to an aging phenotype-related loss mass
and contractile function (Frederick et al. 2016). Adipocyte-specific Nampt knockout mice
had severe insulin resistance in adipose tissue, liver, and skeletal muscle, and adipose tissue
dysfunction, manifested by increased plasma free fatty acid concentrations and decreased
plasma concentrations of a major insulin-sensitizing adipokine, adiponectin (Stromsdorfer
et al. 2016). Additionally, Nampt is critically required for the development of both T and B
lymphocytes (Rongvaux et al. 2008). Interestingly, this dysfunction was shown to be at
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least partially ameliorated in some cell types by the exogenous delivery of NAD+
precursors, such as nicotinamide (NAM) or nicotinamide riboside (NR). However, due to
the variability of the limited tissue-specific Nampt knockout data available, it is unclear
which may be the most vulnerable systems.
Nampt has been understood to be an essential enzyme for embryo development
based on reports that the development of the mouse embryo cannot proceed past e10.5
without Nampt (Revollo et al. 2007). A very recent report has emerged in which this
finding is confirmed. Nampt begins to be expressed at e8.5 in mouse development, and
Nampt deficient embryos cannot develop past e10.5 (Zhang et al. 2017). The essentiality of
Nampt was further confirmed in the adult mouse when knocked out using tamoxifenregulated Cre activity. These mice did not survive longer than 10 days post Nampt
knockout. The authors report severe atrophy of the villi of the gastrointestinal tract, an
increase in serum triglyceride levels, and a catastrophic decrease in abdominal adipose
stores (Zhang et al. 2017). However, their findings were limited, as they did not present
data on any other tissues that may have been affected by Nampt knockout. Additionally,
although these pathologies are attributed to liver dysfunction caused by liver Nampt
depletion, the model of Nampt knockout they used for their studies only yielded 20%
decrease in Nampt expression in the liver.
Here, I investigate the role of global expression of Nampt in a mouse model by
inducing knockout in an adult mouse, thus circumventing the embryonic lethality. My
findings reveal that Nampt is an essential gene necessary to sustain life. The findings also
reveal the different tissues are seemingly more resistant to the depletion of Nampt.
Additionally, I was able to extend the lifespan of Nampt KO mice by supplying the mice
with NR, an exogenous NAD+ precursor. These findings shed new light on the tissuespecific requirements for Nampt.
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5.2
5.2.1

Methods
Generation of Nampt-deficient mouse model
Mouse experiments followed protocols approved by the Western University Animal

Use Committee. All mice were on a C57Bl/6 background. I generated mice in which
Nampt could be globally and inducibly deleted. Namptflox/flox mice were bred with mice
expressing Cre recombinase fused to the mutated ligand binding domain of the human
estrogen receptor (ER) under the control of a chimeric cytomegalovirus immediate-early
enhancer/chicken

ß-actin

promoter

(B6.Cg-Tg(CAG-Cre/Esr1)5Amc/J)

(Jackson

Laboratories, Bar Harbor, ME) (Hayashi and McMahon 2002). To induce Namptflox/flox
recombination and excision by Cre recombinase, 8-10 week old Namptflox/flox;Cre-ERT2(+)
mice (denoted as Nampt KO) were i.p. injected with (1 mg/kg/day) tamoxifen (Tmx) in
sunflower oil vehicle, for five consecutive days. Namptflox/flox;Cre-ERT2(-) (denoted as WT
control) were also injected concomitantly with Tmx in sunflower oil to control for any
effects due to Tmx toxicity. For NR studies, mice were given a daily single dose (1000
mg/kg body weight) by i.p. injection. Initial necropsy studies were performed by the
CMHD Pathology Core at the Toronto Centre for Phenogenomics (Toronto, Ontario,
Canada).
5.2.2

Serum collection and analysis
Serum was collected using an approved standard protocol. Briefly, mice were

anaesthetized and blood was immediately collected by cardiac puncture. Blood was
allowed to clot for 20-30 minutes and then centrifuged for 10 mins at 1,500g to separate the
clotted material from the serum. Serum was then flash frozen and stored at -80°C for future
analysis. Clinical chemistry parameters were measured by standard protocols by Charles
River Laboratories (Wilmington, MA). Plasma insulin was determined by mouse-specific
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ELISA as per manufacturer’s instructions (ALPCO Diagnostics, Salem, NH: mouse
ultrasensitive ELISA #80-NSMSU-E01).
5.2.3

Histology and immunohistochemistry of mouse tissues
Mouse tissues were collected and fixed intact (with the exception of the intestinal

tract which was split open and rolled in order to survey the entire organ) overnight in 4%paraformaldehyde and embedded in paraffin. 10 mm-thick sections were stained with
hematoxylin and eosin (H&E) to broadly evaluate tissue architecture. Immunostaining was
performed on paraffin-embedded sections for Nampt using a rabbit polyclonal anti-Nampt
(A300-372A 1:50; Bethyl Laboratory, Montgomery, TX). Bound primary antibodies
against Nampt were detected using goat anti-rabbit biotinylated antibody (Vector Labs,
Burlington, ON, Canada) and visualized using an ABC kit and diaminobenzidine (DAB,
Vector Labs) and counterstained with Harris’ hematoxylin.
5.2.4

Morphology of esophagus and intestine
Mouse esophagus was removed intact 4%-paraformaldehyde fixed and paraffin

embedded sections were stained with H&E and visualized with an Olympus BX51
microscope. Epithelial structure thickness was quantified from an average of 10 equidistant
measurements around 3 sections 200 µm apart using ImageJ software (NIH, Bethesda,
MD). Mouse intestine was dissected and prepared with the adapted Swiss roll technique to
visualize the entire organ (Williams et al. 2016). Abnormal mucosal architecture was
evaluated in 3 regions of the jejunum 200 µm apart by measuring irregular crypts, and
crypt and villous blunting (Erben et al. 2014).
5.2.5

Laser capture microdissection and RNA isolation of pancreatic islets and
acinar cells.
Laser capture was undertaken on 10 µm-thick frozen sections of WT control and

Nampt KO pancreas (15 days after initiation of Tmx injections) that had been embedded in
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OCT compound (Tissue-Tek). Islet cells and acinar cells were micro-dissected (Arcturus
704 Veritas LCM System, Harlow Scientific, Arlington, VA) from 10 pancreas sections
and RNA extracted using TRIzol (Life Technologies) with the addition of linearized
polyacrylamide (2 mg/ml, Sigma) following phase separation.
5.2.6

Quantitative real-time reverse transcription–polymerase chain reaction
Total RNA was isolated from homogenates of the mouse aorta using TRIzol (Life

Technologies) and the RNeasy Mini Kit following the manufacturer’s protocol (Qiagen,
Valencia, CA). Total RNA was isolated from mouse and human SMCs using the RNeasy
Mini Kit following the manufacturer’s protocol. Transcript abundance of mouse Nampt,
Nrk1, and 18S were assessed using SYBR-green chemistry-based primer sets (Nampt: FGGCACCACTAATCATCAGACCTG R-AAGGTGGCAGCAACTTGTAGCC; Nrk1: FAGAGCTTGCAGAAGCACCTTCC R-CATCCAACAGGAAACTGCTGACA; 18S FGTAACCCGTTGAACCCCATT R-CCATCCAATCGGTAGTAGCG). Quantitative realtime RT-PCR was performed using an ABI Prism (model 7900HT) and Sequence
Detection System software (Life Technologies; Applied Biosystems).

For Nampt

expression in LCM islet and acinar cell samples, relative mRNA abundance was quantified
based on critical threshold (CT) using the comparative CT formula, 2-ΔΔCT, with 18S
mRNA as an internal control. For Nampt and Nrk1 expression in whole tissues, mRNA
abundance was quantified based on the standard curve method, with 18S mRNA as an
internal reference control, and expressed as relative units (r.u.)
5.2.7

Statistical analyses
Values are expressed as mean±standard error of the mean. Statistical analyses were

performed using GraphPad Prism software (GraphPad, La Jolla, CA, USA). Mean data
were compared using Student’s t-test or one-ANOVA with Holm-Sidak post hoc testing.
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Kaplan–Meier survival analysis was used to assess mouse longevity, and data were
compared using log-rank (Mantel-Cox) testing.
5.3
5.3.1

Results
Nampt knockout specifically in adult mice is lethal
To determine whether Nampt expression is a requisite necessity for survival, I

generated a mouse in which Nampt could be globally deleted in the adult. Because Nampt
knockout is embryonically lethal before e10.5 (Revollo et al. 2007, Zhang et al. 2017), the
deletion needed to be inducible in an adult animal and therefore Namptflox/flox;Cre-ERT2(+)
mice were generated. Mice (8-10 weeks old) were injected with tamoxifen (Tmx) for five
days to induce recombination and excision of the Namptflox/flox allele. To determine the
amount of Nampt depletion I evaluated the expression of Nampt mRNA in peri-mortem
Namptflox/flox;Cre-ERT2 (Nampt KO) mice by quantitative PCR. Nampt expression was
reduced in the heart (93.1%, P<0.0001, Fig. 1a), skeletal muscle (94.8%, P=0.0003, Fig.
5.1b), kidney (75.0%, P=0.004, Fig. 5.1c), brain (78.0%, P<0.0001, Fig. 5.1d), and
intestine (77.7%, P=0.003, Fig. 5.1e). There was no significant change in Nampt
expression in the liver (P=0.790, Fig. 5.1f)
Median survival time of Nampt KO mice was 16 days and no mouse survived past
20 days following the initiation of Tmx injection (n=12, P=0.003, Fig. 5.2a). An onset of
rapid weight loss began five days after Tmx injections were initiated and Nampt KO mice
had a 13.2 ± 5.44% decrease in body weight at time of death (P=0.001, Fig. 5.2b).
5.3.2

Nampt knockout is accompanied by gross pathological changes in the intestine
and pancreas
To help determine cause of death following Nampt knockout, a gross pathological

analysis of peri-mortem mice was undertaken. In addition to the weight loss described
above, Nampt KO peri-mortem mice were slow to move and were hunched (Fig. 5.2c).
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Figure 5.1 Nampt expression is decreased in heart, skeletal muscle, kidney, brain and small intestine in
Nampt KO mice
Graphs depicting the amount of Nampt expression in the A) heart, B) skeletal muscle, C) kidney, D), brain,
E) intestine, and F) liver of Nampt KO mice as compared to WT control mice, as measured by quantitative
RT-PCR. Nampt expression was normalized to the internal 18S expression. Tissues were harvested in perimortem mice, on average 15 days following the initiation of Tmx injections (n=3-4 per group, Student’s Ttest).
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Figure 5.2 Nampt knockout is lethal in adult mice
A) Kaplan-Meier survival curve of WT and Nampt KO mice following tamoxifen injection for 5 days (n=8
per group, *P<0.002, Log-rank (Mantel-Cox) test). B) Graph depicts change in weight at the end of lifespan
as compared to the animal’s individual starting weight. C) Images of WT control and peri-mortem Nampt KO
mice at time of death. D) Gross dissection of abdominal cavity of WT control and peri-mortem Nampt KO
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These observations consistently preceded death within 24 hours. Upon abdominal
dissection, it was apparent that the esophagus, stomach, and the small and large intestine
were distended with food materials (Fig. 5.2d). In addition, there was gross evidence of a
loss of pancreatic parenchymal integrity and enlarged lymph nodes. Examination of the
kidney, heart, skeletal muscle, brain, and liver revealed no gross pathology (Table 5.1).
5.3.3

Nampt knockout changes liver serum chemistry parameters
To further characterize the decline of Nampt KO mice, the serum chemistry of a

subset of mice was analysed. Serum was collected 5 days, 10 days, and 15 days following
initiation of Tmx injection (n=3 per group). Five days after initiation of Tmx injection
serum parameters were not significantly different from the range of expected values.
However, ten days after initiation of Tmx injections there was a significant change in levels
of

alanine

aminotransferase

(8.3-fold

increase,

P=0.02,

Fig.

5.3),

aspartate

aminotransferase (27.6-fold increase, P=0.04, Fig. 5.3), alkaline phosphatase (2.9-fold
increase, P=0.01, Fig. 5.3), and glucose (55.9% decrease, P=0.03, Fig. 5.3). Interestingly,
15 days after Tmx injections these levels returned to the range of expected values, except
for aspartate aminotransferase. These serum chemistry changes indicate a possible early
disruption in liver processes.
5.3.4

Nampt knockout affects the epithelial layers of the gastrointestinal tissues
To determine which tissues are affected by the knockout of Nampt, I evaluated

histological sections of the Nampt KO mice. There was no evidence of histological changes
in the heart, liver, kidney, or skeletal muscle of Nampt KO mice (Fig. 5.4). Surprisingly,
while there was gross appearance of dysfunction in the gastrointestinal tract (i.e. distension
of the esophagus, small intestine and colon), there was limited evidence for cellular
disruption. Villus height was variable; villi were midly, but not significantly, blunted in the
intestine (21.2% decrease 15 days after Tmx, P=0.080, Fig. 5.5a,b) with
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Table 5-1 The number of Nampt KO mice with tissue-specific gross pathology 5 days, 10
days, and 15 days following injection of tamoxifen and induction of Nampt knockout
Tissue
Pancreas
Esophagus
Stomach
Jejunum
Ileum
Colon

Pathology finding
(if present)

5 days
post Tmx

10 days
post Tmx

15 days
post Tmx

(n=3)

(n=3)

(n=8)

Loss of parenchymal integrity

3

3

8

1

1

6

0

2

7

0

3

8

0

3

8

0

3

8

Abnormal esophagus morphology,
dilated with food (partially digested)
Dilated stomach filled with food
materials
Dilated with thickened wall filled fully
with liquid and green fecal material,
Enlarged, dilated with thickened wall
filled fully with liquid and green fecal
material
Abnormal colon morphology, dilated
with thicken wall, and filled fully with
liquid and green fecal material

Cecum

Enlarged cecum

0

3

8

Kidney

Small kidney

0

0

2

Testis

Seminal vesicles are smaller. Small
testis

0

0

2

Lymph nodes

Enlarged lymph nodes

0

0

2

Adrenal gland

Small adrenal glands

0

0

2

Heart

None

0

0

0

Skeletal muscle

None

0

0

0

Liver

None

0

0

0
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Figure 5.3 Nampt knockout increases serum levels of aspartate aminotransferase, alanine
aminotransferase, and alanine phosphatase, and decreases circulating glucose levels
Serum was collected from WT control and Nampt KO mice by cardiac puncture 5 days, 10 days, and 15 days
following the initiation of tamoxifen injections (1000ng/mg/ml). Basic serum clinical chemistry was
measured for A) alanine aminotransferase, B) aspartate aminotransferase, C) alkaline phosphatase, D)
glucose. N=3 mice at each time point. Graph depicts data points in addition to mean ± standard deviation, by
one-way ANOVA with Holm-Sidak post hoc testing
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Figure 5.4 Nampt knockout does not have an effect on the histological appearance of the heart, liver, or
kidney
Micrographs of H&E-stained WT control and Nampt KO A) heart (cardiac myocytes), B) liver, and C)
kidney depicting no apparent differences.
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Figure 5.5 Nampt knockout is associated with a blunted villus and crypt architecture in the small
intestine
A) Micrographs of H&E-stained sections of WT control and Nampt KO small intestine. The effect that Nampt
KO had on the tissue was heterogenous; some villi (Vi) and crypts (Cr) were slightly blunted (panel 2), others
were significantly blunted (panel 3). B) Average length of villi in the small intestine (WT control n=3, early
(5 day) n=3, late (10-15 day) n=6, one-way ANOVA with Holm-Sidak post hoc testing). C) Average depth of
crypts in the small intestine (WT control n=3, early (5 day) n=3, late (10-15 day) n=6, one-way ANOVA with
Holm-Sidak post hoc testing).
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some evidence of villus loss in patchy areas. There was also crypt architecture that
appeared mildly, but not significantly, compressed 5 days after the initiation of Tmx
injections (26.2% decrease in crypt depth, P=0.313, Fig. 5.5a,c), and persisted through the
decline of the mice to day 15 (26.9% decrease in crypt depth 15 days after Tmx injection,
P=0.090, Fig. 5.5a,c). Additionally, there was a thinning of the epithelial layer of the
esophagus (Fig. 5.6a,b). Specifically, there was a 52.9% decrease in the average thickness
of the epithelial layer starting 5 days after the initiation of Tmx injections (P=0.0002, Fig.
5.6d).
5.3.5

Nampt knockout affects integrity of the pancreas
Evaluation of the pancreas as early as five days following the initiation of Tmx

injection, I observed evidence of multifocal to coalescing pancreatic acinar atrophy and
islet hyperplasia. Throughout the organ, there is histological evidence that localized acinar
cells have been replaced by ductal cells (acinar-to-ductal metaplasia Fig. 5.7a) and the islet
areas appear enlarged due to increased number of cells (3.1 ± 0.78-fold increase, P=0.03). I
also observed an appearance of interstitial stellate cells, which are often activated upon
injury. Additionally, there was an observed 89.5% decrease in serum insulin levels in perimortem Nampt KO mice (Fig. 5.7b); evidence of a dysfunction of islet cells.
This adverse pancreatic affect was particularly surprising as the baseline expression
of Nampt in the pancreas is reportedly very low to non-existent, particularly in comparison
to Nampt expression in other tissues (Fig. 5.7c) (Samal et al. 1994, Revollo et al. 2007). I
sought to confirm the result in the pancreas using both immunohistochemistry (Fig. 5.7c)
and also the more stringent approach of isolating pancreatic RNA specifically from islet
cells versus acinar cells by laser-capture microdissection. The results revealed that at
baseline Nampt is expressed only in islet cells of the pancreas (Fig. 5.7d,e). There is no
expression detected either by qPCR or immunohistochemistry in acinar cells.
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Figure 5.6 Nampt knockout is associated with a thinning of the epithelial layer of the esophagus
A) Micrographs depicting cross-sections of the dilated Nampt KO esophagus, still containing remnants of
mouse chow (second panel). B) Higher magnification view of the Nampt KO esophagus, depicting the thin
epithelial layer (black line). C) Graph depicting the average area occupied by the epithelial layer in a cross
section of the esophagus (WT control n=3, early (5 day) n=3, late (10-15 day) n=6, *P<0.0001 vs. WT
control, †P<0.0001 vs. WT control, by one-way ANOVA with Holm-Sidak post hoc testing). D) Graph
depicting the average thickness of the epithelial layer in a cross section of the esophagus (WT control n=3,
early (5 day) n=3, late (10-15 day) n=6, *P<0.0001 vs. WT control, †P<0.0001 vs. WT control, by one-way
ANOVA with Holm-Sidak post hoc testing).
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Figure 5.7 Nampt knockout affects the integrity of the pancreas
A) Representative micrographs of the multifocal to coalescing pancreatic acinar atrophy and islet cell
hyperplasia throughout the pancreas at 5, 10 and 15 days following the initiation of Tmx injections. Is: Islet
cells, Ac; Acinar cells, Du: Ductal cells. Black arrows in inset indicate examples of acinar-to-ductal
metaplasia. B) Serum insulin levels measured in peri-mortem Nampt KO mice (WT control n=5, Nampt KO
n=7) C) Graph depicting Nampt mRNA as measured by RT-PCR and normalized to 18S expression in WT
Control mouse tissues (n=3 mice) D) Representative micrographs of immunohistochemistry for Nampt
expression in WT control pancreas harvested from peri-mortem mice (Is: islet cells; Ac: acinar cells). E)
Nampt mRNA signal detected by RT-PCR and expressed as absolute CT values in islet cells and acinar cells
isolated by laser-capture microdissection. Pancreatic tissue from a minimum of 10 sections from 2 mice was
evaluated.
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5.3.6

Nicotinamide riboside delays the decline of Nampt KO mice, but is unable to
ultimately prevent death.
To determine whether delivery of NR, an exogenous precursor to NAD+, would be

sufficient to compensate for the loss of the NAD+-regenerating activity of Nampt, I first
measured the expression of Nrk1. Nrk1 is the enzyme that converts NR to NAD+. The
natural source of oral NR (and other NAD+ precursors NAM and NA) is largely in the food
we eat as broken down by digestion and the microbiome (Bogan and Brenner 2008, Canto
et al. 2015) Interestingly, it was recently shown that the human cytosolic 5′-nucleotidase
CD73 can catalyse the conversion of NMN into NR and that at least some cells are able to
release this nucleoside precursor of NAD+ (Kulikova et al. 2015), suggesting that NR is in
available in the circulation. Nrk1 expression was assessed by qPCR in the heart, skeletal
muscle, liver, and pancreas of control and Nampt KO mice, both at baseline and also in
mice that had been supplemented with daily i.p. injections of NR. In Nampt KO mice
supplemented with NR there was an increase in Nrk1 expression in the liver as compared to
the WT control (2.80-fold, P=0.043, Fig. 5.8a) and a trend towards increase in the heart,
although the data were not significant (1.25-fold, Fig. 5.8b). Interestingly, in the pancreas
of Nampt KO mice, both with and without NR supplementation, there was an increase of
Nrk1 expression (4.48-fold, P=0.182 and 4.82-fold, P=0.009, respectively, Fig. 5.8d). This
suggests a pancreatic dependence on a bio-available source of NAD+, or a precursor to
NAD+.
It was also of interest to deduce whether NR supplementation would be sufficient to
overcome decline and death due to Nampt knockout. I was able to demonstrate that
administration of NR can prolong the survival of Nampt KO mice, doubling the median
survival time from 16 to 34 days (P=0.001, Fig. 5.9a). Interestingly, at 20 days following
Tmx injection (the point at which all Nampt KO mice had died) Nampt KO mice
supplemented with NR began to regain weight, although this was not sustained (Fig. 5.9b).
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Figure 5.8 Expression of Nrk1 is increased in the liver and the pancreas of Nampt KO mice
Graphs depicting the expression of Nrk1 in the A) liver, B) heart, C) skeletal muscle, and D) pancreas of WT
control and Nampt KO mice, both at baseline or supplemented with daily i.p. injections of NR (1000
mg/kg/day). Nrk1 expression was normalized to the internal expression of 18s. N=4 mice per group, oneANOVA with Holm-Sidak post hoc testing.
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Figure 5.9 Global loss of Nampt-mediated NAD+ biosynthesis in the adult mouse in lethal and is
partially rescued by administration of nicotinamide riboside (NR)
A) Kaplan-Meier survival curve of WT and Nampt KO mice. NR (1000 mg/kg/day) was i.p. injected daily
until day of death (n=8 per group, *P=0.001 vs. Nampt KO, by log-rank [Mantel-Cox] testing). B) Graph
depicting weights of mice until time of death (n=8 per group).
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5.4

Discussion
This study is one of the first reports on the essentiality of Nampt expression. Nampt

KO mice i) did not survive longer than 20 days without Nampt expression; ii) underwent
extreme pancreatic atrophy; iii) died with a GI tract filled with food materials; iv) had their
lifespans doubled by supplementing them with NR, but ultimately succumbed to the Nampt
deficiency.
The finding that global Nampt KO is quickly lethal in an adult animal is
noteworthy. Previous reports have mentioned as an observation that Nampt knockout is
lethal in the developing embryo prior to e10.5 (Rongvaux et al. 2002, Fukuhara et al. 2005,
Revollo et al. 2007). Our previous findings have demonstrated that knocking out Nampt
specifically in smooth muscle cells does not lead to the complete failure of SMC-rich
vessels and organs. However, there is a propensity to DNA damage, abnormal expression
of matrix components and senescence in vascular smooth muscle cells along with a
dysfunction, albeit not complete failure, of bladder and intestinal smooth muscle (Watson
et al. 2017). Other reports have indicated that Nampt ablation in the liver, skeletal muscle,
and brain does not lead to the failure of these organs, but it does predispose to a pattern of
aging or degenerative tissue disorder (Stein and Imai 2014, Frederick et al. 2016, Zhou et
al. 2016). Concordantly, our initial expectation was that a global Nampt knockout would
lead to an aging or degenerative phenotype. These results were unexpected; however, my
findings of quick decline and death corroborate the very recent report of a global inducible
Nampt knockout in an adult animal (Zhang et al. 2017).
Nampt-depleted mice demonstrated a striking atrophy of the exocrine pancreas.
This was first observed in peri-mortem Nampt KO mice, but upon further examination this
atrophy began as early as five days after the initiation of Tmx injection. This atrophy was
accompanied by acinar nuclear dysplasia, fibrosis, some necrotic cells, and a striking
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occurrence of acinar-to-ductal metaplasia (ADM). Notably, there was a lack of
inflammatory cells, even with the appearance of a few necrotic cells. ADM is thought to be
a response to pancreatic injury, and has been observed in several conditions including
pancreatitis, chemically induced carcinogenesis, duct ligation, pancreatectomy, chronic
hyperglycemia and animal models of diabetes (reviewed in (Storz 2017)). It was shown
that exocrine cells might also trans-differentiate into ß cells (Minami et al. 2005). Although
there was little evidence for local Nampt expression in the pancreas there was strong
evidence of organ-wide dysfunction, pointing to the requisite need for a source of Nampt or
bioavailable NAD+. This source could, in theory, be i) supplied locally even with Nampt
expression in islet cells, ii) delivered from circulating extracellular Nampt, or iii)
circulating nucleoside NAD+ precursors, such as NR. It has not been established whether or
not the pancreas can use distal sources of Nampt or NAD+ precursors. However, paradigm
of dependence on a distal supply of Nampt has been reported in the case of hippocampal
cells requiring Nampt secreted from adipose tissue (Yoon et al. 2015).
Nampt KO mice had a dilated and chow-filled alimentary canal - from the
esophagus to the colon. There was a thinning of the structure composed of epithelial cells
in these tissues, which may suggest that cell types with high turnover rates are more
dependent on a bioavailable source of NAD+. Dilation and chow arrest may have stemmed
from a malfunctioning exocrine pancreas as reduced secretion of pancreatic enzymes may
result in an increase of undigested food material in the intestines and an increase in water
content due to compensatory osmotic reactions. However, reduced pancreatic enzyme
availability, as seen in cases of pancreatic insufficiency, is often associated with cases of
diarrheal steatorrhea, and not cessation of motility (DiMagno et al. 1973, Pongprasobchai
2013), although these conditions do not have to be exclusive. It is also possible that an
altered motility of the alimentary system affects the propulsion of the content. One
mechanism could be an altered electrical activity of the smooth muscle or altered
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neuro/hormonal regulation of motility. Motility disorders, including diabetic enteropathy,
slow-transit constipation, and ageing-associated motility disorders are linked, directly or
indirectly, to defects in the neural control of the GI tract (Bassotti and Villanacci 2006,
Camilleri et al. 2008, Lomax et al. 2010). An important component of enteric inhibitory
neurotransmission is mediated by a purine neurotransmitter binding to purinoreceptors
(Wood 2006, Gallego et al. 2008, Grasa et al. 2009). NAD+ is a purine substance (ß-NAD+)
released by nerve stimulation in vascular and visceral smooth muscles and neuro-secretory
cells (Smyth et al. 2004, Smyth et al. 2006, Mutafova-Yambolieva et al. 2007, Yamboliev
et al. 2009), raising the possibility that NAD+ could be playing an important role in the
control of gut motility at the neural level.
NAD+ is made available to the cell through more than one pathway. There are at
least five dietary precursors to NAD+, four of which do not require Nampt and NAD+ itself
may be directly delivered to cells from nearby cellular sources (Revollo et al. 2007,
Nikiforov et al. 2015). The last aim of this study was to determine whether supplying
Nampt KO mice with NR, an exogenous precursor that is metabolized to NAD+ via a
Nampt-independent pathway (i.e. Nrk1), could overcome decline and death. Work in our
lab and in others has shown that NR supplementation can increase cellular NAD+ levels.
This NR-derived increase in NAD+ has been protective against various environmentinduced pathologies including noise-induced hearing loss (Brown et al. 2014), high fat dietinduced obesity (Canto et al. 2012), and age-induced muscle dysfunction (Frederick et al.
2016). Supplementing with NR was able to double the lifespan of Nampt KO mice,
suggesting that NR can bolster the effects of the local loss of bioavailable NAD+.
However, NR supplementation was only successful for a time. NR supplemented Nampt
KO mice eventually succumbed to decline and death.
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By evaluating the consequences of Nampt KO in the newly developed inducible
mouse model I am able to propose that i) Nampt expression is essential on a global level,
ii) Nampt expression is variable from tissue to tissue, and even tissues that don’t normally
markedly express Nampt may be susceptible to a global Nampt depletion, iii) exogenous
supplementation of a Nampt-independent NAD+ precursor is not sufficient to completely
compensate for the global loss of Nampt expression; however, lifespan is doubled when
NR is administered. In summary, these data demonstrate that loss of Nampt in the adult is
catastrophic. While the exact pathway of death on a cellular level may still be yet to be
elucidated, it is clear that supplementation with an exogenous NAD+ precursor is powerful,
but cannot overcome the need for a local NAD+-regeneration system.
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CHAPTER 6 - DISCUSSION
Maintaining SMC health and vitality is crucial to protecting vascular stability in the
face of hemodynamic and environmental insults. This is particularly true as these insults
increase and accumulate over time and with age. Expanding our understanding of how
SMCs resist stress is critical to developing strategies that enable a well-functioning
vascular system over a long period of time.
The novel findings presented in this thesis contribute to understanding how the
NAD+-regenerating enzyme, Nampt, enables SMCs in vivo to resist key stresses that are
exacerbated with aging. First, I developed a novel mouse knockout model wherein Nampt
was knocked out in SMCs. The aortas of these knockout mice were susceptible to stressinduced dissections, and the Nampt-KO aortic SMCs were compromised. These SMCs
accumulated a range of DNA lesions that, I propose, pushed the cells to a fate of early cell
senescence and cell loss. Second, I determined that the paradigm of low NAMPT
expression correlating with a higher occurrence of DNA damage also exists in human
aortic tissue obtained from patients with dilated aortas. Remarkably, the pattern of NAMPT
expression in these aortas was associated with changes in the methylation status of the
NAMPT promoter region, suggesting epigenetic control over NAMPT expression. Third, I
determined that ablating Nampt expression in SMCs leads to a global shift in gene
expression involving the downregulation of genes that produce collagens and the
upregulation of genes that favour the production and assembly of certain proteoglycans.
Fourth, I have demonstrated that Nampt is an essential gene in the adult mouse, and the
knockout of Nampt is fatal within 20 days. Interestingly, I also determined that delivering
NR to the knockout animal (NR is available as a dietary supplement) was sufficient to
double its lifespan. Collectively, these findings reveal new functions for Nampt in the
context of supporting SMC health and longevity.
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6.1

Nampt knockout in SMCs
Previous work done in Dr. Pickering’s lab established that Nampt is a

phosphoribosyltransferase and that it plays a role in vitro in extending the lifespan of
SMCs. However, the role of Nampt in SMCs in vivo had not been established. My finding
that Nampt-KO SMCs were part of a vasculature that developed largely normally was
somewhat surprising. This is because prior reports indicated that global Nampt knockout
was embryonic lethal (Revollo et al. 2007). Additionally, specific knockout of Nampt in T
and B cells led to a near complete loss of these cells in mice (Rongvaux et al. 2008).
Recently, additional cell-specific Nampt knockouts have been reported. Nampt
knockout in forebrain excitatory neurons lead to hippocampal and cortical atrophy,
astrogliosis, microgliosis, and abnormal dendritic morphology by 2-3 months of age (Stein
et al. 2014). Adipose-specific Nampt KO mice were found to have severe insulin resistance
in adipose tissue, liver, and skeletal muscle, as well as adipose tissue dysfunction
(Stromsdorfer et al. 2016). The deletion of Nampt in mice in both heart and skeletal muscle
was embryonically lethal, whereas a skeletal muscle-specific deletion led to exhibited
progressive weakness and loss of both endurance and bone structure, along with an
increase of senescence markers in the skeletal muscle cells (Frederick et al. 2016). Thus,
together with my data, it is becoming clear that different tissues have different
requirements for Nampt.
6.2

Nampt knockout and SMC DNA
A striking consequence of Nampt knockout in SMCs was the accumulation of DNA

lesions. These included oxidative damage, as indicated by the presence of 8-oxo-dG, and γH2AX foci, an indication of double stranded DNA breaks. Classically, DNA damage in
uncovered in the context of tumours. In this regard, it is noteworthy that Nampt is
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overexpressed in various cancers, including prostate, pancreatic, ovarian, fibrosarcoma,
lung, colon, and myeloid (Hasmann and Schemainda 2003, Beauparlant et al. 2009,
Watson et al. 2009, Olesen et al. 2010, Wang et al. 2011, O'Brien et al. 2013, Xiao et al.
2013, Chan et al. 2014, Chini et al. 2014), and that the inhibition of Nampt is studied as
tumour therapy. Inhibition of Nampt in some cancer cells can induce apoptosis, inhibit
glycoloysis and nucleotide metabolism, decrease carbon flux through the TCA cycle, and
suppress ATP synthesis (Tan et al. 2013, Tolstikov et al. 2014). Cell death follows a >90%
reduction in ATP (Watson et al. 2009, Tan et al. 2013, Chan et al. 2014, Del Nagro et al.
2014). However, with less catastrophic ATP depletion, inhibition of Nampt has been found
to sensitize tumour cells to oxidative stress and DNA-damaging agents (Hasmann and
Schemainda 2003, Yang et al. 2007, Watson et al. 2009, Bi et al. 2011, Wang et al. 2011).
Importantly, the work presented in Chapter 2 is the first report in non-cancerous, welldifferentiated cells of the association of Nampt depletion with a susceptibility to DNA
damage.
6.3

Nampt knockout and senescence
Widespread evidence of senescence in the aortic media of SMC-Nampt KO mice

infused with Ang II was another striking finding. Previous studies in Dr. Pickering’s lab
demonstrated that inhibiting Nampt in SMCs in culture led to premature senescence, while
overexpressing Nampt protected SMCs from undergoing replicative senescence (van der
Veer et al. 2007). Additionally, it has been demonstrated that infusion of Ang II in vivo has
been associated with an increase of SA β–gal activity the media of C57Bl/6 mice (Chen et
al. 2016). Ang II has also been shown to induce SA β–gal activity in that aortic media of
Sirt1 KO mice, aged mice, and aged Col1a1-/- mice (Vafaie et al. 2014, Chen et al. 2016).
Interestingly, although I found senescence markers to be more abundant following Ang II
infusion, I also detected evidence of senescence in the aortas of SMC-knockout mice at
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baseline. Baseline senescence was not observed in Sirt1 KO mice (Chen et al. 2016),
suggesting that the senescence-promoting effects of Nampt knockout are not exclusively
mediated via a decrease in Sirt1 activity, but also involve the activity of other NAD+dependent processes.
6.4

Nampt knockout and Parp1 activity
It is well established that knocking down Nampt activity can lead to a depletion of

bioavailable NAD+(Revollo et al. 2004). As Parp1 requires NAD+ to function, a depletion
could compromise the PAR-moiety forming activity of Parp1. I observed this paradigm in
SMC-Nampt KO mouse aortas, as detailed in Chapter 2. Notably, levels of Parp1 were
unchanged, but the ability to form poly-ADP-ribose moieties was abrogated. This was
associated with impaired repair of damaged DNA, consistent with the body of evidence of
Parp1’s involvement in multiple DNA damage repair pathways (Ray Chaudhuri and
Nussenzweig 2017). Upon supplying the Nampt KO SMCs with NR, a precursor to NAD+,
I was able to restore the ability of the cells to form PAR moieties; the hypothesis being that
Parp1 retained its catalytic capacity, but the building blocks required to form PAR moieties
(i.e. NAD+, acting as cosubstrate) were unavailable.
Recently there has been evidence that low bioavailable NAD+ not only limits the
PAR-synthetic activity of Parp1, but directly promotes the protein-protein interaction of
Parp1 and its inhibitor DBC1. NAD+ interacts with DBC1 via nudix homology domains
(NDHs) (Li et al. 2017). NDHs have been considered protein homology domains of
previously unknown function that have recently been discovered to be NAD+ binding
domains that regulate protein-protein interactions (Srouji et al. 2017). A decline in NAD+
promotes the binding of DBC1 to Parp1, which inhibits Parp1’s ability to mediate DNA
repair (Li et al. 2017). It is speculated that this function allows a cell to adapt to
fluctuations in NAD+ abundance without degrading it, and to serve as a negative-feedback
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loop to prevent Parp1 from depleting NAD+ down to lethal levels during DNA damage
(Yang et al. 2007). It is possible that this paradigm explains the predisposition to DNA
damage in SMC-Nampt KO mice, without widespread medial cell death.
6.5

SMC Nampt knockout and future directions
The studies carried out in Chapter 2 provide insight into the role Nampt plays in

vivo in SMCs. Using a mouse model of SMC-specific Nampt knockout I uncovered that
Nampt deficient SMCs developed into a close-to normal aorta.

However, when this

vasculature was subjected to hemodynamic stress of Ang II, the Nampt-deficient aortas
were prone to dissection. These dissections were associated with an increased burden of
cells with DNA damage and senescent cells.
The main phenotype uncovered in the SMC-Nampt KO aortas was related to a
deficiency in Parp1 activity, activity very much dependent on the bioavailability of NAD+.
It would be interesting to determine whether supplying an exogenous source of NAD+ to
the animal would regenerate Parp1 activity. I have demonstrated in vivo that delivering the
NAD+ precursor, NR, to Nampt-KO SMCs in vitro restored Parp1 activity. Thus,
undertaking Ang II-infusion experiments in SMC-Nampt KO mice, while supplementing
the animal with NAD+ precursors, either NR or NMN, would be important. NR may be of
particular interest as it can be obtained in a dietary fashion. As Nampt levels have been
shown to decrease in aged tissues (Stein and Imai 2014), along with concomitant drops in
NAD+ levels, it is of particular interest to know if a dietary supplement could offset the
effects of this drop.
Furthermore, the bulk of my studies were restricted to the largest vessel, the aorta.
While the failure of this vessel occurs often in an acute and catastrophic fashion,
compromised function of smaller arteries can have important long-term effects on blood
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pressure and flow. Therefore, it would be interesting to characterize the consequences of
Nampt knockout in the more distal vasculature this mouse model.
6.6

Nampt expression in human aortopathy
The correlation between low Nampt in mouse aortic SMCs and susceptibility to

aortic dissection and hemorrhage caused me to consider whether this correlation exists in
human aortic pathologies. As presented in Chapter 3, I uncovered that NAMPT content
was lower in dilated human aortas that in non-dilated aortas, with an inverse relationship
between the aortic diameter and medial SMC NAMPT content. This fits an emerging
pattern of reduced Nampt in aged or compromised tissues (Yoshino et al. 2011, Stein and
Imai 2014). The current study may be the first to identify such a relationship in human
diseased tissue. It is interesting to note that a downregulation of the NAD+-dependent
enzyme Sirt1 has been associated with aortic aneurysms in humans (Chen et al. 2016), and
decreased Sirt1 activity has been found in the dysfunctional vasculature of aged mice (de
Picciotto et al. 2016). As Sirt1 activity is dependent on the bioavailability of NAD+, the
described Sirt1 effects could depend, at least in part, on the NAD+-regenerating activity of
Nampt.
6.7

Nampt expression and DNA damage in human aortopathy
A remarkable discovery presented in Chapter 3 was the presence of double-stranded

DNA breaks in human aortic medial tissue. While there were rare breaks (indicated by the
presence of γ-H2AX foci) detected in the media of normal control tissue, the incidence of
γ-H2AX foci was significantly increased in tissue obtained from patients with dilated
aortas. This is the first in situ evidence for double-stranded DNA lesions in nonatherosclerotic human aortic media (Gray et al. 2015). Cells in which these foci were
detected also demonstrated low Nampt expression. Although the data do not prove
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causation, the single-cell relationship between low NAMPT and unresolved DNA strand
breaks strengthens the potential for a mechanistic relationship.
Although the activity of DNA damage repair enzymes was not evaluated in the
human aortopathy samples, I propose that the persistence of DNA breaks was due to a
deficiency of repair mechanisms. There has been uncertainty as to whether DNA damage
occurs in “post-mitotic” tissues, and if it does occur, whether repair of DNA breaks occurs
in post-mitotic tissues. However, studies of post-mitotic neural tissue have found that these
tissues do endure DNA damage, and also have the capability to repair DNA damage (Chow
and Herrup 2015). Much of the damage is attributable to radiation or reactive oxygen
species, but also to gene transcription that generates DNA damage through topoisomerase I
cleavage complexes (Katyal et al. 2014). Additionally, even in post-mitotic cells, DNA
damage repair processes such as base excision repair, single-strand break repair, and nonhomologous end joining have been detected (Iyama and Wilson 2013). Importantly, the
activities of a number of NAD+-dependent enzymes have been associated with these repair
pathways, including Parp1, Sirt1, and Sirt6, thus strengthening the case for a potential
mechanistic relationship with Nampt (Mostoslavsky et al. 2006, Mao et al. 2011, Dobbin et
al. 2013, Ray Chaudhuri and Nussenzweig 2017).
6.8

Epigenetic control of Nampt expression
The discovery that NAMPT expression varied from patient to patient prompted an

investigation into what could potentially be regulating NAMPT expression. To date it has
been understood that Nampt expression was regulated by the binding of the circadian
transcription factors Bmal1 and Clock (Nakahata et al. 2009). Expression of Clock:Bmal1
is in turn mediated by Sirt1 activity (Nakahata et al. 2008), and thus Nampt expression is
regulated by its own NAD+-regenerating activity.
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To facilitate transcription, the Clock:Bmal1 complex binds to enhancer-box (E-box)
sites in the Nampt promoter region. My analysis of the Nampt promoter region also
revealed CpG islands; regions that are susceptible to DNA hypermethylation, which
interferes with gene transcription. Accordingly, patient samples with low levels of Nampt
expression in their aortic media had higher levels of DNA methylation in the Nampt
promoter region. There is a growing body of evidence that local CpG islands undergo DNA
hypermethylation with aging (Jones et al. 2015). Hypermethylation of the Nampt promoter
region during aging could be part of the sequence of events driving cells to a low NAD+state, and perpetuating an aging or frailty phenotype.
6.9

Future directions for human aortic Nampt studies
The data presented in Chapter 3 represented predominantly bicuspid aortic valve

patients. However, low aortic NAMPT was observed not only the dilated aortas of patients
with a bicuspid aortic valve but also those with a tricuspid aortic valve and Marfan
syndrome. A larger series would be required to determine if there are aortic diseasespecific differences in NAMPT expression and also if NAMPT expression in SMCs is
relevant to atherosclerotic abdominal aortic aneurysms. It would also be beneficial to
attempt to correlate NAMPT expression with NAD+ levels in the aortic media, although this
could require larger pieces of human aorta to be harvested.
DNA methylation is a heritable epigenetic mark involving the covalent transfer of a
methyl group to the C-5 position of the cytosine ring of DNA by DNA methyltransferases
(DNMTs) (Chen and Li 2006). It would be interesting to evaluate the expression or activity
status of DNMTs, particularly DNMT1 (responsible for maintaining DNA methylation
patterns) and DNMT3a or 3b (which are responsible for de novo methylation of DNA), in
the aortic media of patients with dilated aortas (Robert et al. 2003, Hino et al. 2009, Daniel
et al. 2011).
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6.10 SMC Nampt and extracellular matrix
Studies in Chapter 2 revealed that SMC-Nampt depletion conveyed a vulnerability
to the aorta and a susceptibility to SMC dropout. Thoracic aortic aneurysm and dissection
disease (TAAD) is classically associated with SMC dropout, but also damaged elastic
fibers, compromised smooth muscle function, pooled mucoid material, and remodeled
collagen fibers (Humphrey et al. 2015).
The studies in Chapter 4 involved transcriptome profiling of Nampt-knockout
SMCs. RNA expression array analysis revealed a notable change in the transcriptome. The
expression of genes related to collagen production and assembly was significantly
depressed and the expression of genes related to mucoid/proteoglycan material was
significantly increased. This is consistent with an aortic wall environment seen in aged
tissues, and in TAAD tissues (Humphrey et al. 2015). Loss of collagen fiber integrity
decreases mechanical strength, which can render the aortic wall vulnerable to rupture
(Wenstrup et al. 2006). Proteoglycans that can accumulate and pool in localized areas with
aging and as part of the pathology in TAADs contribute to the risk of dissection
(Roccabianca et al. 2014).
6.11 SMC Nampt knockout and SMAD signalling
Identifying a mechanistic link between Nampt knockdown and ECM transcriptome
changes was outside the scope of the work presented in Chapter 4. However, I was able to
identify Smad7 as a potential upstream driver of these changes using a prediction algorithm
built into the Upstream Analysis tool from IPA. Smad7 is an inhibitor of TGF-β signaling
by preventing formation of Smad2/3:Smad4 complexes that initiate the TGF-β signalling
(Shi and Massague 2003). TGF-β signaling is associated with enhanced collagen and
fibronectin synthesis and deposition (Ignotz and Massague 1986), increased elastin
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expression (Kucich et al. 2002), and direct repression of MMPs (Yan and Boyd 2007).
TGF-β signaling also increases the size of glycosaminoglycan chains on both bigylcan and
decorin (Schonherr et al. 1993, Dadlani et al. 2008). Interestingly, NAD+-dependent Sirt1mediated deacetylation of Smad7 has been documented. Deacetylation of Smad7 targets it
for degradation, and inhibition of Smad7 deacetylation leads to greater Smad7 stability and
activity (Kume et al. 2007). This may be significant as disruptions in TGF-β signalling
have been identified in aortic pathologies such as Marfan syndrome and in Loeys-Dietz
syndrome (Loeys and Dietz 1993, Jones and Ikonomidis 2010). TGF-β signaling has been
implicated not only in matrix deposition, but also in matrix degradation, positioning it as a
critical mediator of the balance of structure and composition of the vascular ECM (Jones
and Ikonomidis 2010). Accordingly, my data raise the possibility of a Nampt-Smad7
dependency that is relevant to health and disease.
6.12 Future directions for the link between Nampt expression and the control of
ECM transcription.
The NAD+-dependent activity of Sirt1 has been found to regulate the stability of
Smad7 by deacetylation (Kume et al. 2007). Therefore a depletion of Nampt-generated
NAD+ in the cell could, consistent with my hypothesis, have an effect on the stability of
Smad7. It would be important to evaluate the acetylation status of Smad7 and consequent
Smad7 protein levels in WT and Nampt KO SMCs. Loss-of-function and overexpression of
Smad7 and measuring the expression of key ECM proteins would help to illuminate its
role. A change in the phosphorylation status of Smad2/3 would also indicate functionally a
change in Smad7 activity, as Smad7 is a key regulator of the TGF-β signalling pathway
(Yan and Chen 2011, Beppu 2013).
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6.13 Global Nampt knockout
Studies presented in Chapters 2, 3, and 4 all focus on the role of Nampt specifically
in SMCs. Chapter 5 explored the role Nampt plays in all other organs, and how the need
for Nampt in SMCs can compare to the requirements of different tissues. Reports to date
have indicated that Nampt knockout is embryonically lethal prior to e10.5 (Revollo et al.
2007). Therefore I developed a mouse model wherein Nampt could be conditionally
deleted at a post-natal time-point. Nampt KO mice did not survive longer than 20 days the
acute knockout event. Interestingly, this early death was not due to vascular SMC
abnormalities but was associated with rapid degeneration of the exocrine pancreas, gut
epithelial abnormalities, and halted gastrointestinal transit of undigested food. It is
interesting to note that soon after these studies had been undertaken, reports of a similar
knockout model were published (Zhang et al. 2017). A similar time-course of decline was
reported; rapid weight loss after the induction of the knockout with death occurring within
5-10 days of knockout. The authors report severe atrophy of the villi of the gastrointestinal
tract, an increase in serum triglyceride levels, and a catastrophic decrease in abdominal
adipose stores (Zhang et al. 2017). These results were attributed to liver dysfunction caused
by liver Nampt depletion, however, the model of Nampt knockout they used for their
studies only yielded 20% decrease in Nampt expression in the liver. Also, mice that are
subjected to calorie restriction for any reason can reduce their body fat stores remarkably
quickly – i.e. up to 20% within 72 hours (Tang et al. 2017). Their findings were limited, as
they did not present data on any other tissues that may have been affected by Nampt
knockout.
The results of my Nampt knockout study suggest that some tissues are more quickly
vulnerable to knockout than others, indicating cell differences in their requirement for
NAD+ bioavailability. In tissue-specific knockout of Nampt, mice lacking Nampt in
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forebrain excitatory neurons showed abnormal morphology and accelerated aging (Stein et
al. 2014). Ablation of Nampt in adult neural stem cells also causes signs of accelerated
aging in this neural cell population (Stein and Imai 2014). Knockout of Nampt in skeletal
muscle contributed to an aging phenotype-related loss mass and contractile function
(Frederick et al. 2016). Adipocyte-specific Nampt knockout mice had severe insulin
resistance in adipose tissue, as well as liver, and skeletal muscle, and adipose tissue
dysfunction (Stromsdorfer et al. 2016). In my model of global Nampt knockout, none of
these tissues were grossly abnormal, save for the loss of most of the adipose tissue stores.
In contrast, the pancreas seems to be profoundly affected. Remarkably, there doesn’t seem
to be strong, local, baseline expression of Nampt in the pancreas, therefore it may be
dependent on distal sources of Nampt-generated NAD+. This would agree with the concept
that some tissues are “NAD+-frail”; i.e. they aren’t autonomously able to regenerate the
NAD+ they need to function. This is ascribed namely to the pancreas and brain, as there is
little evidence of Nampt expression (Revollo et al. 2007), yet there is dependence on NAD+
availability (Ramsey et al. 2008, Yoon et al. 2015). It is of particular interest to note,
however, that the concept of the pancreas being “NAD+-frail” is in relation to the NAD+
requirement of the β islet cells of the pancreas for glucose-stimulated insulin secretion
(Imai 2016). And yet in my model of global Nampt knockout it was the exocrine pancreas
that experienced a more robust failure.
6.14 Supplementation of the NAD+ supply pathway
Evidence is accumulating that a lack of bioavailable NAD+ may underline a number
of pathologies associated with aging. As such, strategies to prevent or overcome this
metabolic decline could have therapeutic benefit. During the course of my experiments I
observed an upregulation in the expression of Nrk1, the enzyme responsible for converting
NR to NAD+, in the pancreas and liver of Nampt KO mice. This increase was also seen in
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the aorta and brain of Nampt KO mice during previous work in our lab measuring Nrk1
expression. NR is a naturally occurring precursor to NAD+ that is easy to obtain and
deliver. I attempted to circumvent the lethality of Nampt knockout with NR
supplementation. NR did not ultimately succeed in eliminating the lethal effects of Nampt
knockout. However, it did strikingly double the lifespan of the Nampt knockout mouse.
This was particularly impressive given the otherwise rapid decline in mouse health. The
reason why the beneficial effect of NR supplementation was not sustained is unclear.
Regardless, the ability of NR to slow and transiently reverse the decline in mouse health, in
the setting of profound, widespread impairment of NAD+ synthesis, holds promise for
conditions of less severely impaired NAD+ metabolism.
6.15 Future directions of Nampt knockout and NAD+ supplementation therapy
NR is a molecule found in dietary sources, and such would be a nutrient
supplement. My findings thus constitute a novel example of a defect in an essential gene
that can be reversed, at least partially, with a nutritional supplement. Most examples of
genetic disorders treated by diet involve the omission of a nutrient that might be
problematic. For example, phenylketonuria is the absence or deficiency in phenylalanine
hydroxylase, an enzyme involved in metabolizing or converting phenylalanine into
tyrosine, and patients are managed by following a diet that limits phenylalanine (found in
foods that contain protein). Future studies to determine which tissues are most able to
withstand Nampt knockout when supplemented with NR would be an important step to
then designing therapeutic trials.
6.16 Summary
As described in this thesis, the NAD+-regenerating enzyme Nampt is critical to the
resistance of hemodynamic and oxidative stress insults that are experienced by SMCs in
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the aortic media. Depletion of Nampt in SMCs leads to an overwhelming increase in the
burden of DNA lesions, which may push these cells to a senescent phenotype. Nampt
depletion is also associated with a decrease of collagen production and assembly, along
with an increase in proteoglycan deposition, further leading the instability of the aorta. In
the face of a life-long accumulation of stresses that may serve to shift Nampt expression
and NAD+ levels to pathologically low levels, strategies of supplementation with
exogenous NAD+ precursors may help to buffer against the consequences. However, the
need for a local Nampt-dependent regeneration of NAD+ may never be overcome in certain
tissues, and disturbed NAD+ metabolism may be the nexus on which the fate of a cell
hinges. Collectively, my findings reveal new processes by which SMCs stay healthy and
functional, with important implications for mitigating the consequences of the
accumulation of the stresses that push blood vessels, and other organs, to catastrophic
failure.
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APPENDIX I - GENE WRITING CONVENTIONS
DNA
cDNA
Genotypes*
mRNA
Protein

Human
NAMPT
NAMPT
NAMPT
NAMPT

Mouse
Nampt
Nampt
Nampt
Nampt
Nampt

*

Gene symbols are italicized when published, as are allele symbols. Transgenes, which are not part of the native
genome, are not italicized (from JAX)

For reference, see:
http://www.jci.org/kiosk/publish/genestyle
http://www.biosciencewriters.com/Guidelines-for-Formatting-Gene-and-ProteinNames.aspx
http://www.informatics.jax.org/mgihome/nomen/gene.shtml#gaas
http://www.genenames.org/about/guidelines#Appendix1
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